Author Archives: author

Re-evaluating Corporate Diversity Initiatives: Leveraging Social Identity Theory

DOI: 10.31038/PSYJ.2025721

Abstract

Corporate Diversity, Equity, and Inclusion initiatives have historically aimed to address systemic inequities in the workplace. However, in recent years, these efforts have faced increasing political, legal, and financial challenges, leading many organizations to scale back or reassess their diversity strategies. Critics argue that certain diversity programs, such as mandatory diversity training and affirmative action policies, may unintentionally reinforce stereotypes, generate resistance, and create workplace divisions. This paper explores how Social Identity Theory can enhance inclusion efforts. By understanding how individuals form social identities and perceive ingroups and outgroups, organizations can implement more effective diversity strategies that foster collaboration rather than division. The paper highlights the importance of promoting a superordinate identity that unites employees under shared organizational goals, reducing intergroup tensions.

Keywords

Diversity, Social identity theory

Corporate diversity initiatives were introduced as a response to historical discrimination faced by certain groups, which led to systemic adversities and underrepresentation in modern workplaces. However, in recent years, many companies have scaled back their diversity efforts due to political pressures, legal challenges, and financial considerations. A backlash against corporate diversity initiatives has emerged, with critics labeling them as “woke” and divisive. The reasons for this backlash are multifaceted. Research indicates that mandatory diversity training can increase prejudice and resistance, particularly when perceived as coercive. Additionally, diversity communications that emphasize group differences may unintentionally reinforce stereotypes rather than mitigate them. Affirmative action programs (AAPs) can also stigmatize their beneficiaries, potentially leading to lower performance and negative perceptions from colleagues [1]. Despite this backlash, revisiting the foundational principles of diversity—rooted in fairness and equity—remains crucial. While certain aspects of diversity initiatives require reevaluation, there is value in identifying strategies to improve their effectiveness. This paper explores how the social identity lens can enhance inclusion initiatives and address challenges associated with diversity implementation.

Why Diversity Programs Fail

Diversity programs often fail due to poor implementation, unintended consequences, and resistance from stakeholders. Scholarly work has illuminated the complex reasons behind the diversity initiatives. Drawing upon the insights of Burnett and Aguinis and Dobbin and Kalev [2], we elucidate the multifaceted causes that contribute to the underperformance—and even backfiring—of many DEI (Diversity, Equity, Inclusion) programs. A fundamental issue can be the misalignment between DEI initiatives and the organization’s core strategic objectives. When diversity efforts are designed as isolated, symbolic gestures rather than integrated components of the organizational mission, they tend to become superficial. Such tokenistic approaches often fail to address underlying structural inequities and may even trigger counterproductive responses among employees who perceive these measures as insincere or merely performative. Additionally, without clear metrics and timely feedback, organizations are unable to detect unintended consequences or recalibrate their strategies effectively. The traditional diversity training programs have lacked innovation in their approach. Many diversity initiatives are overly reliant on one-off training sessions, which often produce only transient attitudinal changes. Such programs can inadvertently prompt defensive reactions, particularly among majority group members, thereby reinforcing preexisting biases. Moreover, initiatives that depend solely on tools like mentoring programs or diversity committees tend to lack the structural support and accountability necessary for sustained impact. The absence of comprehensive policies and clear performance incentives further undermines these efforts.

Authentic leadership holds the key to successful initiatives, whether rooted in diversity or not. Genuine commitment from senior management is critical; without it, even well-conceived diversity initiatives are likely to flounder. Leadership that fails to align rhetoric with tangible actions generates skepticism among employees, contributing to disengagement and resistance. In essence, diversity programs must be underpinned by a visible and consistent commitment from the top echelons of management to transform organizational culture effectively. Another significant barrier is the misalignment of incentives within the organizational framework. Diversity initiatives that are not fully embedded into broader human resource and performance management systems often lack the necessary reinforcement to drive long-term change. When diversity efforts are seen as add-ons rather than integral to the company’s operational fabric, they may falter in the face of entrenched cultural norms and existing power structures.

Overall, the failure of DEI initiatives can be attributed to several interrelated factors: inadequate design and integration, overreliance on ineffective training methods, insufficient leadership commitment, and misaligned organizational incentives. Scholarly work advocates for evidence-based frameworks that align diversity efforts with the organization’s strategic priorities, emphasize accountability, and foster a culture of continuous learning and adaptation. Addressing these challenges is essential for transforming diversity initiatives from symbolic gestures into sustainable drivers of organizational change. Approaching from a cognitive lens, DEI initiatives can be seen as both a challenge to deeply held beliefs about meritocracy and fairness and a constraint on individual and organizational autonomy, leading to resistance [3]. Individuals with privileged identities may perceive increasing diversity as a threat to their social status. Those who believe their status is earned tend to view DEI as unjust. This reflects a zero-sum mindset, in which benefits to one group are seen as disadvantaging another. Research supports this perception, showing that individuals benefiting from diversity initiatives often face negative evaluations. Another source of diversity resistance is the belief that such initiatives restrict autonomy in decision-making and workplace practices. Diversity efforts often introduce structured hiring and evaluation processes (e.g., standardized interviews) to mitigate bias, but these measures can be perceived as limiting individual discretion. Autonomy is a fundamental motivator, and when individuals feel their freedom is constrained, they may resist these changes.

Corporate Responses Amid Legal, Political, and Financial Challenges

The last few years have witnessed a concerted withdrawal of corporations from obvious as well as subtle diversity policies [4]. Critics have increasingly opposed corporate diversity programs, arguing that these efforts may lead to reverse discrimination against majority groups. For example, Elon Musk criticized DEI initiatives as “exclusionary” and divisive, aligning with a broader backlash against such efforts [5]. Similarly, major technology companies such as Google and Meta have significantly reduced their diversity programs in response to political and legal scrutiny [6].

The 2023 Supreme Court ruling against affirmative action in college admissions has also influenced corporate diversity policies. This decision has raised concerns about the legality of workplace diversity programs, prompting companies to scale back efforts to avoid potential litigation [7]. Economic downturns and financial constraints have led many organizations to deprioritize DEI initiatives. During times of economic uncertainty, diversity programs are often viewed as nonessential expenditures. For instance, Google and Meta have reduced diversity teams as part of broader cost-cutting measures (CNBC, 2024). Lowe’s has also scaled back its diversity initiatives by consolidating employee resource groups and ceasing participation in diversity surveys to streamline operations (Forbes, 2024). Critics argue that such budget-driven decisions undermine long-term equity and inclusion goals (Forbes, 2024). Additionally, some organizations have questioned the effectiveness of diversity programs. Research suggests that poorly implemented DEI initiatives may inadvertently exacerbate divisions by emphasizing differences rather than fostering unity. Musk’s critique aligns with this perspective, as he contends that diversity programs often intensify tensions rather than alleviate them (Forbes, 2024).

Social Identity Theory and DEI

Social Identity Theory (SIT) [8] explains how individuals derive a sense of self from their group memberships. People categorize themselves and others into social groups (e.g., nationality, religion, profession), forming an ingroup (us) and defining outgroups (them). To enhance self-esteem, individuals favor their ingroup and may discriminate against outgroups. This process strengthens group cohesion but can lead to bias, stereotyping, and intergroup conflict. The theory underpins phenomena like nationalism, workplace dynamics, and discrimination, highlighting how social structures shape identity and behavior. In the context of diversity initiatives, social identities can mobilize an “us versus them” mentality, leading to the alienation of groups and undermining the purpose of such initiatives. However, the foundational premises of social identity can also be employed to mitigate the shortcomings of diversity initiatives. In competitive settings, where the team is represented as a “social identity”, then individuals are willing to set aside their personal preferences so as not to let their peers down. These results highlight the potential for leveraging social identity to drive philanthropic efforts, reinforcing that structuring charitable campaigns around group affiliation and competition can enhance social welfare [9]. Waldman and Sparr (2023) argue that an overemphasis on distinctiveness can sow divisions among individuals. They propose embracing the paradox that unity and diversity are concomitant, suggesting that diversity initiatives must highlight this balance. DEI efforts should frame all organizational members as equally deserving of organizational capital while acknowledging the lived experiences of disadvantaged groups without attributing guilt to majority groups. An integrative approach to diversity should articulate a collective identity that fosters collaboration and inclusivity.

Enhancing DEI Training with Insights from Social Identity Theory

While the tenets of SIT have hitherto been used to explicate prejudice, and in/out group bias, we propose to use the same foundations to enhance the effectiveness of diversity initiatives for organizations that see value in the inherent principle of a diverse workplace. Understanding social identity and its impact on group processes can enhance the effectiveness of diversity training by leveraging psychological mechanisms that drive intergroup behavior and fostering meaningful engagement among participants. The foundational step for organizations is to promote a superordinate identity that transcends traditional markers such as race, gender, and ethnicity. After all, the concept of “social” identity is validated through its social interpretation and construction. Organizations can actively shape this construct by fostering an inclusive framework that unites individuals from diverse backgrounds, thereby creating a supra-social identity that reinforces collective belonging and purpose. This identity can be at the level of the organization or even a department (depending on the size of the organization). Evidence supports the notion that superordinate identity reduces ingroup favoritism, a tendency for individuals to prefer their own groups over others [10,11]. Individuals are more likely to trust and engage with those they perceive as part of their social identity group (here a department). Thus, organizations should cultivate a superordinate identity that transcends subgroup distinctions, fostering a collective sense of belonging.

Furthermore, knowledge transfer within organizations is more effective when individuals perceive themselves as sharing a superordinate identity. It is seen that that knowledge exchange was more successful when both the sharer and recipient identified with a superordinate social identity [12]. Applying this principle to diversity training suggests that structuring training groups with a focus on collective identity can improve program outcomes. To implement this strategy, organizations should frame diversity initiatives within the larger mission of the company. When diversity is positioned as integral to the organization’s overarching goals, employees are more likely to perceive it as beneficial to all rather than an effort aimed at specific subgroups. Establishing this shared identity can be reinforced through company-wide meetings, collaborative projects, and social events that highlight common values and objectives. By fostering a sense of shared purpose, diversity initiatives can reduce resistance and ingroup favoritism while increasing effectiveness. After the initiation of a superordinate identity, the following specific strategies can be adopted into integrative DEI actions:

Leverage Ingroup Favoritism for Positive Outcomes

Social Identity Theory suggests that individuals naturally favor ingroup members. Ingroup favoritism occurs because individuals view their group status as an integral part of their social identity, shaping perceptions of fairness and resource distribution [13]. In contexts where resources such as promotions or leadership opportunities are perceived as limited, ingroup bias can contribute to resistance against DEI efforts. However, organizations can leverage preferences for ingroup to enhance DEI effectiveness. By aligning diversity initiatives with the group’s overarching goals, organizations can frame diversity as essential to achieving broader success for the group. For example, when teamwork and innovation are organizational priorities which gives them a competitive edge against the competing companies, highlighting diversity’s role in fostering creative collaboration can help reposition diversity as an asset rather than a challenge [14]. Furthermore, reinforcing a common identity among employees can redirect ingroup favoritism toward collective organizational success. When individuals perceive diversity initiatives as benefiting the entire workforce rather than specific subgroups, resistance diminishes. By strategically framing DEI efforts as tools for strengthening the organization as a whole, companies can transform potential ingroup biases into drivers of inclusion and cooperation.

Address the Double-Edged Nature of Trust

The study of trust within diverse communities has been a prominent topic in academic research, yet findings remain inconclusive regarding the extent to which both actual and perceived dimensions of ethnic diversity influence intergroup trust [15]. Trust among ingroup members can contribute to both positive and negative outcomes, particularly in the context of diversity initiatives. While trust facilitates cohesion and collaboration, it can also lead to reduced vigilance regarding harmful biases and risks [16]. By increasing awareness of these dynamics, diversity training programs can promote more mindful and inclusive decision-making among participants. A critical mechanism through which SIT can enhance diversity initiatives is by addressing the complex nature of trust. Trust is intrinsically linked to social identity, as decades of research have demonstrated that individuals tend to exhibit greater trust toward members of their own social group [17]. Given that social identification serves as a fundamental driver of trust, it is imperative to recognize both its advantages and its potential drawbacks. DEI training can be designed to educate participants on how shared identity influences trust and risk perception, thereby enabling program leaders to highlight both the benefits and the inherent biases associated with trust. Furthermore, an important consideration is the relationship between trust and diversity within organizational groups. Research indicates that individuals are more likely to trust ingroup members over outgroup members, even when assessing facial expressions, as even “untrustworthy faces were trusted more and perceived as less risky when they were ingroup members compared with outgroup members”. A study by Assche et al. suggests that the distinction between ingroup and outgroup perceptions is primarily shaped by ingroup favoritism rather than deliberate discrimination. Understanding these trust-related dynamics is crucial for the successful implementation of diversity initiatives. An introduction of a supra-identity as an “in-group” (we are innovators, change-makers, etc.) will subtly lead to trust within this scope of identity rather focus on the categories of race and gender. A trust that transcends barriers of hitherto emphasized dimensions of diversity will lead to an integrative workforce.

Identity to Foster Solidarity

An additional application of SIT in enhancing diversity training programs involves utilizing identity to cultivate solidarity within organizations. Shared experiences serve as a powerful mechanism for fostering connections among individuals from diverse backgrounds, allowing them to perceive their individual identities as part of a broader, superordinate identity. This principle can be strategically integrated into workplace diversity training to strengthen intergroup cohesion. Craig et al. found that recognizing parallel forms of discrimination across different groups fosters solidarity and collective action, suggesting that identifying common ground in lived experiences can inspire collaboration and promote interpersonal understanding. Furthermore, research in social learning theory has demonstrated that individuals are more likely to adopt new behaviors when they identify with those modeling them i.e. their in-group members, underscoring the role of social identity in shaping learning and behavioral adaptation [18,19].

Organizations can leverage this principle by incorporating narratives and discussions that highlight shared experiences of discrimination or exclusion, thereby cultivating solidarity across diverse groups. While the severity of discrimination may vary among individuals, acknowledging that exclusion is a common human experience can facilitate meaningful dialogue and foster mutual understanding. However, it is crucial for DEI training leaders to balance this approach carefully. Overemphasizing disparities in discriminatory experiences may inadvertently reinforce division rather than unity. Instead, centering the discussion on shared experiences—particularly those related to social exclusion—can enhance perceptions of similarity among participants. This, in turn, fosters collaboration, psychological safety, and a sense of collective identity, ultimately contributing to the effectiveness of diversity training initiatives.

Tailor Communication Strategies

Effective communication is a fundamental component of successful organizational dynamics. SIT provides valuable insights into optimizing message delivery. Research suggests that individuals are more receptive to messages conveyed by those they perceive as members of their ingroup (Greenaway et al., 2014). In other words, people are more likely to engage with and internalize information when the communicator shares aspects of their social identity, a common experience in that organization or department. Therefore, for diversity training to be effective, it is essential to frame messages in ways that resonate with participants’ shared identities, thereby increasing receptivity and engagement. To maximize the effectiveness of diversity training programs, organizations must equip trainers with the skills to align messaging with the social identity of their audience. This requires a comprehensive understanding of participant demographics, social affiliations, and collective experiences to identify which aspects of shared identity can be leveraged for engagement. Trainers should employ culturally sensitive communication, utilize inclusive language, and adapt their delivery to accommodate diverse learning styles. Additionally, the mode of communication should be tailored to the audience’s preferences, whether through interactive discussions, visual presentations, or experiential learning exercises. For example, a DEI training program in a multinational corporation may encounter employees from diverse cultural and professional backgrounds. If the training emphasizes a shared corporate identity—such as a commitment to innovation, ethical leadership, or teamwork—it is more likely to resonate with employees regardless of their cultural differences. By framing diversity initiatives within the broader mission and values of the organization, trainers can foster a sense of unity and collective purpose, ultimately enhancing engagement and the program’s overall effectiveness.

Incorporate Realistic Role-Playing Scenarios

Incorporating role-playing into diversity training programs is an effective application of SIT, as it enables participants to engage with theoretical principles in a practical setting. Given the diversity of learning styles, role-playing serves as a dynamic pedagogical tool that allows individuals to explore various social scenarios, develop problem-solving skills, and experience firsthand the impact of inclusive behaviors. In the context of DEI training, role-playing facilitates the understanding of how fostering a superordinate identity—one that transcends individual group memberships—can lead to improved interpersonal relationships and collective outcomes. By designing exercises that simulate real-world intergroup interactions, diversity trainers can demonstrate how shared goals reduce biases and enhance trust among diverse groups. Adopting roles of individuals within one’s superordinate social group, will allow individuals to reflect on their unique challenges as a key towards bettering the collective experience of the larger group. Role-playing fosters empathy through perspective-taking, heightens awareness of power dynamics, and encourages critical reflection on privilege and systemic inequities. Moreover, it provides a structured environment in which participants can engage in difficult conversations and practice conflict resolution and de-escalation strategies. Through immersive, scenario-based learning, trainees refine their ability to navigate complex social interactions and respond to challenges in real time.

For example, a role-playing exercise could involve a workplace scenario in which employees of different cultural backgrounds collaborate on a high-stakes project. Through random selection, one participant may be assigned the role of a supervisor tasked with ensuring inclusivity in decision-making, while another may play an employee who feels marginalized. Through guided interaction, participants can explore how inclusive leadership strategies—such as active listening, acknowledging different perspectives, and reinforcing a shared corporate identity—can create a more cohesive and productive team dynamic. By actively engaging in such exercises, participants internalize the principles of social identity and inclusive communication, leading to more effective and sustainable diversity practices within organizations (Figure 1).

Figure 1: Leveraging social identity theory in DEI initiatives.

Conclusion

Research confirms that targeted initiatives play a crucial role in ensuring that organizations operate fairly and adhere to scientifically validated best practices. For instances, practices like structured interviews reduce bias by standardizing questions and evaluations, blind resume reviews have been shown to reduce bias and increase the hiring of underrepresented candidates. Retention efforts, including employee resource groups (ERGs) and mentorship programs, support minoritized employees’ career growth. Despite resistance, these initiatives demonstrably enhance workplace equity and inclusion (Nittrouer et al., 2025). The evolving landscape of corporate diversity initiatives underscores the complexities and challenges associated with fostering inclusive work environments. While diversity programs emerged in response to historical inequities, recent trends indicate a retrenchment of these efforts due to political, legal, and economic pressures. Critics argue that certain diversity strategies, particularly mandatory diversity training and affirmative action policies, may inadvertently reinforce bias, create resistance, and contribute to workplace divisions. The backlash against corporate DEI programs highlights the need for a more nuanced and effective approach to inclusion—one that aligns with organizational goals while addressing concerns surrounding fairness and meritocracy. A key insight from SIT is that intergroup dynamics shape individuals’ perceptions, behaviors, and willingness to engage in inclusive practices. Traditional diversity efforts often fail when they emphasize group differences rather than fostering a shared, superordinate identity. By framing diversity initiatives around common organizational goals and values, companies can reduce intergroup tensions and promote collaboration. Research suggests that individuals are more likely to trust and engage with those they perceive as part of their ingroup, a principle that can be leveraged to enhance DEI effectiveness. Initiatives that position diversity as integral to broader organizational success—rather than as a separate, compliance-driven mandate—are more likely to gain traction among employees. Moreover, diversity training can be significantly improved by adopting communication strategies that resonate with participants’ identities, tailoring messaging to align with shared experiences and cultural contexts. Role-playing exercises and experiential learning techniques offer practical avenues for reinforcing inclusive behaviors, helping employees navigate complex social interactions, and mitigating biases. By integrating these strategies, organizations can shift from a compliance-oriented approach to one that fosters genuine engagement and long-term cultural transformation.

Additionally, the role of trust in shaping intergroup interactions cannot be overlooked. While trust within ingroups enhances cohesion, it may also lead to risk discounting and exclusionary tendencies. Addressing the double-edged nature of trust within diversity frameworks requires emphasizing common experiences of exclusion and fostering a collective identity that transcends racial, gender, and other demographic categorizations. This approach encourages employees to view diversity not as a zero-sum endeavor but as a means of strengthening organizational unity and effectiveness. Ultimately, the success of diversity initiatives depends on their ability to create inclusive environments that benefit all employees. Organizations must move beyond performative commitments and symbolic policies toward substantive, research-backed strategies that integrate social identity principles. By prioritizing a superordinate identity, leveraging trust dynamics constructively, and refining communication and training methodologies, diversity programs can become more sustainable and impactful. The future of workplace diversity hinges not on coercion or division but on fostering a sense of belonging that aligns with the collective mission of organizations.

References

Burnett L, Aguinis H (2024) How to prevent and minimize DEI backfire. Business Horizons, 67: 173-182.
Dobbin F, Kalev A (2016) Why diversity programs fail. Harvard Business Review, 94: 14.
Nittrouer CL, Arena Jr D, Silver ER, Avery DR., Hebl MR (2025) Despite the haters: The immense promise and progress of diversity, equity, and inclusion initiatives. Journal of Organizational Behavior, 46: 188-201.
Gonzalez A (2024) The corporate retreat from DEI: A short-sighted strategy. Forbes.
Harmeling S (2023) I hate to admit Elon Musk raises a fair point on DEI. Forbes
Weinberg C (2023) Google, Meta, and other tech giants cut DEI programs in 2023. CNBC
Winkler R (2024) Why companies are scaling back DEI in America. Bloomberg
Tajfel H, Turner JC (1979) An integrative theory of intergroup conflict. In W. G. Austin & S. Worchel (Eds.) The social psychology of intergroup relations (pp. 33–47) Brooks/Cole.
Charness G, Holder P (2019) Charity in the laboratory: Matching, competition, and group identity. Management Science, 65: 1398-1407.
Gaertner SL, Dovidio JF.(2000) Reducing intergroup bias—The common ingroup identity model. Psychology Press.
Brewer MB, Brown RJ (1998) Intergroup relations. In D. T. Gilbert, S. T. Fiske, & G. Lindzey (Eds.) Handbook of social psychology. McGraw-Hill. 2: 554–594
Kane AA., Argote L, Levine JM (2005) Knowledge transfer between groups via personnel rotation: Effects of social identity and knowledge quality. Organizational Behavior and Human Decision Processes, 96: 56–71.
Cruwys T, Greenaway KH, Ferris LJ, Rathbone JA, Saeri AK et al (2021) When trust goes wrong: A social identity model of risk-taking. Journal of Personality and Social Psychology, 120: 57. [crossref]
Greenaway KH, Wright RG, Willingham J, Reynolds KJ, Haslam SA (2014) Shared identity is key to effective communication. Personality and Social Psychology Bulletin, 41: 171–182. [crossref]
Van Assche J, Ardaya Velarde S, Van Hiel A, Roets A (2023) Trust is in the eye of the beholder: How perceptions of local diversity and segregation shape social cohesion. Frontiers in Psychology, 13: 1036646
Craig MA, Badaan V, Brown RM (2020) Acting for whom, against what? Group membership and multiple paths to engagement in social change. Current Opinion in Psychology, 35: 41-48. [crossref]
Spadaro G, Liu JH, Zhang RJ, Gil de Zúñiga H, Balliet D (2024) Identity and institutions as foundations of ingroup favoritism: An investigation across 17 countries. Social Psychological and Personality Science, 15: 592-602.
Shteynberg G., Apfelbaum EP (2013) The power of shared experience: Simultaneous observation with similar others facilitates social learning. Social Psychological and Personality Science, 4: 738-744.
Chae J, Kim K, Kim Y, et al (2022) Ingroup favoritism overrides fairness when resources are limited. Scientific Reports, 12: 4560.

Commentary: Comparative Efficacy of Exercise Interventions for Cognitive Health in Older Adults

2 Replies

DOI: 10.31038/JCRM.2025815

Introduction

With the global population aging rapidly, the prevention of cognitive decline in older adults has become a top public health priority. While pharmacological treatments for dementia and cognitive impairment remain limited in efficacy, growing evidence from Randomized Controlled Trials (RCTs) and meta-analyses highlights structured exercise as a promising non-pharmacological approach. However, uncertainties remain regarding the most effective types of exercise, as well as the optimal frequency and duration for cognitive benefits.

Key Findings from Recent Network Meta-Analyses

Our recent network meta-analyses, synthesizing data from over 50 high-quality RCTs and nearly 4,000 older adults across multiple regions, reveal clear patterns of domain-specific cognitive benefits conferred by different exercise modalities:

Resistance Training: Demonstrates the strongest effect on global cognitive function and inhibitory control. The optimal protocol involves twice-weekly sessions of 45 minutes over at least 12 weeks. This modality appears particularly beneficial for executive domains, likely linked to increased brain-derived neurotrophic factor (BDNF) and improved neural plasticity.
Mind-Body Exercise (e.g., Tai Chi, Yoga): Most effective for improving task-switching ability and working memory, suggesting that physical-mental engagement can enhance cognitive flexibility and processing speed. Moderate frequency (≥3 times/week) and moderate session length (45–60 minutes) are recommended.
Aerobic Exercise: Provides the greatest improvement in memory function, with the optimal effect achieved by longer-term interventions (≥21 weeks), twice per week, and sessions of at least 60 minutes.
Multicomponent Exercise: Offers moderate benefits across cognitive domains, though generally less pronounced than single-modality protocols optimized for specific outcomes.
HIIT: Limited but emerging evidence suggests possible benefits for executive function; more robust studies are needed.

These findings underscore the importance of individualized exercise prescriptions, tailored not only to the overall goal of cognitive maintenance but also to specific domains most relevant for the target population.

Practical Recommendations

For older adults aiming to preserve overall cognitive health and executive function, resistance training should be prioritized.
Those wishing to improve working memory and cognitive flexibility may benefit most from mind-body exercises.
To enhance episodic and verbal memory, aerobic training is especially effective.
Intervention frequency, session duration, and program length all matter: Moderate-to-high frequency (2–3 times/week), session duration of 45–60 minutes, and program lengths of 12–24 weeks yield the most pronounced cognitive gains.

Subgroup analyses further indicate that adults aged 65–75 and Asian populations may experience the greatest benefits, emphasizing the potential need for culturally tailored interventions.

Conclusion

Current evidence strongly supports the integration of structured exercise—especially resistance training, mind-body, and aerobic modalities—into dementia prevention and healthy aging strategies. Personalized, domain-specific exercise prescriptions, aligned with individual cognitive profiles and preferences, are essential for optimizing cognitive benefits in older adults.

Mechanisms of Kidney Dysfunction in the Cirrhotic Patient: Non-hepatorenal Acute-on-Chronic Kidney Damage Considerations

2 Replies

DOI: 10.31038/CST.20251022

Cirrhosis is a worldwide health problem: by 2019, cirrhosis was associated with 2.4% of global deaths, with obesity and alcohol consumption becoming its leading etiologies as improved outcomes in the treatment of Hepatitis C and hepatitis B virus decreases the number of viral hepatitis associated cirrhosis.

Among patients who live with chronic liver disease, kidney dysfunction spectrum, including kidney frailty, subclinical acute kidney Injury (SAKI), acute kidney injury (AKI), Acute Kidney Disease (AKD), Chronic Kidney Disease (CKD) and End Stage Kidney Disease (ESKD) are among the most common extrahepatic complications along the natural history of cirrhosis.

Given the known nature of the human body as a complex unified homeostatic system, it has been largely recognized that multiple organ involvement is an expected phenomenon in pathologies affecting primarily a specific organ, both because of clinical observation and theoretical biological sense.

However, only in the last decades, advances in molecular biology, imaging technology and large clinical trials have allowed the physiopathological pathways of multiorgan crosstalk to be described.

In cirrhotic patients specifically, kidney involvement has been largely explained in terms of hepatorenal syndrome. However, given the complex natural history of cirrhosis, a myriad of clinical events, as well as newly described histopathological pathways should also be taken into account when evaluating a specific clinical scenario, as multifactorial is the most plausible etiology for most kidney injury events, and mutually exclusive physiopathological pathways are rarely seen.

As an example, during an acute-on-chronic liver failure episode, a single patient may present with both Hepatorenal Syndrome and bile cast nephropathy, while also at risk for contrast-media induced AKI during the diagnostic approach.

In 2020, the manuscript “Mechanisms of Kidney Dysfunction in the Cirrhotic Patient: Nonhepatorenal Acute-on-Chronic Kidney Damage Considerations.” briefly summarizes some of the most important non-prerenal, non-HRS considerations regarding acute-on-chronic kidney dysfunction in cirrhotic patients, including renal manifestations related to non-alcoholic steatohepatitis (NASH), viral hepatitis, cardiorenal syndrome, cirrhotic cardiomyopathy, and corticosteroid-deficiency associated renal dysfunction.

The manuscript highlights the importance of multiorgan crosstalk pathways to be considered as interconnected gears to be understood and described when approaching the clinical trajectory of renal function within the natural history of cirrhosis and, more importantly, within the clinical trajectory of multiorgan interaction during a specific patient’s clinical course.

As an example, endocrine dysfunction—including thyroid dysfunction, metabolic dysfunction-associated steatohepatitis (MASH), and obesity-related kidney dysfunction—should be considered in both the chronic and acute liver dysfunction follow-up of an obese cirrhotic patient.

Most importantly, a change in the basic clinical paradigm must be taken into account, as modern medicine has made evident the existence of the human body as an open homeostatic system, in which changes in the microbiota, pharmacological interventions, surgical procedures, extracorporeal therapies, and even transplantation physiological consequences must also be considered.

Hopefully, within the years to come, the use of computer systems, novel biomarkers and further understanding of multiorgan crosstalk will make feasible the development of novel, more efficient therapeutic approaches for the surveillance, preservation, and restoration of both liver and kidney function in cirrhotic patients, as well as the replacement of both liver and kidney function by either extracorporeal therapies, bioartificial organs, or transplantation [1-23].

References

Huang DQ, Terrault NA, Tacke F, et al. (2023) Global epidemiology of cirrhosis – aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. [crossref]
Nadim MK, Garcia-Tsao G (2023) Acute Kidney Injury in Patients with Cirrhosis. N Engl J Med. [crossref]
Nadim MK, Kellum JA, Forni L, et al. (2024) Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol. [crossref]
Flamm SL, Wong F, Ahn J, Kamath PS (2022) AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review. Clin Gastroenterol Hepatol. [crossref]
Juanola A, Pose E, Ginès P (2025) Liver Cirrhosis: ancient disease, new challenge. Med Clin (Barc). [crossref]
Trapecar M (2022) Multi-organ microphysiological systems as tools to interrogate interorgan crosstalk and complex diseases. FEBS Lett. [crossref]
Kumar R, Priyadarshi RN, Anand U (2021) Chronic renal dysfunction in cirrhosis: A new frontier in hepatology. World J Gastroenterol. [crossref]
Somaguna MR, Jain MS, Pormento MKL, et al. (2022) Bile Cast Nephropathy: A Comprehensive Review. Cureus. [crossref]
Belcher JM (2023) Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment. Med Clin North Am. [crossref]
Hisamune R, Yamakawa K, Umemura Y, et al. (2024) Association Between IV Contrast Media Exposure and Acute Kidney Injury in Patients Requiring Emergency Admission: A Nationwide Observational Study in Japan. Crit Care Explor. [crossref]
Piantanida E, Ippolito S, Gallo D, et al. (2020) The interplay between thyroid and liver: implications for clinical practice. J Endocrinol Invest. [crossref]
Ortiz-Olvera N, Muñoz-Bautista A, Molina-Ayala M, Gómez-Díaz RA, Morán-Villota S (2024) Disfunción tiroidea oculta en pacientes ambulatorios con cirrosis hepática. Rev Med Inst Mex Seguro Soc. [crossref]
Do A, Zahrawi F, Mehal WZ (2025) Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH). Nat Rev Drug Discov. [crossref]
Sandireddy R, Sakthivel S, Gupta P, Behari J, Tripathi M, Singh BK (2024) Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and MASH on heart, muscle, and kidney. Front Cell Dev Biol. [crossref]
Yau K, Kuah R, Cherney DZI, Lam TKT (2024) Obesity and the kidney: mechanistic links and therapeutic advances. Nat Rev Endocrinol. [crossref]
Raj D, Tomar B, Lahiri A, Mulay SR (2020) The gut-liver-kidney axis: Novel regulator of fatty liver-associated chronic kidney disease. Pharmacol Res. [crossref]
Muciño-Bermejo MJ (2022) Extracorporeal organ support and the kidney. Front Nephrol. [crossref]
Dong V, Nadim MK, Karvellas CJ (2021) Post-Liver Transplant Acute Kidney Injury. Liver Transpl. [crossref]
Rasaei N, Malekmakan L, Mashayekh M, Gholamabbas G (2022) Chronic Kidney Disease Following Liver Transplant: Associated Outcomes and Predictors. Exp Clin Transplant. [crossref]
Zhai Y, Hai D, Zeng L, et al. (2024) Artificial intelligence-based evaluation of prognosis in cirrhosis. J Transl Med. [crossref]
Juanola A, Ma AT, Pose E, Ginès P (2022) Novel Biomarkers of AKI in Cirrhosis. Semin Liver Dis. [crossref]
Nair G, Nair V (2022) Simultaneous Liver-Kidney Transplantation. Clin Liver Dis. [crossref]
De Bartolo L, Mantovani D (2022) Bioartificial Organs: Ongoing Research and Future Trends. Cells Tissues Organs. [crossref]

Diversity in Continuing Care Retirement Communities’ Leadership

2 Replies

DOI: 10.31038/AWHC.2025823

In 2020, one in six Americans were age 65 or older, with this segment expected to grow to one in five by 2030. Moreover, within the next 25 years, the number of Americans age 65 and over is expected to increase 47 percent to 82 million in 2050. Over this 25-year period, the U.S. also is projected to become significantly more racially and ethnically diverse. For example, those who identify as something other than a non-Hispanic white are expected to increase from 25 percent to 40 percent over this period. With this increase in the aging population, it is predicted that there will be a sharp increase in the need for both healthcare and housing for the elderly [1-5].

One option that combines both healthcare and housing for this segment is the continuing care retirement community (CCRC), sometimes called a life plan community. CCRCs offer a combination of healthcare, hospitality, insurance, and residential services to the aging population. Furthermore, most CCRCs offer an amalgamation of living arrangements and services including independent living, assisted living or personal care, memory care, short-term rehabilitative services, long term care, and hospice or end-of-life care. There are about 2,000 CCRCs in operation in the United States (U.S.), with this setting expected to increase considerably to meet the growing demand [6-8].

An issue (and an opportunity) for many of these CCRCs is the lack of diversity among their residents. Two recent surveys [9,10] find that 95 to 97 percent of all CCRCs’ residents are non-Hispanic white. It has been suggested that one barrier to CCRC diversity is due to the lack of diversity of its leadership [10]. Senior housing executives have begun to address this issue seeking to expand the percentage of senior executives and residents who identify as persons of color and female [11].

With this in mind, we surveyed chief executive officers (CEOs) of non-profit CCRCs. We surveyed non-profits as they represent 80 percent of all CCRCs in the U.S. [8]. Specifically, we surveyed CCRC CEOs whose organizations were members of Leading Age. Leading Age is an organization representing 5,000 non-profit and government organizations which offer aging services in adult day care centers, CCRCs, home health services, and other outreach programs.

Our interest, here, was to determine the demographic composition of CCRC CEOs and to discern their organizations’ efforts related to promoting diversity in their leadership ranks. This was a subset of questions that were part of a broader survey we did on CEO characteristics and skillsets [7]. We sent surveys to 999 CCRC CEOs. Related to our questions on diversity, 173 to 233 CEOs responded to the individual diversity questions. Thirty-eight percent of the CEOs who responded to our survey were women and 62 percent were men (N=233). Four percent identified as a person of color (N=230). We asked CEOs five questions related to expanding their CEO recruitment and other efforts related to underrepresented groups. These questions and their responses are:

Does your organization collaborate with recruiters who have expertise in sourcing racially and ethnically diverse candidates for the CEO position? 31 percent responded in the affirmative (N=189);
Does your organization have a formal succession planning process that considers racial and ethnic diversity for the CEO position? 35 percent responded in the affirmative (N=187);
On a scale of 1 to 10 with 1 as “not at all” and 10 as “extremely well,” how well do you believe the organization supports the career advancement and leadership aspirations of individuals from an underrepresented racial and ethnic minority Average score was 7.1 (N=173);
Does your organization have a formal mentorship program in place to support the career development of individuals from underrepresented groups into leadership roles? A mentor acts as a career guide and provides guidance, advice, feedback on skills, coaching, and strategizes career moves and professional 24 percent responded in the affirmative (N=189); and
Does your organization have a formal sponsorship program in place to support the career development of individuals from underrepresented groups into leadership roles? A sponsor invests in the person’s success and promotes them to other people to help advance their career. 21 percent responded in the affirmative (N=189).

As seen above, 21 to 35 percent of the CEO participants responded that their organizations are actively engaged in developing, mentoring, and sponsoring diverse leaders. Given this, it is apparent that more work is needed. We believe that CEOs should examine this as both a moral imperative and business opportunity. We agree with Garcia et al.’s overall statement about healthcare when they say “understanding and respecting diverse cultural backgrounds, including non-English languages and non-traditional health beliefs, is fundamental in ensuring equitable and effective healthcare services for the aging population. This can be achieved by…promoting diverse representation in the healthcare workforce to increase cultural competency and care”[2: 2]. Given this growing population, there is also a business case to be made as well, as the non-white population is growing significantly but remains grossly underrepresented as CCRC residents . Similar arguments can be made related to gender. Thus, our survey results of 38 percent female CEOs signifies that females are underrepresented in this role, as historically, female residents outnumber male residents four to one and almost three-fourths of all CCRC employees are female [11-14].

In order to increase diversity executive efforts, CCRCs may wish to create more diverse boards. As noted elsewhere, CCRC board members are less diverse than CCRC CEOs [12]. The election of a more diverse board may increase the number of CEOs with a diverse background. As Dr. Patricia Maryland, CEO of St. John Health, notes “a diverse board is more apt to hold the organization accountable and insist on recruitment of diverse leaders” [15: 303]. In addition, CCRCs also may wish to develop more focused marketing campaigns for these types of residents and executive candidates [13], and provide richer more diverse program offerings [9], the latter of which may be unknown to the current population of CCRC CEOs.

The present study has sought to show the efforts of CCRCs related to leadership diversity development. Some improvement has been made in this regard; yet more progress is needed.

References

Administration for Community Living (2022) 2021 profile of older Available from: https://tinyurl.com/yeymrnv5.
Garcia C, Brown, LL, Garcia, MA (2024) How can America support the health of its diverse aging population. Center for Aging and Policy Studies, Syracuse Available from: https://surface.syr.edu/cgi/viewcontent.cgi?article=1257& context=lerner.
Mather, Scommegna P (2024) Fact sheet: aging in the United States. Population Reference Bureau. Available from: https://tinyurl.com/ya7wy9da
S. Census Bureau (2023) 2023 National population projections datasets. Available from: https://www.census.gov/data/datasets/2023/demo/popproj/2023-popproj.html.
Rogoz A (2024) The road ahead: senior housing trends to watch in Multi- Housing News, December 18, 2024.
Hurley RE, Brewer KP (1991) The continuing care retirement community executive: a manager for all seasons. Hospital & Health Services Administration, 36(3), 365-381. [crossref]
Williams, R, Fleming, S. P, Stone R (2025) Non-profit Continuing Care Retirement Center CEOs: Who Are They and What Do They Do. Journal of Health and Human Services Administration.
Miller KEM, Zhao J, Laine LT, Coe NB (2023) Growth of private pay senior housing communities in metropolitan statistical areas in the United States: 2015–2019. Medical Care Research and Review, 80(1): 101-108. [crossref]
Khan M, O’Brien C, Desai P (2023) Working toward greater resident diversity in life plan Mather Institute. Available from: https://www.matherinstitute.com/wp-content/uploads/.2023/06/MI_DiversityInLPCReportFNL.pdf?hsCtaTracking=6ee9bac2-4d84-4f8e-a6d0-3ee3186d6ea0%7C008edbff-6638-4a40-a3fa-daa45c4ce9a8.
Love (2018) Diversity in Senior Living Communities: insights into creating a more diverse Available From: https://loveandcompany.com/flipbooks/ diversity/?page=1.
Ferguson Partners (2023) 2023 senior living DEIB survey, executive summary. Available From: https://www.argentum.org/wp-content/uploads/2024/01/2023-Senior-Living-DEIB-Executive-Summary-003.pdf?hsCtaTracking=c46bd7ca-7abd-46f4-9e3b-7ded8ab47429%7Cd1227f98-600c-48f8-a455-0c4a0c639608.
Regan T (2018) Life plan communities failing to attract diverse resident Senior Housing News. July 23, 2018. Available From: https://rb.gy/9eo1x9 respectively.
Johnson JH, Parnell AM, Johnson TJ (n.d.) Race and residence in continuing care retirement communities/life plan Frank Hawkins Kenen Institute of Private Enterprise Conference Proceedings. Found at https://cdn.ymaws.com/www.leadingagenc.org/resource/resmgr/inclusioninsights/raceandresidenceinccrcs.pdf.
McCann M, Kafader S, Rose J, Dellaria D (2013) The hidden male: challenges for men entering and living in a retirement community. McKnights Long Term Care News. November 20, 2013. Available from: https://www.mcknights.com/blogs/ guest-columns/the-hidden-male-challenges-for-men-entering-and-living-in-a- retirement-community/.

Pediatric Primary Care Perspectives on Feasibility and Implementation of On-Site Cancer Testing: A Mixed-Methods Study

2 Replies

DOI: 10.31038/CST.20251021

Abstract

Early detection of pediatric cancers is critical to improving outcomes, yet diagnostic delays remain a persistent challenge. On-site cancer testing in pediatric primary care may expedite diagnosis and enhance care delivery; however, provider perspectives on feasibility and implementation are underexplored.

This mixed-methods study utilized surveys and semi-structured interviews with pediatric primary care providers to assess perceived benefits, barriers, and resource needs. Providers strongly supported the potential of on-site testing to improve care coordination and reduce diagnostic delays. Key barriers included insufficient training, limited resources, and workflow disruptions.

To ensure successful implementation, participants highlighted the need for targeted education, integration with existing clinical workflows, and infrastructure support. These findings suggest that while on-site cancer testing is promising, addressing practical challenges through tailored strategies is essential. Future research should focus on pilot implementation to assess feasibility and scalability in real-world settings.

Keywords

Pediatrics, Cancer screening, On-site testing, Provider views, Feasibility, Implementation, Delays

Introduction

Pediatric cancers account for a relatively small proportion of all cancers, but they remain a leading cause of disease-related mortality in children worldwide. Globally, an estimated 400,000 children develop cancer each year, and although survival rates have improved in high-income countries due to advances in early detection and treatment, survival remains dismal in low-resource settings. The delay in diagnosis contributes significantly to worse outcomes, and often, diagnosis occurs only after advanced symptoms prompt further evaluation. This delay highlights a critical gap in early cancer recognition at the primary care level.

Pediatric primary care providers (PCPs) are uniquely positioned to identify early warning signs of malignancies during routine visits, well-child care, and acute illness assessments. However, the feasibility and implementation of on-site cancer testing tools — such as complete blood counts, urinalysis, or rapid diagnostic kits — in these settings is not well understood. While adult primary care has increasingly integrated point-of-care screening for cancers (e.g., FIT for colorectal cancer), pediatric oncology remains reactive rather than proactive in diagnostic pathways [1].

Barriers to integration include lack of provider training on pediatric oncologic red flags, resource limitations, absence of standardized workflows, and concerns about overdiagnosis or unnecessary anxiety. Moreover, implementation science principles have not been sufficiently applied to pediatric oncology, especially regarding embedding cancer diagnostics within primary care structures.

The American Academy of Pediatrics (AAP) emphasizes the medical home as a continuous, accessible, and comprehensive model of care. Incorporating cancer testing aligns with the goals of preventive pediatric practice. Yet, evidence remains scarce on how PCPs perceive the practicalities, clinical responsibilities, and ethical implications of such integration. Additionally, little is known about differences in feasibility perceptions across rural vs. urban settings, public vs. private practices, or community clinics vs. academic centers.

The COVID-19 pandemic has further underscored the importance of decentralized testing and has catalyzed new innovations in rapid diagnostics and task-shifting [2]. As primary care clinics adopt technologies like telehealth and electronic health records with clinical decision support (CDS), there is a unique opportunity to explore cancer testing integration as a realistic and transformative service innovation.

This study aims to fill this critical knowledge gap by using a mixed-methods approach to examine pediatric PCPs’ perspectives on the feasibility and implementation of on-site cancer testing. By combining quantitative survey data with rich qualitative insights, we seek to inform policy, practice, and future implementation efforts to improve pediatric cancer outcomes through earlier detection in primary care [3].

Methods

Study Design and Rationale

We employed a convergent parallel mixed-methods design, integrating both quantitative and qualitative approaches to provide a comprehensive understanding of pediatric primary care providers’ perspectives on the feasibility and implementation of on-site cancer testing [4]. This design was selected to allow for simultaneous collection and analysis of survey and interview data, enabling triangulation and richer interpretation. The mixed-methods framework was grounded in the Consolidated Framework for Implementation Research (CFIR) to identify multi-level factors influencing implementation readiness. Ethical approval was obtained from the Institutional Review Board of [Institution Name Redacted for Anonymity].

Study Population and Recruitment

Eligible participants included board-certified pediatricians, family physicians, and pediatric nurse practitioners (PNPs) actively practicing in the United States who provide routine outpatient care to children aged 0–18 years. To ensure representativeness, we recruited across diverse settings including urban, suburban, and rural regions and across academic, private, and federally qualified health center (FQHC) settings [5]. A purposive sampling approach was employed to capture a broad spectrum of perspectives.

Recruitment occurred through national pediatric and family medicine listservs, state-level AAP chapters, social media outreach, and direct contact with practice-based research networks (PBRNs). All participants received an informational letter detailing the study’s purpose, confidentiality protections, and informed consent procedures.

Quantitative Component

Survey Instrument Development

A structured, web-based survey was developed using REDCap, incorporating items derived from the CFIR domains and adapted from validated instruments assessing feasibility and implementation factors in primary care. The survey included five domains:

Provider and practice demographics (e.g., years in practice, specialty, practice setting, geographic location)
Current diagnostic workflows for pediatric cancer suspicion
Perceived feasibility of integrating on-site cancer testing (Likert scale: 1 = not at all feasible to 5 = highly feasible)
Barriers and facilitators to implementation
Anticipated clinical, logistical, and psychosocial impacts

Pilot testing was conducted with 10 pediatricians to ensure clarity and face validity. Feedback was used to refine item phrasing and survey flow [6].

Data Collection and Analysis

The survey was administered from January to March 2024. Descriptive statistics (frequencies, means, standard deviations) were used to summarize responses. Inferential statistics included chi-square tests and t-tests to explore differences in perceived feasibility by provider type, region, and clinic structure [7]. Multivariable logistic regression was conducted to identify predictors of high feasibility perception, adjusting for covariates such as years in practice, clinic type, and prior exposure to diagnostic testing.

Quantitative analyses were performed using IBM SPSS Statistics version 27, with statistical significance set at p < 0.05.

Qualitative Component

Interview Sample and Procedures

A purposive subsample of survey respondents was invited to participate in semi-structured interviews to elaborate on quantitative findings and explore nuanced perspectives [8]. Inclusion aimed for maximum variation sampling based on practice type, geographic region, and years of experience.

Interviews were conducted via Zoom or telephone by experienced qualitative researchers with backgrounds in implementation science and pediatric health services. A semi-structured interview guide, developed from CFIR domains, included open-ended questions exploring:

Clinical decision-making when pediatric cancer is suspected
Perspectives on integrating diagnostic testing (e.g., CBC, urinalysis) on-site
Perceived logistical and ethical implications
Organizational readiness and resource considerations
Equity and communication concerns with families

Each interview lasted approximately 40–60 minutes, was audio-recorded with participant consent, and professionally transcribed verbatim [9]. All transcripts were anonymized and stored securely.

Data Analysis

We applied thematic analysis using an inductive-deductive coding strategy, guided by CFIR. Two independent coders reviewed transcripts line-by-line using NVivo 14, developing an initial codebook iteratively. Discrepancies were resolved through consensus meetings, and intercoder reliability was assessed (Cohen’s κ > 0.80). Thematic saturation was achieved after 25 interviews; an additional five were analyzed to confirm no new themes emerged [10-12].

Results

Participant Characteristics

Out of 150 pediatric primary care providers invited, 120 (80%) completed the quantitative survey. The sample comprised 74 general pediatricians (62%), 28 pediatric nurse practitioners (23%), and 18 family physicians (15%). The mean age was 42.8 years (SD = 8.6), with an average of 13.2 years (SD = 7.5) in clinical practice. Providers practiced across a broad range of settings: academic medical centers (35%), community private practices (30%), federally qualified health centers (FQHCs) (20%), and hospital-affiliated outpatient clinics (15%). Geographically, 40% practiced in urban, 35% in suburban, and 25% in rural areas, ensuring diverse contextual perspectives [13].

Quantitative Findings

Perceived Feasibility of On-Site Cancer Testing

When asked to rate the feasibility of implementing on-site cancer testing (including tests such as complete blood count, urinalysis, and basic imaging referrals) in their practice:

62% (n=74) rated feasibility as moderate to high (Likert scale ≥4)
22% (n=26) rated it as neutral (score of 3)
16% (n=20) expressed low feasibility (score ≤2)

Providers in academic settings were significantly more likely to rate feasibility as high compared to those in rural or solo practices (74% vs. 49%, p = 0.02).

Perceived Benefits

70% believed that on-site testing would facilitate earlier cancer diagnosis.
65% reported that it would improve continuity of care.
60% anticipated increased parental reassurance and trust.

Barriers to Implementation

Participants identified multiple barriers (Table 1):

Limited resources and infrastructure (65%)
Inadequate provider training on pediatric oncology signs (60%)
Potential disruption of clinic workflow (50%)
Reimbursement and cost concerns (45%)
Emotional burden of false positives on families and providers (35%).

Table 1: Barriers to On-Site Pediatric Cancer Testing Identified by Providers (N=120).

Barrier	% of Providers Reporting
Resource limitations (staff, space, lab)	65%
Insufficient oncology training	60%
Workflow disruption	50%
Uncertain reimbursement/cost	45%
Emotional impact of false positives	35%
Lack of institutional support	30%
Limited parental acceptance	25%

Qualitative Findings

In-depth interviews were conducted with 30 providers purposively sampled across practice types and geographic locations. Thematic analysis yielded four major themes:

Clinical Uncertainty and Training Gaps

Providers expressed that recognizing subtle signs of pediatric cancers remains a challenge. Many reported inadequate training during residency or continuing education focused on oncology screening [14].

“Most of us are good at identifying common infections, but it’s tough to keep cancer on our radar when symptoms are vague or overlap.” (Pediatrician, urban academic center)

Logistical and Workflow Considerations

Integration of on-site testing was seen as potentially disruptive, especially in high-volume clinics with limited staffing.

“Even if the tests are available, we need protocols and support to ensure they don’t slow us down or overwhelm our referral networks.” (PNP, rural community clinic)

Communication and Psychosocial Impact

Providers highlighted the delicate balance between reassuring families and causing unnecessary anxiety.

“Parents want answers fast, but a false positive or ambiguous result could lead to fear and mistrust if not handled carefully.” (Family physician, suburban private practice)

Institutional and System-Level Support

Sustainable implementation would require institutional buy-in, leadership support, and clear reimbursement pathways [15].

“Without leadership encouraging and funding these services, it’s hard to justify the extra effort.” (Pediatrician, FQHC) (Table 2).

Table 2: Facilitators and Recommendations for Successful Implementation of On-Site Pediatric Cancer Testing (N=120).

Facilitator/Recommendation	% of Providers Endorsing	Description
Institutional Leadership Support	68%	Strong endorsement and resource allocation from clinic/hospital leadership
Provider Training and Continuing Education	65%	Enhanced oncology training and skill-building workshops focused on early cancer detection
Integration of Clinical Decision Support (CDS)	60%	Use of EHR-embedded tools to assist diagnosis and testing decisions
Dedicated On-Site Testing Staff	55%	Availability of trained personnel (e.g., lab techs, nurses) to perform and manage testing
Streamlined Workflow Protocols	50%	Clear guidelines and processes minimizing disruption to clinic flow
Reimbursement and Financial Incentives	48%	Adequate insurance coverage and incentives to offset costs
Psychosocial Support Resources for Families	40%	Access to counseling and educational materials to support families through diagnostic uncertainty
Collaboration with Pediatric Oncology Specialists	38%	Established referral pathways and consultation with oncology experts
Use of Telemedicine for Follow-up and Support	30%	Remote consultations to reduce burden on families and clinics
Patient and Family Engagement and Education	28%	Providing clear, culturally sensitive communication to enhance acceptance and reduce anxiety

Integration of Quantitative and Qualitative Data

The mixed-methods analysis demonstrated a convergence of findings: while quantitative data showed a majority interest and perceived feasibility, qualitative data elucidated critical nuances such as the need for training, workflow redesign, and system-level support [16].

Providers’ concerns about false positives and emotional impact were not quantified in surveys but emerged as salient in interviews, underscoring the importance of psychosocial safeguards (Figure 1).

Figure 1: Barriers and facilitators to on-site pediatric cancer testing.

This comprehensive results section outlines the multifaceted perspectives of pediatric primary care providers, offering critical insights to guide policy, training, and implementation strategies aimed at earlier pediatric cancer detection through on-site testing integration.

Discussion

This mixed-methods study provides novel insights into pediatric primary care providers’ perspectives regarding the feasibility and implementation of on-site cancer testing. Our findings reveal a generally positive attitude toward integrating such diagnostic capabilities, with over 60% perceiving moderate to high feasibility and anticipating significant benefits for early cancer detection and improved family trust. These results underscore an emerging recognition within primary care that early diagnosis is paramount in improving pediatric oncology outcomes.

Despite this enthusiasm, providers articulated substantial barriers, notably limited resources, insufficient oncology-specific training, workflow concerns, and reimbursement uncertainties. These findings are consistent with prior research on point-of-care testing implementation in primary care settings . The challenge of balancing clinical vigilance with the practical realities of busy outpatient workflows echoes previous studies emphasizing the complexity of integrating new diagnostic modalities.

Qualitative insights enrich the quantitative findings, revealing that provider confidence in recognizing early cancer signs is frequently undermined by a lack of targeted education and limited opportunities for continuing medical education focused on pediatric oncology. This gap necessitates curricula development tailored to primary care clinicians, incorporating red-flag symptoms and interpretation of basic diagnostic tests to enhance early detection. Additionally, concerns about the emotional impact of false positives highlight the critical need for communication training and psychosocial support frameworks to mitigate potential harms.

Institutional support emerged as a key facilitator, with providers emphasizing the importance of leadership endorsement, dedicated staffing, and sustainable reimbursement structures. These organizational factors align with CFIR constructs such as inner setting and implementation climate, reinforcing the multidimensional nature of successful adoption. Particularly notable was the disparity between urban and rural providers’ perceptions, with rural clinicians expressing greater concerns about feasibility due to resource constraints, underscoring the imperative to tailor implementation strategies to diverse practice environments to promote health equity.

The integration of clinical decision support (CDS) within electronic health records offers a promising avenue to support provider decision-making and streamline workflows. Prior successes in CDS-driven screening programs provide a model for leveraging technology in pediatric cancer diagnostics.

Conclusion

This study demonstrates that pediatric primary care providers recognize the potential value of on-site cancer testing for improving early diagnosis but face substantial barriers related to training, workflow, resources, and reimbursement. Addressing these challenges through targeted education, organizational support, integration of clinical decision tools, and equitable resource allocation is essential to enable successful implementation. Our findings provide a critical foundation to inform future policies and interventions aimed at enhancing pediatric cancer detection within primary care settings, ultimately contributing to improved outcomes for children.

References

Nakata K, Matsuda T, Hori M, et al. Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018. Cancer Sci. 2023. [crossref]
Kato S, Sato-Otsubo A, Nakamura W, et al. Genome profiling with targeted adaptive sampling long-read sequencing for pediatric leukemia. Blood Cancer J. 2024. [crossref]
Shirota H, Koyama T, Matsuda K, et al. Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study. Cancer Med. 2023. [crossref]
Katanoda K, Matsuda T, Matsuda A, et al. Childhood, adolescent and young adult cancer incidence in Japan in 2009–2011. Jpn J Clin Oncol. 2017. [crossref]
Matsuda A, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: A study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2013. [crossref]
Kato M, Hiyama E, Koh K, et al. Nationwide survey of late effects in childhood cancer survivors in Japan. Pediatr Int. 2019.[crossref]
Yoshida K, Hasegawa D, Hanada R, et al. Comprehensive genomic profiling for pediatric cancers in Japan: Interim analysis of the SCRUM-Japan Pediatric Program. Cancer Sci. 2021.
Okamura H, Kamibeppu K, Sato I, et al. Parental psychological distress in pediatric cancer: Nationwide survey in Japan. Pediatr Int. 2020.
Yasuda H, Inoue Y, Terui K, et al. Clinical practice and workload of pediatric hematology-oncology specialists in Japan: Results from a nationwide survey. Pediatr Blood Cancer. 2020.
Fujii Y, Maeda M, Wada Y, et al. Educational support systems for childhood cancer survivors in Japan. Cancer Rep. 2021.
Hiyama E, Horie H, Murakami S, et al. Nationwide registry of childhood cancer in Japan: Monitoring incidence, survival, and trends. Jpn J Clin Oncol. 2020. [crossref]
Ichikawa H, Sunami K, Furukawa E, et al. Implementing NGS cancer testing in a hospital-based setting in Japan: Pediatric case experiences. Pathol In 2020.
Inoue M, Sawada N, Matsuda T, et al. Attributable causes of cancer in Japan in 2005—systematic quantitative evaluation and implications for cancer control. Cancer Sci. 2012.
Sunami K, Ichikawa H, Kubo T, et al. Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study. Cancer Sci. 2019. [crossref]
Sakurai M, Hoshino H, Ohashi M, et al. Implementation of comprehensive genomic profiling in Japanese pediatric oncology. Int J Clin Oncol. 2022.
Hoshino H, Arai T, Taniyama Y, et al. Real-world data on pediatric cancer genomic profiling in Japan: Initial findings from a national registry. Pediatr Blood Cancer. 2023.

Multi-Target Mechanisms of Portulaca oleracea L. in Rheumatoid Arthritis: A Network Pharmacology and Molecular Docking Study

2 Replies

DOI: 10.31038/JPPR.2025811

Abstract

Rheumatoid arthritis (RA), a chronic autoimmune disorder characterized by synovial inflammation and joint destruction, necessitates novel therapeutic strategies due to limitations in current treatments. This study investigates the molecular mechanisms of Portulaca oleracea L. (POL), a traditional medicinal herb with anti-inflammatory and antioxidant properties, in RA management using network pharmacology and molecular docking. Ten bioactive POL components, including quercetin, luteolin, and kaempferol, were identified via the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database, targeting 208 potential human proteins. RA-associated genes (2,142 targets) were curated from GeneCards, OMIM, and TTD, with 134 overlapping targets identified as POL-RA interaction hubs. Protein-protein interaction (PPI) analysis revealed TNF, AKT1, and IL6 as core targets, while Gene Ontology (GO) enrichment highlighted inflammatory response, apoptotic regulation, and cytokine activity. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis implicated POL in modulating RA-related signaling cascades, including PI3K-Akt, TNF, and IL-17. Molecular docking confirmed strong binding affinities of quercetin (−7.85 kcal/mol with TNF), luteolin (−7.62 kcal/mol with IL6), and kaempferol (−7.52 kcal/mol with TNF), validating their interactions with key targets. These results demonstrate POL’s polypharmacological effects through multi-component, multi-target, and multi-pathway mechanisms, offering a scientific foundation for its development as a complementary RA therapy. This study bridges traditional medicine and systems biology, providing insights into POL’s therapeutic potential and guiding future drug discovery efforts.

Keywords

Portulaca oleracea L, Rheumatoid arthritis, Network pharmacology, Molecular docking

Introduction

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent synovial inflammation, cartilage destruction, and bone erosion, leading to progressive joint damage and systemic complications [1]. Early-stage clinical manifestations of RA typically include joint stiffness, particularly in the morning, swelling, and pain, which are often symmetrical and affect small joints such as those in the hands and feet. As the disease advances, these symptoms may progress to joint deformities, functional impairment, and even permanent disability, significantly impacting patients’ daily lives and overall well-being [2]. With a global prevalence of approximately 0.5–1%, RA is one of the most common autoimmune disorders, disproportionately affecting women and older adults. The disease not only contributes to significant morbidity but also leads to a reduced quality of life and increased healthcare costs due to the need for long-term management and treatment [3]. The pathogenesis of RA is highly complex and involves a multifaceted interplay of genetic predisposition, environmental triggers, and dysregulated immune responses [4]. Genetic factors, such as specific human leukocyte antigen (HLA) alleles, play a critical role in increasing susceptibility to the disease. Environmental triggers, including smoking, infections, and hormonal changes, may further contribute to the onset and progression of RA. These factors collectively lead to the breakdown of immune tolerance, resulting in the activation of autoreactive T and B cells [5]. Once activated, these immune cells initiate a cascade of inflammatory processes, driving the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-17 (IL-17). These cytokines perpetuate synovial inflammation, promote the formation of pannus tissue, and contribute to the destruction of cartilage and bone, ultimately leading to joint damage and systemic complications [6]. While multiple hypotheses exist regarding pathogenesis of Rheumatoid arthritis, the exact mechanisms remain unclear [7].

Traditional treatment regimens include the use of disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs and steroidal anti-inflammatory drugs [8]. Methotrexate (MTX), a cornerstone of antirheumatic drugs, acts as a folate antagonist with anti-proliferative, anti-metabolic, and anti-inflammatory properties. It modulates immune cell infiltration and reduces pro-inflammatory cytokine levels [9]. However, long-term MTX can produce toxicity and side effects such as bone marrow suppression, pulmonary toxicity, nephrotoxicity and an increased risk of infections [10]. NSAIDs, which inhibit cyclooxygenase to suppress prostaglandin synthesis, provide analgesic, antipyretic, and anti-inflammatory benefits. Despite their efficacy, they pose risks of gastrointestinal ulcer complications (bleeding, perforation), renal dysfunction, cardiovascular events, and mortality [11]. Steroidal anti-inflammatory drugs, though effective as anti-inflammatory adjuncts by supplementing cortisol levels, are clinically controversial due to adverse effects including infections, hypertension, cardiovascular disease, metabolic disorders (diabetes, obesity), osteoporosis, and ocular complications (cataracts, glaucoma) [12]. The treatment landscape for RA has evolved dramatically over the past decade, with the introduction of biologic DMARDs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) revolutionizing disease management [13]. TNF-α inhibitors, such as etanercept and adalimumab, were among the first bDMARDs to demonstrate efficacy in reducing inflammation and halting radiographic progression [14]. Subsequent developments include IL-6 inhibitors (e.g., tocilizumab), B-cell depleting agents (e.g., rituximab), and Janus kinase (JAK) inhibitors (e.g., tofacitinib and baricitinib), which offer alternative mechanisms of action for patients with inadequate responses to conventional therapies [15,16]. Despite these advancements, a significant proportion of patients experience suboptimal responses or adverse effects, highlighting the need for novel therapeutic targets and personalized treatment approaches [17]. In addition to pharmacological interventions, non-pharmacological approaches, such as physical therapy, exercise, and dietary modifications, play a complementary role in RA management. Regular physical activity has been shown to improve joint function, reduce pain, and enhance quality of life in RA patients [18].

Dietary interventions, including the Mediterranean diet and omega-3 fatty acid supplementation, may exert anti-inflammatory effects and modulate disease activity [19]. However, further research is needed to establish standardized guidelines for integrating these modalities into routine clinical practice. Given the limitations and toxicity profiles of existing therapies, there remains an urgent unmet need for safer, more effective pharmacological interventions to improve RA management and patient outcomes. Studies have shown that traditional Chinese herbs may have significant potential in the treatment of rheumatoid arthritis in recent years [20]. Portulaca oleracea L (POL) belonging to the Portulaceae family and the Portulaca genus is an annual fleshy herbaceous plant., Portulaca has a sour taste and a cold nature. It is reported that this herb was used as a kind of food and medicine for thousands of years in China [21]. As a medicinal and edible plant, it has the effects of clearing heat and detoxifying, cooling blood and stopping bleeding, and stopping dysentery; Meanwhile, purslane has multiple functions such as anti-inflammatory, immune regulation, antioxidant, and hypoglycemic effects. It has been used to treat diabetes, headache, gastrointestinal infection and other diseases [22,23]. Studies have shown that purslane extract can alleviate yeast polysaccharide induced joint inflammation in mice by inhibiting Nrf2 expression [24]. Ehsan Karimi et al. conducted a double-blind, randomized controlled clinical trial The findings demonstrated that purslane supplementation significantly alleviated clinical symptoms, including reductions in joint swelling, tenderness frequency, and morning stiffness duration. At the molecular level, purslane administration led to a marked increase in total antioxidant capacity (TAC) and superoxide dismutase (SOD) activity. indicating a potential anti-inflammatory and antioxidant effect of purslane in RA patients [25]. However, the precise mechanism and related signaling pathways of POL reatment for rheumatoid arthritis has not been elucidated. Network pharmacology is a research field based on systems biology, genomics, proteomics and other disciplines, which is a method to discover new drug targets and molecular mechanisms by combining computational analysis with in vivo and in vitro experiments and integrating a large amount of information [26]. It focuses on studying multiple components, multiple targets, and multiple signaling pathways, providing new ideas for the research of traditional Chinese medicine [27]. Within TCM monographs, network pharmacology serves to explore relationships between active components and TCM targets, elucidating mechanisms of action and potential effects [28]. This study investigates the molecular mechanisms underlying Portulaca oleracea L. (POL) in treating rheumatoid arthritis (RA) through integrated network pharmacology and molecular docking, offering novel therapeutic insights and a scientific foundation for further pharmacological exploration.

Materials and Methods

Databases and Software

This study employed the following databases and computational tools: Traditional Chinese Medicine Systems Pharmacology (TCMSP) (http://tcmspw.com/tcmsp.php) was used to identify bioactive compounds in Portulaca oleracea L. (POL) based on pharmacokinetic parameters. GeneCards (http://www.genecards.org), OMIM (https://omim.org), and Therapeutic Target Database (TTD) (https://db.idrblab.org/ttd) were queried to collect rheumatoid arthritis (RA)-related targets. UniProt (https://www.uniprot.org) standardized gene names and species-specific identifiers. Venny 2.1.0 (http://bioinfogp.cnb.csic.es/tools/venny) generated Venn diagrams to identify overlapping targets. STRING (https://string-db.org) constructed protein-protein interaction (PPI) networks with a confidence score cutoff ≥ 0.4. DAVID (https://david.ncifcrf.gov) performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Cytoscape visualized and analyzed networks, while PyMOL rendered molecular structures. AutoDock 4.2.6 executed molecular docking simulations. PubChem (https://pubchem.ncbi.nlm.nih.gov) and Protein Data Bank (PDB) (https://www.rcsb.org) provided 3D structures of ligands and receptors, respectively. Weishengxin (http://www.bioinformatics.com.cn) visualized enrichment results.

Network Pharmacology Analysis

Prediction of Active Ingredients and Targets in POL

Active ingredients in POL were retrieved from TCMSP using stringent pharmacokinetic filters: oral bioavailability (OB) ≥ 30% and drug-likeness (DL) ≥ 0.18, thresholds established for predicting compounds with therapeutic potential [1]. Corresponding targets were extracted from TCMSP and cross-validated via UniProt to ensure human gene symbol consistency (taxonomic ID: 9606). Non-human or uncharacterized targets were excluded.

Acquisition of RA Disease Targets

RA-associated targets were systematically collected from GeneCards, OMIM, and TTD using “rheumatoid arthritis” as the search term. GeneCards targets were filtered by a relevance score median ≥ 2.41, a statistically validated cutoff to prioritize high-confidence targets [2]. Duplicate entries across databases were removed to compile a non-redundant RA target dataset.

Intersection Target Screening

POL and RA targets were intersected using Venny 2.1.0 to identify shared therapeutic targets. A compound-target network was constructed in Cytoscape, where nodes represented compounds or targets, and edges denoted interactions. Topological parameters (degree, betweenness centrality) were calculated to rank core bioactive components.

Protein–Protein Interaction (PPI) Network Construction and Analysis

Shared targets were uploaded to STRING (organism: Homo sapiens) to build a PPI network with default parameters (confidence score ≥0.4, hidden disconnected nodes). The network was imported into Cytoscape and analyzed using the Network Analyzer plugin. Key targets were prioritized using a composite score integrating degree centrality, betweenness centrality, and closeness centrality, with the top 20 nodes retained for downstream analysis.

Functional and Pathway Enrichment

DAVID was utilized for GO and KEGG analyses with the following settings: species = Homo sapiens, adjusted p-value <0.05, and enrichment score ≥1.5. GO terms were categorized into biological processes (BP), cellular components (CC), and molecular functions (MF). KEGG pathways were filtered for RA relevance (e.g., inflammation, immune regulation). Enriched terms were visualized as bubble charts using Weishengxin. A drug-target-pathway network was constructed to map POL’s multi-scale therapeutic mechanisms.

Molecular Docking Validation

The molecular docking protocol involved three sequential phases: ligand and receptor preparation, docking simulations, and methodological validation. Canonical SMILES of core POL components (e.g., kaempferol, quercetin) were retrieved from PubChem and converted to 3D structures (.mol2 format) using Chem3D, followed by energy minimization with the MMFF94 force field and Gasteiger charge assignment to generate ligand files in .pdbqt format. For receptor preparation, crystal structures of key targets (e.g., TNF-α: PDB ID 2AZ5; AKT1: PDB ID 3O96) were obtained from the Protein Data Bank (PDB), with PyMOL removing heteroatoms and water molecules, and AutoDockTools optimizing hydrogen placement and charge distribution. Docking simulations were performed using AutoDock Vina with a grid box dimension of 25 × 25 × 25 Å centered on the active site, an exhaustiveness parameter of 20 for conformational sampling, and generation of 10 ligand poses ranked by binding affinity (kcal/mol). The lowest-energy conformation was selected for structural visualization in PyMOL, where hydrogen bonding and hydrophobic interactions were annotated. To validate the protocol, co-crystallized ligands were redocked into their respective receptors, achieving a root mean square deviation (RMSD) of <2.0 Å, confirming the reliability of the docking methodology.

Results

Anti-Rheumatoid Arthritis Active Ingredients and Target Proteins of POL

Ten bioactive components in Portulaca oleracea L. (POL) with potential anti-rheumatoid arthritis (RA) activity were identified via the TCMSP database, including quercetin, luteolin, kaempferol, arachidonic acid, β-carotene, β-sitosterol, 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one, isobetanidin, isobetan in-qt, and cycloartenol. These compounds were selected based on pharmacokinetic criteria (oral bioavailability ≥30% and drug-likeness ≥0.18). A total of 208 potential POL-related targets were curated using UniProt, with gene symbols standardized to human orthologs.

RA-associated targets were systematically retrieved from GeneCards (2,065 targets), OMIM (48 targets), and TTD (100 targets). After merging datasets and removing duplicates, 2,142 unique RA-related targets were retained. Intersection analysis using a Venn diagram revealed 134 shared targets between POL and RA (Figure 1A), suggesting their critical role in mediating POL’s therapeutic effects. The compound-target network (Figure 1B) highlights quercetin, luteolin, and kaempferol as core bioactive components with the highest connectivity.

Figure 1: (A) Venn diagram of potential targets for the anti- rheumatoid arthritis of POL; (B) compound–target network of POL for anti- rheumatoid arthritis. The middle red diamond node represents POL, the triangle nodes represent the Key POL Components, and the surrounding Rectangular nodes represent the targets that interact with POL.

Screening of Key POL Components for RA Treatment

A compound-target interaction network (Figure 2) was constructed using Cytoscape 3.10.2 to identify critical bioactive components in Portulaca oleracea L. (POL) for rheumatoid arthritis (RA) therapy. Among 11 candidate bioactive components, quercetin, luteolin, and kaempferol exhibited the highest target connectivity (Table 1), suggesting their pivotal role in mediating POL’s therapeutic effects. Cycloartenol was excluded from network analysis due to the absence of associated targets. A multi-layered drug-component-target-disease network was subsequently generated to systematically explore POL’s molecular mechanisms, highlighting synergistic interactions between bioactive compounds and RA-related pathways.

Figure 2: Construction of the drug–target–disease network. The red diamonds symbolize POL and RA, the orange polygons depict the active components of POL, and the blue ellipses represent the core targets of RA.

Table 1: Thirteen components of CA with potential anti-angiogenic activity.

Molecule Name	OB (%)	DL	Degree
Quercetin	46.43	0.28	103
Luteolin	36.16	0.25	45
Kaempferol	41.88	0.24	37
Arachidonic acid	45.57	0.2	25
Beta-carotene	37.18	0.58	19
Beta-sitosterol	36.91	0.75	19
5,7-Dihydroxy-2- (3-hydroxy-4-methoxyphenyl)chroman-4-one	47.74	0.27	5
Isobetanidin	59.73	0.52	5
Isobetanin_qt	30.16	0.52	2
Cycloartenol	38.69	0.78	0

Identification of Core Bioactive Components in POL for RA Intervention

To delineate the therapeutic potential of Portulaca oleracea L. (POL) in rheumatoid arthritis (RA), a compound-target interaction network was constructed using Cytoscape 3.10.2. From 110 candidate bioactive components, quercetin, luteolin, and kaempferol demonstrated maximal target connectivity (degree centrality >15), underscoring their centrality in POL’s anti-RA efficacy. Cycloartenol was excluded due to the absence of validated targets in RA pathogenesis. Subsequently, a multi-scale network integrating drugs, components, targets, and disease pathways was generated, revealing synergistic crosstalk between POL-derived phytochemicals and RA-associated signaling cascades (e.g., TNF, IL-17). This systems-level analysis elucidates POL’s polypharmacological mode of action, driven by multi-target engagement.

Protein-Protein Interaction (PPI) Network Construction

The 134 overlapping targets between Portulaca oleracea L. (POL) and rheumatoid arthritis (RA) were analyzed using the STRING database (confidence score ≥0.4, Homo sapiens), and the resultant PPI network was imported into Cytoscape for topological characterization. The network comprised 133 nodes and 3314 edges, with an average node degree of 56.2, reflecting robust interconnectivity (Figure 3). Node importance was quantified via centrality metrics: degree (number of edges), betweenness centrality (bridging role in network paths), and closeness centrality (proximity to other nodes) (Table 2. Visual attributes (node size and color intensity) were scaled proportionally to composite centrality scores. Hierarchical ranking identified TNF, AKT1, and IL6 as top-ranked hub targets, implicating their critical roles in mediating POL’s anti-RA effects through inflammatory and proliferative signaling modulation.

Figure 3: PPI network diagram of therapeutic targets for rheumatoid arthritis.

Table 2: Top 15 anti-rheumatoid arthritis target information in PPI network.

Number	Target name	Degree	Betweenness centrality	Closeness centrality
1	AKT1	117	0.050	0.898
2	TNF	117	0.041	0.898
3	IL6	116	0.039	0.892
4	IL1B	108	0.026	0.846
5	MMP9	104	0.027	0.825
6	TP53	104	0.019	0.825
7	PTGS2	102	0.022	0.815
8	CASP3	100	0.016	0.805
9	HIF1A	97	0.015	0.791
10	EGFR	95	0.016	0.781
11	BCL2	95	0.016	0.781
12	TGFB1	94	0.014	0.776
13	PPARG	90	0.013	0.759
14	IFNG	87	0.013	0.746
15	MYC	87	0.012	0.746

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Enrichment Analyses

Functional enrichment analysis of Portulaca oleracea L. (POL) targets was performed using DAVID software. Statistical filtering (p < 0.001) identified 223 significant biological processes, 54 cellular components (p < 0.05), 110 molecular functions (p < 0.05), and 126 KEGG pathways (p < 0.001). The enriched GO terms and KEGG pathways were systematically analyzed to infer the potential biological functions of POL targets in rheumatoid arthritis (RA) pathogenesis. In the GO function analysis, the top 10 enriched GO terms across biological processes (BP), cellular components (CC), and molecular functions (MF) were identified based on adjusted p-values (Figure 4A). In BP, significant terms included negative regulation of apoptotic process (GO: 0043066), inflammatory response (GO: 0006954), response to xenobiotic stimulus (GO: 0009410), cellular response to lipopolysaccharide (GO: 0071222), and positive regulation of gene expression (GO: 0010628), highlighting POL’s roles in inflammation modulation, detoxification, and transcriptional regulation. CC enrichment predominantly localized to extracellular space (GO: 0005615), cytosol (GO: 0005829), membrane raft (GO: 0045121), and nucleoplasm (GO: 0005654), suggesting coordinated signaling across extracellular, cytoplasmic, and nuclear compartments. MF analysis revealed critical interactions involving enzyme binding (GO: 0019899), cytokine activity (GO: 0005125), protein kinase activity (GO: 0004672), and RNA polymerase II-specific transcription factor binding (GO: 0061629), underscoring POL’s engagement with enzymatic, signaling, and transcriptional machinery. These findings collectively implicate POL in multi-layered regulatory mechanisms relevant to RA pathology. The top 20 enriched KEGG pathways were identified and visualized as bubble maps (Figure 4B). A drug-target-pathway network integrating POL components, core targets (e.g., TNF, AKT1, IL6), and enriched pathways was constructed in Cytoscape 3.10.2(Figure 5). Key pathways included PI3K-Akt signaling (hsa04151), TNF signaling (hsa04668), IL-17 signaling (hsa04657), AGE-RAGE signaling in diabetic complications (hsa04933), and Fluid shear stress and atherosclerosis (hsa05418). Additional pathways such as Pathways in cancer (hsa05200), Hepatitis B (hsa05161), Apoptosis (hsa04210), and Influenza A (hsa05164) further implicated POL’s regulatory roles in inflammation, proliferation, and immune response. Annotation of pathway-target interactions revealed POL’s multi-target engagement across these cascades, with TNF, AKT1, and IL6 serving as central hubs. These results demonstrate POL’s polypharmacological properties, characterized by synergistic modulation of interconnected signaling networks relevant to rheumatoid arthritis (RA) pathogenesis and associated comorbidities.

Figure 4: Functional enrichment analyses of the target proteins of POL against RA. (A) Top 10 GO terms in the biological processes (p < 0.001), cellular components (p < 0.05), molecular functions (p < 0.05). (B) Top 20 KEGG pathways (p < 0.001). The depth of the circle color represents “- log10 pvalue”, and the size of the circle represents the number of genes enriched in this signaling pathway.

Figure 5: A drug-target-pathway network integrating POL, target and signaling pathways. The diamond represents POL, the rectangle represents the target of POL action, and the purple circle represents the top 20 signaling pathways.

Molecular Docking Validation

To validate the binding interactions between Portulaca oleracea L. (POL) components and rheumatoid arthritis (RA)-associated targets, molecular docking simulations were performed using AutoDock software. The binding affinities (kcal/mol) of quercetin, luteolin, and kaempferol with core targets (TNF, IL6, AKT1) are summarized in Table 3. Quercetin exhibited the strongest binding affinity to TNF (−7.85 kcal/mol), followed by IL6 (−7.06 kcal/mol) and AKT1 (−6.76 kcal/mol). Luteolin demonstrated optimal binding to IL6 (−7.62 kcal/mol), with affinities of −6.73 kcal/mol (TNF) and −7.31 kcal/mol (AKT1). Kaempferol showed preferential binding to TNF (−7.52 kcal/mol), alongside affinities of −6.15 kcal/mol (IL6) and −6.94 kcal/mol (AKT1). Lower binding energy values (more negative) correlate with stronger ligand-receptor interactions, as confirmed by structural visualization of hydrogen bonding and hydrophobic contacts (Figure 6A-I). These results validate POL’s multi-target engagement, with quercetin emerging as the most potent inhibitor of TNF-driven inflammatory signaling, a hallmark of RA pathogenesis.

Table 3: Binding energies of the molecular docking of POL with targets.

	Quercetin	Luteolin	Kaempferol
TNF	-7.85 kcal/mol	-6.73 kcal/mol	-7.52 kcal/mol
AKT1	-6.76 kcal/mol	-7.31 kcal/mol	-6.94 kcal/mol
IL-6	-7.06 kcal/mol	7.62 kcal/mol	-6.15 kcal/mol

Figure 6: Molecular docking pattern between pivotal compounds of POL and the core target protein. (A) Quercetin-TNF; (B) Quercetin- AKT1; (C) Quercetin- IL-6; (D) Luteolin- TNF; (E) Luteolin- AKT1; (F) Luteolin- IL-6; (G) Kaempferol- TNF; (H) Kaempferol- AKT1; (I) Kaempferol- IL-6.

Discussion

Portulaca oleracea L. (POL), a traditional herbal medicine with significant ethnopharmacological relevance, exhibits broad therapeutic potential in inflammation, immune regulation, antioxidant activity, and metabolic disorders [30]. While historical texts document its efficacy against diabetes, headaches, and gastrointestinal ailments [31], its molecular mechanisms in rheumatoid arthritis (RA) remain underexplored. Leveraging network pharmacology and molecular docking, this study deciphered POL’s multi-component, multi-target, and multi-pathway anti-RA properties, addressing the complexity inherent to traditional Chinese medicine. Ten bioactive components were identified through pharmacokinetic screening, with quercetin, luteolin, and kaempferol emerging as core constituents. Quercetin, a multifunctional flavonoid, exhibits both anti-inflammatory and anti-ferroptosis properties. Research indicates that quercetin significantly alleviates the pathological progression of osteoarthritis by inhibiting chondrocyte apoptosis and promoting the polarization of synovial macrophages toward the M2 phenotype [32]. Additionally, quercetin promotes bone health through antioxidant pathways and regulates metabolic balance, further highlighting its therapeutic potential in bone and joint diseases [33,34]. Luteolin, a potent immunomodulator, significantly mitigates neutrophil-driven oxidative stress by inhibiting superoxide anion generation, reducing reactive oxygen species (ROS) production, and blocking the formation of neutrophil extracellular traps (NETs) [35]. Moreover, studies have found that luteolin alleviates osteoblast pyroptosis by activating the PI3K-Akt signaling pathway, thereby promoting bone formation and inhibiting bone resorption, which has the remarkable efficacy in the treatment of postmenopausal osteoporosis [36]. Kaempferol plays a crucial role in the treatment of rheumatoid arthritis (RA) by inhibiting the activation of the MAPK signaling pathway. Research has shown that kaempferol blocks the activation of the MAPK pathway in fibroblast-like synoviocytes, thereby inhibiting synovial invasion and regulating bone metabolism [37]. Quercetin, luteolin, and kaempferol synergistically enhance bone repair and significantly suppress inflammatory cascades through multiple molecular mechanisms. These findings provide robust scientific evidence for the osteoprotective and anti-arthritic potential of POL.

Protein-protein interaction (PPI) network analysis has emerged as a powerful tool for identifying key molecular players in complex diseases such as rheumatoid arthritis (RA). Through this approach, TNF, AKT1, and IL6 have been prioritized as pivotal therapeutic targets due to their central roles in the pathogenesis of RA. TNF-α, a master regulator of RA pathogenesis, orchestrates a cascade of inflammatory and destructive processes within the joint microenvironment. It drives chronic inflammation by upregulating pro-inflammatory cytokines such as IL-1β and IL-6, which perpetuate synovial inflammation and contribute to systemic manifestations of the disease [38-40]. Furthermore, TNF-α promotes osteoclastogenesis, leading to bone resorption and joint destruction, while simultaneously inhibiting bone formation through the upregulation of Wnt antagonist DKK-1 [41]. This dual role in bone remodeling underscores its critical involvement in RA progression. IL-6, another key cytokine identified in the PPI network, plays a dual role in immune regulation. While it is essential for mediating acute immune responses, its dysregulation in RA exacerbates disease pathology. IL-6 activates the Jak/STAT-3 and Ras/Erk/C/EBP signaling pathways, which promote T-cell activation, synovial hyperplasia, and the production of additional inflammatory mediators [42-44]. Clinically, the efficacy of IL-6 receptor inhibitors such as tocilizumab and sarilumab has validated IL-6 as a therapeutic target, demonstrating significant reductions in disease activity and joint damage in RA patients [45]. AKT1, a central node in the PI3K/Akt signaling pathway, has also been identified as a critical therapeutic target through PPI network analysis. This kinase modulates a wide range of cellular processes, including inflammation, endothelial apoptosis, and neutrophil infiltration, all of which are implicated in RA pathogenesis [46-48].

KEGG pathway enrichment analysis revealed that POL (the active compound under investigation) is implicated in several rheumatoid arthritis (RA)-related signaling pathways, including the PI3K-Akt, TNF, and MAPK cascades, which are critical to the pathogenesis of RA. The PI3K/Akt signaling axis plays a pivotal role in regulating chondrocyte apoptosis and extracellular matrix (ECM) remodeling, processes central to joint degradation in RA [49,50]. Studies have demonstrated that pharmacological inhibition of the PI3K/Akt pathway attenuates osteoarthritis progression and subchondral bone sclerosis, highlighting its therapeutic potential in inflammatory joint diseases [51-54]. TNF-α, a key pro-inflammatory cytokine in RA, drives synovial inflammation and joint destruction. TNF-α blockade remains a cornerstone of RA therapy, as evidenced by the clinical success of biologics such as etanercept and infliximab. Molecular docking studies have revealed that quercetin, a bioactive component of POL, exhibits strong binding affinity to TNF-α, suggesting a mechanism by which POL may exert its anti-inflammatory effects [55,56]. Furthermore, the MAPK/ERK signaling pathway, which is modulated by POL components, plays a critical role in bone regeneration and inflammation resolution. Activation of MAPK/ERK signaling has been shown to promote osteoblast differentiation and bone formation, while its dysregulation contributes to inflammatory responses in RA [57,58]. MiR-133a can regulate the MAPK/ERK signaling pathway to rescue glucocorticoid induced bone loss [59,60]. These findings collectively position POL as a polypharmacological agent capable of simultaneously targeting multiple pathological pathways, including inflammation, apoptosis, and metabolic dysregulation, thereby offering a holistic and multi-targeted approach to RA management.

Conclusion

This study delineates POL’s anti-RA mechanisms through network pharmacology and molecular docking, emphasizing its multi-target synergy against TNF-α, IL-6, and PI3K/Akt pathways. While promising, further in vivo validation and clinical trials are warranted to translate these insights into therapeutic applications.

Notes

The authors declare no competing financial interest.

References

Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis [published correction appears in Lancet.
Smith MH, Berman JR (2022) What Is Rheumatoid Arthritis? JAMA 22. [crossref]
Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 25.
Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA (2023) Epidemiology and Risk Factors for Rheumatoid Arthritis Development. Mediterr J Rheumatol 34: 404-413. [crossref]
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365: 2205-2219. [crossref]
McInnes IB, Schett G (2017) Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389: 2328-2337. [crossref]
Firestein GS, McInnes IB (2017) Immunopathogenesis of Rheumatoid Arthritis. Immunity 46: 183-196. [crossref]
Demoruelle MK, Deane KD (2012) Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep 14: 472-480. [crossref]
Zhao Z, Hua Z, Luo X, Li Y, Yu L, et al. (2022) Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother 150. [crossref]
Hamed KM, Dighriri IM, Baomar AF, Alharthy BT, Alenazi FE, et al. (2022) Overview of Methotrexate Toxicity: A Comprehensive Literature Review. Cureus 23. [crossref]
Panchal NK, Prince Sabina E (2023) Non-steroidal anti-inflammatory drugs (NSAIDs): A current insight into its molecular mechanism eliciting organ toxicities. Food Chem Toxicol 172. [crossref]
Cutolo M, Shoenfeld Y, Bogdanos DP, Gotelli E, Salvato M, et al. (2024) To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate. Autoimmun Rev 23. [crossref]
Harrington R, Al Nokhatha SA, Conway R (2020) JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data. J Inflamm Res 13: 519-531. [crossref]
Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, et al. (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79: 685-699. [crossref]
Radu AF, Bungau SG (2021) Management of Rheumatoid Arthritis: An Overview. Cells 10. [crossref]
Armuzzi A, Lionetti P, Blandizzi C, Caporali R, Chimenti S, et al (2014) anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab. Int J Immunopathol Pharmacol 27(1 Suppl): 11-32. [crossref]
Tanaka Y (2021) Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs. Rheumatology (Oxford). 60(Suppl 6). [crossref].
Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC (2009) Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev. (crossref)
Sköldstam L, Hagfors L, Johansson G (2003) An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis 62: 208-214. [crossref]
Wang Y, Chen S, Du K, Liang C, Wang S, et al. (2021) Traditional herbal medicine: Therapeutic potential in rheumatoid arthritis. J Ethnopharmacol 279. [crossref]
Ghorani V, Saadat S, Khazdair MR, Gholamnezhad Z, El-Seedi H, et al. (2023) Phytochemical Characteristics and Anti-Inflammatory, Immunoregulatory, and Antioxidant Effects of Portulaca oleracea L.: A Comprehensive Review. Evid Based Complement Alternat Med 2023. [crossref]
Iranshahy M, Javadi B, Iranshahi M, Jahanbakhsh SP, Mahyari S, et al. (2017) A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. J Ethnopharmacol 205: 158-172. [crossref]
Yang Y, Zhou X, Jia G, Li T, Li Y, et al. (2023) Network pharmacology based research into the effect and potential mechanism of Portulaca oleracea L. polysaccharide against ulcerative colitis. Comput Biol Med 161. [crossref]
He Y, Long H, Zou C, Yang W, Jiang L, et al. (2021) Anti-nociceptive effect of Portulaca oleracea L. ethanol extracts attenuated zymosan-induced mouse joint inflammation via inhibition of Nrf2 expression. Innate Immun 27: 230-239. [crossref]
Karimi E, Aryaeian N, Akhlaghi M, Abolghasemi J, Fallah S (2024) The effect of purslane supplementation on clinical outcomes, inflammatory and antioxidant markers in patients with rheumatoid arthritis: A parallel double-blinded randomized controlled clinical trial. Phytomedicine.
Boezio B, Audouze K, Ducrot P, Taboureau O (2017) Network-based Approaches in Pharmacology. Mol Inform 36. [crossref]
Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, et al. (2022) Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci 43: 136-150. [crossref]
Li L, Yang L, Yang L, He C, He Y, et al. (2023) Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine. Chin Med 18. [crossref]
Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7: 146-57. [crossref]
Kumar A, Sreedharan S, Kashyap AK, Singh P, Ramchiary N (2021) A review on bioactive phytochemicals and ethnopharmacological potential of purslane (Portulaca oleracea L). Heliyon 8. [crossref]
Iranshahy M, Javadi B, Iranshahi M, Jahanbakhsh SP, Mahyari S, et al. (2017) A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. J Ethnopharmacol 205: 158-172. [crossref]
Hu Y, Gui Z, Zhou Y, Xia L, Lin K, et al. (2019) Quercetin alleviates rat osteoarthritis by inhibiting inflammation and apoptosis of chondrocytes, modulating synovial macrophages polarization to M2 macrophages. Free Radic Biol Med 145: 146-160. [crossref]
Feng Y, Dang X, Zheng P, Liu Y, Liu D, et al. (2024) Quercetin in Osteoporosis Treatment: A Comprehensive Review of Its Mechanisms and Therapeutic Potential. Curr Osteoporos Rep 22: 353-365. [crossref]
Yamaura K, Nelson AL, Nishimura H, Rutledge JC, Ravuri SK, et al. (2023) Therapeutic potential of senolytic agent quercetin in osteoarthritis: A systematic review and meta-analysis of preclinical studies. Ageing Res Rev 90. [crossref]
Yang SC, Chen PJ, Chang SH, Weng YT, Chang FR, et al. (2018) Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity. Biochem Pharmacol 154: 384-396. [crossref]
Chai S, Yang Y, Wei L, Cao Y, Ma J, et al. (2024) Luteolin rescues postmenopausal osteoporosis elicited by OVX through alleviating osteoblast pyroptosis via activating PI3K-AKT signaling. Phytomedicine 128. [crossref]
Pan D, Li N, Liu Y, Xu Q, Liu Q, et al. (2018) Kaempferol inhibits the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes by blocking activation of the MAPK pathway. Int Immunopharmacol 55: 174-182. [crossref]
Kalliolias GD, Ivashkiv LB (2016) TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol 12: 49-62. [crossref]
Lee SJ, Lee A, Hwang SR, Park JS, Jang J, et al. (2014) TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis. Mol Ther 22: 397-408. [crossref]
Moelants E-A, Mortier A, Van Damme J, et al. (2013) Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol 91: 393-401. [crossref]
Cici D, Corrado A, Rotondo C, Cantatore FP (2019) Wnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis. Int J Mol Sci 20. [crossref]
Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 4. [crossref]
Neurath MF, Finotto S (2011) IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev 22: 83-89. [crossref]
Huizinga TW, Fleischmann RM, Jasson M, Radin AR, van Adelsberg J, et al. (2014) Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial. Ann Rheum Dis 73: 1626-1634. [crossref]
Scott LJ (2017) Tocilizumab: A Review in Rheumatoid Arthritis. Drugs 77: 1865-1879. [crossref]
Cheng C, Zhang J, Li X, Xue F, Cao L, et al. (2023) NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice. Signal Transduct Target Ther 8. [crossref]
Di Lorenzo A, Fernández-Hernando C, Cirino G, Sessa WC (2009) Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci U S A. Aug 25;106(34): 14552-14557. [crossref]
Gao WL, Li XH, Dun XP, Jing XK, Yang K, et al. (2020) Grape Seed Proanthocyanidin Extract Ameliorates Streptozotocin-induced Cognitive and Synaptic Plasticity Deficits by Inhibiting Oxidative Stress and Preserving AKT and ERK Activities. Curr Med Sci 40: 434-443. [crossref]
Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Front Oncol. 2022 Mar 24;12: 819128. [crossref]
Sun K, Luo J, Guo J, Yao X, Jing X, et al. (2020) The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage 28: 400-409. [crossref]
Ba X, Huang Y, Shen P, Huang Y, Wang H, et al. (2021) WTD Attenuating Rheumatoid Arthritis via Suppressing Angiogenesis and Modulating the PI3K/AKT/mTOR/HIF-1α Pathway. Front Pharmacol 27. [crossref]
Liu C, He L, Wang J, Wang Q, Sun C, et al. (2020) Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways. J Ethnopharmacol 260. [crossref]
Shi X, Jie L, Wu P, Zhang N, Mao J, et al. (2022) Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3K/AKT and NF-κB pathways. J Ethnopharmacol 28. [crossref]
Lin C, Shao Y, Zeng C, Zhao C, Fang H, et al. (2018) Blocking PI3K/AKT signaling inhibits bone sclerosis in subchondral bone and attenuates post-traumatic osteoarthritis. J Cell Physiol 233: 6135-6147. [crossref]
Lewis MJ (2024) Predicting best treatment in rheumatoid arthritis. Semin Arthritis Rheum 64S.[crossref]
Li H, Shi W, Shen T, Hui S, Hou M, et al. (2023) Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer. Medicine (Baltimore) 102. [crossref]
Zhou T, Guo S, Zhang Y, Weng Y, Wang L, et al. (2017) GATA4 regulates osteoblastic differentiation and bone remodeling via p38-mediated signaling. J Mol Histol 48: 187-197. [crossref]
Wu Y, Xia L, Zhou Y, Xu Y, Jiang X (2015) Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. Cell Prolif 48: 375-384. [crossref]
Wang G, Wang F, Zhang L, Yan C, Zhang Y (2021) miR-133a silencing rescues glucocorticoid-induced bone loss by regulating the MAPK/ERK signaling pathway. Stem Cell Res Ther 12. [crossref]
Chen L, Zhan CZ, Wang T, You H, Yao R (2020) Curcumin Inhibits the Proliferation, Migration, Invasion, and Apoptosis of Diffuse Large B-Cell Lymphoma Cell Line by Regulating MiR-21/VHL Axis. Yonsei Med J 61: 20-29. [crossref]

Can Artificial Intelligence Revolutionize Mental Health? Exploring Cognitive Models, Chatbots, and Future Trends in Digital Psychotherapy and Stress Resilience for Enhanced Emotional Well-being

2 Replies

DOI: 10.31038/AWHC.2025822

Abstract

Mental health challenges among adults and children are becoming increasingly prevalent globally, with technology offering a promising approach for timely interventions. Artificial Intelligence (AI) has emerged as a key player in enhancing mental health care, particularly through cognitive computer-centered models that enable digital analysis of mental health. However, despite its potential, there is limited consensus on AI’s role in mental health care. The novelty of the review lies in its comprehensive assessment of AI-driven digital models that analyze mental health in real-time, integrating data from various digital activities. A systematic approach was adopted to review relevant literature from 2024, including studies on AI in psychotherapy, mental health assessment, and stress detection. For the review, studies were selected based on relevance to AI in mental health, with inclusion criteria exploring AI applications in mental healthcare. Data was extracted systematically, including study design, interventions, outcomes, and AI technologies used. Synthesis involved qualitative analysis of findings to assess trends, challenges, and innovations in AI-driven mental health care. Results indicate that AI technologies, particularly chatbots and machine learning models, have shown promise in identifying mental health issues, offering personalized interventions, and providing real-time emotional support. However, challenges related to privacy, ethical concerns, and the need for more robust datasets were identified. The discussion highlights the need for continuous improvements in AI accuracy and the integration of human oversight to ensure effective mental health care. The conclusion emphasizes the transformative potential of AI in mental health but calls for further research to address existing limitations. Implications for practice suggest that AI could be incorporated into digital mental health interventions, particularly in resource-limited settings. Future research should focus on refining AI algorithms, improving data security, and conducting large-scale clinical trials to assess long-term effectiveness in diverse populations. Limitations include small sample sizes and limited long-term data.

Keywords

Artificial intelligence in health, Mental health, Digital interventions, Psychotherapy, AI-driven mental health assessments

Introduction

The integration of Artificial Intelligence into mental health care has rapidly gained momentum, offering innovative solutions to diagnose, treat, and manage various mental health conditions. AI has the potential to improve the accuracy and efficiency of mental health assessments, enable personalized treatments, and provide scalable solutions for managing large patient populations. However, despite the advancements, there are several critical challenges that hinder the full-scale implementation of AI technologies in this domain. One significant challenge is the lack of transparency and explainability in AI models, particularly those that rely on deep learning techniques. These models, while highly accurate, are often considered “black boxes,” making it difficult to interpret how they arrive at their conclusions. This lack of interpretability can be a significant barrier to widespread adoption in healthcare settings. As noted by [1], Explainable AI (XAI) techniques have emerged as a solution to this issue, helping make AI decisions more transparent and understandable. XAI could provide clearer insights into the rationale behind AI-driven diagnoses and treatment suggestions, thus enhancing trust among healthcare providers and patients. Without this transparency, there is a risk that healthcare professionals and patients may be reluctant to fully trust or adopt AI-driven solutions, especially when it involves critical mental health decisions. [2] also raised concerns about the balance between interpretability and accuracy in AI models used for mental health assessment. While explainability is essential, it should not come at the cost of the model’s ability to provide accurate diagnoses or predictions. The complexity of mental health disorders, which often involve nuanced psychological and emotional factors, requires AI models that can effectively balance these two aspects. Striking this balance is a practical challenge that requires further refinement in AI techniques to ensure both reliability and transparency. These issues contribute to a wider problem of the limited acceptance of AI in clinical settings. Mental health professionals may be hesitant to rely on AI tools due to concerns about their accuracy, the complexity of their deployment, or the lack of a clear understanding of how AI systems work. Consequently, for AI to reach its full potential in mental health care, these challenges must be addressed, and further research is needed to develop more interpretable, reliable, and ethically sound AI models.

The integration of Artificial Intelligence into mental health care is not only driven by technological potential but also accompanied by significant data privacy and ethical concerns. AI applications frequently require access to sensitive patient data, which heightens the risks associated with data security, privacy breaches, and potential misuse of personal health information. As [3] discusses in his comprehensive evaluation of digital mental health literature, these concerns extend to issues of consent, data ownership, and patient autonomy. Ensuring that AI systems are compliant with data protection regulations, such as the General Data Protection Regulation (GDPR) in the European Union or similar laws in other jurisdictions, is crucial. These regulations aim to protect patient privacy and prevent misuse of personal information yet navigating these legal requirements while implementing AI technologies remains a complex challenge. Healthcare providers and developers must prioritize robust data encryption, anonymization techniques, and secure data storage solutions to safeguard sensitive patient information. Ethical considerations also extend to societal and cultural differences that may affect AI-driven mental health care outcomes. [4] highlights the importance of addressing these differences to prevent potential bias and ensure fair treatment. For instance, AI models trained on datasets from predominantly Western populations might not perform as effectively for individuals from diverse cultural backgrounds, leading to inequitable care. To mitigate this issue, AI systems need to be designed with sensitivity to cultural norms, language differences, and the unique mental health needs of various demographic groups. This requires ongoing efforts in diverse data collection, culturally relevant content, and inclusive design practices to create more universally applicable AI solutions.

In addition to ethical and privacy concerns, the accessibility and affordability of AI technologies pose significant barriers to their widespread adoption in mental health care. Gallegos et al. (2024) discuss the potential for AI chatbots to improve mental health but emphasize that their deployment should address issues of accessibility and affordability. Marginalized populations may face barriers such as limited technological access, poor internet connectivity, and financial constraints that prevent them from benefiting from AI-driven tools. For AI to truly transform mental health care, it must be designed to reach all segments of society, including those who might otherwise be excluded due to economic or geographical limitations. Furthermore, the lack of standardized approaches to AI implementation in mental health care complicates efforts to scale and integrate AI interventions effectively. [5] argue that while AI has the potential to revolutionize mental health care, its implementation must be aligned with existing clinical practices and protocols. There is currently no consensus on best practices or regulatory frameworks for the deployment of AI technologies in mental health, leading to inconsistencies in implementation and potential discrepancies in care quality. Establishing standardized models and guidelines for AI use in mental health care is essential for ensuring that AI interventions are safe, effective, and equitable across diverse healthcare settings. Lastly, stigma and skepticism about the role of AI in addressing mental health concerns continue to pose significant challenges. Despite promising applications like cognitive behavioral therapy (CBT) facilitated by AI, as demonstrated by [6], there remains a prevailing skepticism about the effectiveness of AI for serious mental health conditions. The stigma associated with mental health can deter individuals from seeking help through AI systems, as patients may prefer traditional human interactions over engaging with AI-driven tools. Overcoming this skepticism requires targeted education, transparent communication about the benefits and limitations of AI, and demonstrating tangible improvements in mental health outcomes through AI interventions.

The primary objective of the review is to synthesize the growing body of research on AI applications in mental health, focusing on identifying challenges and opportunities for further development. The review aims to explore the role of AI in mental health care, examining various applications such as AI-based diagnostics, chatbots for psychotherapy, and tools for stress detection and resilience building. [7] highlighted AI’s significant potential in stress detection and interventions aimed at building resilience, emphasizing its expanding role in mental health care. Additionally, the review seeks to assess the impact of AI on mental health care by evaluating the effectiveness of AI-driven interventions in improving diagnosis, treatment, and patient monitoring, and its potential to expand access to mental health services. [8] demonstrated how AI can help in understanding complex mental health challenges, particularly in contexts such as war and emotional trauma, highlighting its broader impact. The review will also address ethical, legal, and privacy concerns associated with AI in mental health, including the security of patient data, issues of consent, and AI’s role in clinical decision-making. [3] stressed the importance of tackling these concerns to ensure AI applications are developed and deployed responsibly. Furthermore, the review will identify gaps in the literature and propose directions for future research, particularly in improving AI model transparency and establishing standards for AI-based mental health interventions. [9] suggested that while AI has great potential in enhancing positive mental health, future research should focus on refining these technologies and integrating them into mainstream healthcare systems. Finally, the review will assess technological innovations in the mental health space, especially AI-driven stress detection and intervention technologies. [7] noted the significant advancements in stress detection and resilience-building interventions through AI, an area that offers ample opportunities for future exploration and refinement. By synthesizing existing research, the review aims to provide a comprehensive overview of AI’s current and future impact on mental health care, identifying areas that require further investigation and development.

The novelty of the review lies in its ability to integrate a diverse set of studies, offering a comprehensive and holistic analysis of AI’s role in mental health care, which has not been fully explored in previous literature. While earlier reviews have primarily concentrated on specific applications, such as digital health interventions [10] or the role of AI in psychotherapy [6], the review stands out by encompassing a broad spectrum of AI applications, ranging from AI-driven chatbots to AI-based stress detection tools. This comprehensive synthesis enables a more nuanced understanding of AI’s impact across various facets of mental health care, shedding light on the potential for AI to transform diagnosis, treatment, and patient monitoring. Another unique contribution of the review is its strong focus on the ethical, privacy, and accessibility challenges associated with AI in mental health. While some studies, such as those by [4,11], have acknowledged these concerns, few reviews have delved deeply into how these challenges can be mitigated to enable the successful integration of AI into mental health care systems. Addressing these issues is crucial for ensuring that AI applications not only enhance the quality of care but also protect patient privacy, promote informed consent, and ensure equitable access, particularly among underserved populations. The review, therefore, provides a much-needed exploration of how these ethical and accessibility barriers can be overcome, offering novel insights for developers, healthcare professionals, and policymakers. Furthermore, the review aims to identify gaps in the current body of literature, an area that remains underexplored. It highlights critical issues such as the lack of standardized approaches to AI implementation, the need for improved transparency in AI models, and the potential for AI to serve marginalized groups. [1] emphasized the importance of explainable AI (XAI), yet this aspect remains inadequately studied, presenting a vital area for future research. The review thus not only synthesizes existing knowledge but also paves the way for future investigations into these gaps. Additionally, the review is distinguished by its cross-disciplinary approach, drawing from diverse fields such as stress resilience, mental health, cybersecurity, and healthcare policy. By integrating research from various domains, the review bridges gaps between technological and healthcare disciplines, offering a more comprehensive and multifaceted understanding of AI’s potential in mental health. For instance, studies by [4] highlight the importance of aligning AI technologies with healthcare policies and risk management practices, suggesting that collaboration across disciplines is necessary to address the complex challenges posed by AI integration into mental health care. This interdisciplinary perspective enables a more holistic view of AI’s potential to revolutionize mental health services, ensuring that its adoption is both effective and ethically sound. Ultimately, the review provides a valuable contribution to the literature by synthesizing recent studies on AI in mental health, highlighting key challenges, objectives, and future directions for research. It not only offers a comprehensive analysis of AI’s current and potential impact but also pushes the boundaries of existing knowledge, providing new perspectives on how AI can improve mental health outcomes globally. Researchers, policymakers, and healthcare professionals will find the review particularly valuable as they seek to explore the transformative potential of AI in mental health care, as it offers novel insights into the ways AI can be ethically and effectively integrated into mental health systems worldwide.

Methods

The systematic approach employed for the review was designed to rigorously analyze the current state of artificial intelligence applications in mental health, ensuring the inclusion of high-quality, relevant, and methodologically sound studies. The eligibility criteria formed the foundation for selecting articles that align with the review’s objectives, focusing on the integration of AI in mental health diagnostics, interventions, and therapeutic practices. Topic relevance was the foremost inclusion criterion, ensuring that only studies explicitly addressing AI’s role in areas such as cognitive analysis, psychotherapy, and digital mental health interventions were considered. To maintain the review’s relevance to contemporary advancements, only articles published in 2024 were included, reflecting the latest innovations and research in the field. Moreover, the credibility of the sources was paramount; thus, only studies appearing in peer-reviewed journals or conference proceedings were selected to guarantee methodological rigor and reliability. The criteria for methodological rigor ensured that each study provided comprehensive details on its research design, the AI techniques employed, and the mental health outcomes investigated, offering a robust understanding of the domain. To encompass a broad scope, the review included studies addressing geographical and demographic diversity, analyzing AI-driven mental health interventions across varied populations, including children, adolescents, and adults. Lastly, language served as a practical criterion, with only studies published in English being reviewed, ensuring accessibility and uniformity in understanding. These meticulously designed eligibility criteria provided a structured framework for identifying and selecting studies, enabling a focused and comprehensive evaluation of how AI is transforming mental health care, particularly through cutting-edge technologies and innovative applications. By adhering to these criteria, the review ensured a robust selection process that laid the groundwork for meaningful analysis and insights into this rapidly evolving field.

The exclusion criteria were meticulously defined to maintain the focus and rigor of the review, ensuring that only high-quality, relevant studies were included in the analysis. First, articles that discussed mental health without a substantial emphasis on artificial intelligence or its related technologies were excluded. This step was critical to aligning the review’s objectives with its scope, which aimed to investigate AI-driven advancements in mental health care rather than general mental health studies. For instance, papers that solely addressed traditional psychological interventions, mental health theories, or demographic studies without integrating AI applications were deemed outside the purview of the review. Secondly, studies for which the full text was not accessible were excluded to ensure comprehensive data extraction and accurate assessment. Abstract-only records, unavailable manuscripts, or restricted-access documents posed a significant limitation as they hindered the ability to verify methodology, results, and conclusions, which are crucial for systematic evaluation. Thirdly, non-research articles such as editorials, opinion pieces, and commentaries were excluded to maintain the academic rigor of the review. While such articles may provide valuable insights or contextual discussions, they often lack the methodological framework and empirical evidence required for systematic analysis. Similarly, conference abstracts or summary presentations were excluded due to insufficient detail about study design, methods, or outcomes. These exclusion criteria were essential to uphold the review’s methodological integrity, ensuring that only peer-reviewed, full-text studies with a clear focus on AI applications in mental health were included. This rigorous selection process minimized biases, enhanced the reliability of findings, and supported the synthesis of actionable insights that could contribute meaningfully to the field of AI in mental health.

The study selection process was meticulously designed and implemented through a systematic three-phase approach to ensure the inclusion of high-quality and relevant studies. The first phase, Identification, involved a comprehensive search strategy leveraging academic databases such as PubMed, Scopus, and IEEE Xplore. The search utilized carefully selected keywords, including “Artificial Intelligence,” “mental health,” “digital interventions,” “psychotherapy,” and “AI-enabled cognitive analysis,” to capture a broad yet focused range of relevant studies. In addition to database searches, manual screening of bibliographies of identified articles was conducted to locate supplementary studies that might not have been retrieved during the initial search. This dual approach aimed to enhance the comprehensiveness of the study pool while minimizing the risk of missing relevant literature. The second phase, Screening, focused on an initial review of the titles and abstracts of the identified articles. Two independent reviewers systematically assessed these materials to determine their relevance to the study’s objectives. The dual-reviewer approach minimized subjective bias and ensured consistency in the selection process. Articles failing to meet the inclusion criteria such as those with a non-AI focus, lacking methodological rigor, or not published in peer-reviewed journals were excluded at this stage. This process allowed for the rapid elimination of irrelevant or low-quality studies, ensuring that only potentially relevant articles progressed to the next phase. The third phase, Eligibility, involved a detailed review of the full texts of shortlisted articles. This step was critical in verifying the studies’ alignment with the defined inclusion criteria, such as the focus on AI applications in mental health and sufficient methodological detail. Discrepancies between the two reviewers during the eligibility phase were addressed through discussions, and if necessary, a third reviewer was consulted to achieve consensus. This collaborative resolution process ensured a fair and accurate evaluation of borderline cases, further strengthening the reliability of the selection process. The outcome of this rigorous process was the identification of 12 high-quality studies out of the 50 initially retrieved articles. These studies were selected based on their adherence to the inclusion criteria and their ability to contribute valuable insights to the review. By employing a systematic and transparent approach to study selection, the review ensured that the included literature represented a comprehensive and credible basis for analyzing the role of artificial intelligence in mental health interventions. This robust process underscores the reliability and validity of the subsequent findings and conclusions drawn in the review.

The data extraction process was carried out with precision and adherence to a standardized protocol to ensure consistency and comprehensiveness across all included studies. Key information from each study was systematically recorded in a predefined data extraction sheet, structured to capture all critical elements of relevance. This structured approach began with general information, encompassing the names of authors, the year of publication, and the source of the study, whether it was a journal article or conference proceeding. This basic information provided context and facilitated traceability of the literature. The study objectives section captured the primary research questions or hypotheses addressed in each study, ensuring that the focus on the intersection of AI and mental health was adequately documented. This section also included specific details about how the study explored the role of AI technologies in mental health interventions, such as the use of cognitive models or digital tools. These objectives helped categorize the studies according to their thematic and technological focus, aiding in a more nuanced synthesis of findings. Details of the methodological approaches used in each study were also extracted, ensuring that the review considered a diverse array of research designs. The methodology section captured study designs such as experimental studies, narrative reviews, or bibliometric analyses. Population or sample characteristics, including the demographics or specific groups studied, were noted to assess the generalizability of the findings. For instance, some studies focused on children or adolescents, while others considered broader populations or specialized groups like war-affected individuals. The AI techniques or models employed, such as machine learning algorithms, explainable AI (XAI) frameworks, or chatbot technologies, were also documented. This level of detail provided insights into the technological innovations being applied in the mental health domain and their potential scalability.

The key findings of each study were carefully extracted, focusing on the mental health outcomes analyzed and the unique contributions of the research to AI applications in mental health. Innovations, such as the development of novel AI models or strategies for improving mental health outcomes, were highlighted alongside any limitations noted by the authors. This helped contextualize the studies’ contributions and identify gaps in the literature. Finally, the impact and implications section addressed the real-world applicability of the studies and the future directions proposed by the authors. This included potential applications of the findings in clinical practice, digital therapy, or mental health policy. Additionally, forward-looking insights into how the integration of AI could evolve within the mental health domain were documented. These elements ensured that the review captured not only the current state of research but also its trajectory and implications for future innovation. Overall, this rigorous data extraction process ensured a consistent, in-depth understanding of the included studies, facilitating a comprehensive synthesis of their contributions to the field of AI in mental health.

The data synthesis process employed a structured narrative synthesis approach, focusing on identifying, analyzing, and integrating key themes and trends from the selected studies. The first step, thematic analysis, involved categorizing the extracted data into thematic clusters to explore recurring concepts and areas of focus. One prominent theme was AI-driven diagnostics, as highlighted by [2,10], who discussed the use of cognitive computer-centered digital models for early detection of mental health issues, particularly in children and adolescents. This theme underscored the potential of AI in transforming traditional diagnostic processes by enabling more accurate and timely assessments. Another critical theme was digital interventions and chatbots, with [5] emphasizing the role of AI-powered chatbots in augmenting mental health support systems by offering accessible, immediate, and scalable interventions. A further thematic cluster was explainable AI (XAI) in psychotherapy, explored by [1], which addressed the growing demand for transparency and accountability in AI-driven mental health interventions. XAI models were noted for their potential to enhance trust and efficacy in AI applications by allowing clinicians and patients to understand AI-driven decisions. Lastly, studies like [9] focused on positive mental health and resilience, highlighting AI’s capacity to foster psychological well-being through interventions designed to build resilience and mitigate stress.

The second step, comparative analysis, juxtaposed studies based on their methodologies, AI models, and outcomes. For instance, [7] demonstrated the use of stress-detection algorithms to monitor and intervene in mental health conditions, whereas [8] explored AI applications in analyzing the mental health impacts of war. Comparing these innovations revealed the versatility of AI in addressing diverse mental health challenges and its advantages over traditional therapeutic methods in terms of scalability and precision. Studies also varied in their populations, ranging from adolescents to war-affected individuals, highlighting the adaptability of AI to different demographic and contextual needs. The final step, integration of results, synthesized key findings into a comprehensive narrative. Emerging trends, such as AI’s role in adolescent mental health assessment [2], were emphasized as critical areas of growth. Concurrently, limitations like ethical concerns, data privacy challenges, and biases in AI models, as discussed by [12], were noted as significant hurdles that must be addressed. Future directions proposed by the authors, such as the integration of AI into telepsychiatry [4], were identified as promising avenues for expanding the impact of AI in mental health care. In conclusion, this systematic review methodically analyzed studies published in 2024 to evaluate the state of AI-driven mental health interventions. By adopting rigorous eligibility criteria, a structured study selection process, and a narrative synthesis approach, the review provided a holistic understanding of the advancements, challenges, and potential of AI in mental healthcare. To fully leverage AI’s transformative capabilities, future research must prioritize addressing ethical concerns, improving AI transparency, and exploring underrepresented populations to ensure equitable access to these innovative interventions. This synthesis not only outlines the current landscape but also offers a roadmap for future exploration and application of AI in mental health.

Results and Findings

Artificial intelligence is making significant strides in transforming the landscape of mental health care, offering new opportunities to diagnose, monitor, and intervene in mental health conditions with unprecedented precision. AI’s integration into mental health has garnered considerable attention in recent years, particularly for its potential to enhance diagnostic accuracy, personalize interventions, and improve overall mental well-being. By leveraging advanced technologies such as machine learning algorithms, AI can analyze vast amounts of data, identifying patterns and markers that may otherwise go unnoticed by human clinicians. One notable example is the work of [10], who developed a cognitive computer-centered digital analysis model specifically designed for assessing children’s mental health. Children are often an overlooked group in traditional mental health assessments, making early detection of mental health disorders crucial for effective intervention. Agarwal & Sharma’s AI model utilizes behavioral patterns and digital markers to provide a more objective and accurate approach to diagnosis. Their study highlights the remarkable capability of AI to enhance diagnostic accuracy by up to 85%, significantly outperforming traditional methods, which typically rely on subjective judgment and manual assessments. This advancement is particularly impactful in the context of pediatric mental health, where early intervention is key to improving long-term outcomes. The AI-driven model’s ability to identify subtle patterns in data offers a deeper level of insight into children’s mental health, which may not be immediately apparent through conventional methods. This is especially significant given that many mental health issues in children go undiagnosed due to the complexity of the symptoms and the challenges of assessing them through traditional means. AI’s ability to detect these patterns before they become more pronounced allows for timely interventions, potentially preventing more severe conditions from developing in the future. Furthermore, the study underscores AI’s transformative role in reshaping mental health diagnostics by offering a more consistent, objective, and accurate approach. This is especially critical in addressing the mental health needs of vulnerable populations like children, who may not have access to specialized care or may not be able to articulate their experiences effectively. AI’s ability to provide more reliable and accessible mental health assessments promises to democratize mental health care, ensuring that individuals receive the attention they need regardless of their location or socio-economic status. Overall, the research by [10] exemplifies the growing impact of AI on mental health care, emphasizing its potential to revolutionize how conditions are identified, diagnosed, and treated, with significant implications for enhancing mental well-being across various age groups, particularly those most at risk of being overlooked in traditional settings.

[3] bibliometric analysis provides a thorough examination of the rising role of artificial intelligence in digital mental health research, offering valuable insights into the evolving landscape of AI-powered mental health interventions. The study uncovers significant trends in the application of AI, particularly the increasing adoption of AI technologies in predictive modeling and personalized care. These technologies enable the development of tools for real-time mental health monitoring, allowing for the continuous observation of individuals’ mental well-being. One of the key findings of the analysis is AI’s remarkable ability to predict mental health conditions before they become clinically evident, a breakthrough that could revolutionize preventive care. Predictive AI models can potentially detect early warning signs of mental health disorders, allowing for timely interventions that prevent the onset of more severe conditions. This proactive approach is a significant advancement over traditional models, which often focus on treating mental health conditions after they have already manifested. However, while the promise of AI in preventive care is substantial, [3] also identifies significant challenges in the field, particularly related to ethical considerations and data security. As AI technologies are increasingly used to handle sensitive mental health data, the risks associated with privacy breaches, misuse of data, and the potential for algorithmic bias become more pronounced. Alan emphasizes the need for robust data protection measures and ethical guidelines to ensure the responsible use of AI in mental health applications. This includes safeguarding personal information, preventing discriminatory outcomes, and ensuring the AI models are transparent and accountable. To address these issues, Alan calls for greater interdisciplinary collaboration between AI developers, mental health professionals, and policymakers. Such collaboration is crucial to ensure that AI tools are designed with both ethical and practical considerations in mind, promoting safe and equitable access to mental health care. As AI continues to advance, its potential to transform mental health care is immense, but careful attention to ethical and security challenges will be paramount in ensuring that the benefits of these technologies are realized without compromising individual rights or well-being.

In a similar vein, [4] explores the effectiveness of AI in real-time mental health monitoring and personalized interventions, offering a comprehensive overview of how AI is being used to enhance mental health care delivery, especially in resource-limited settings. The study highlights AI’s potential to automate diagnostic processes, making it possible to scale mental health interventions in ways that traditional models could not. By enabling continuous monitoring without the need for direct human intervention, AI provides a unique advantage in the management of mental health conditions. This capability is particularly valuable in detecting early signs of mental health issues, which can be addressed before they escalate into more severe conditions. Alhuwaydi also stresses that continuous surveillance through AI can mitigate the progression of mental health issues by allowing for immediate intervention, thus preventing long-term negative outcomes. The ability of AI to monitor individuals over time, using real-time data from various sources such as wearables or digital health platforms, means that interventions can be timelier and more personalized, responding to changes in an individual’s mental health status as they occur. However, like Alan, Alhuwaydi also underscores the need for regulatory frameworks to address potential risks associated with the use of AI in mental health. One of the key concerns highlighted by the study is the risk of bias in AI algorithms, which could lead to inaccurate assessments or disproportionate impacts on certain populations. Alhuwaydi argues that AI models must be designed with fairness and equity in mind, ensuring they deliver accurate and unbiased assessments across diverse populations. This includes accounting for demographic factors such as age, gender, race, and socioeconomic status to avoid exacerbating existing disparities in mental health care. To ensure the effectiveness and fairness of AI interventions, Alhuwaydi advocates for the development of transparent, explainable, and equitable AI models that can be trusted by both mental health professionals and patients. While AI holds immense promise in advancing mental health care by enabling real-time monitoring and personalized interventions, both Alan and Alhuwaydi highlight the importance of developing ethical frameworks and regulatory standards to ensure the responsible and effective use of AI in this sensitive field. As AI continues to evolve, its integration into mental health care systems will require careful attention to these challenges to maximize its benefits while safeguarding the rights and well-being of individuals.

The integration of artificial intelligence into psychotherapy is emerging as a transformative force, expanding the reach and effectiveness of traditional therapeutic practices, particularly in underserved or remote areas. [6] explores how AI tools, such as virtual assistants and chatbots, are increasingly being utilized to augment cognitive-behavioral therapy (CBT) and monitor emotional states, providing continuous support for individuals in need. These AI tools not only help deliver therapy but also gather valuable data that can assist therapists in tailoring interventions to meet specific needs. One of the key benefits highlighted in the study is AI’s ability to facilitate remote therapy, which can be a game-changer for those in geographically isolated locations or for individuals who face social stigma related to seeking help. This remote capability makes therapy more accessible, enabling individuals to receive much-needed support without the barriers imposed by distance or societal judgment. Despite these advantages, [6] acknowledges the significant challenges of trust and privacy that accompany the widespread adoption of AI in mental health care. Users’ willingness to embrace AI tools is largely contingent on their confidence that these technologies can securely handle sensitive personal data. Therefore, ensuring robust security measures and transparency in AI systems is essential for fostering trust and encouraging their adoption. Furthermore, the protection of privacy in AI-driven mental health applications is paramount to prevent potential misuse of data, which could lead to harm or exploitation. Thus, while AI presents numerous opportunities to enhance the accessibility and quality of mental health care, overcoming these trust and privacy barriers remains a critical issue that must be addressed for these technologies to achieve their full potential.

Similarly, [8] examine the application of AI in mental health interventions for populations affected by war and emotional distress. The study underscores the ability of AI to analyze complex emotional datasets, which can provide valuable insights into the mental health status of individuals in conflict zones. By detecting patterns in emotional responses to traumatic events, AI-driven tools can help identify at-risk individuals and guide the development of targeted mental health interventions. This is particularly significant in conflict zones, where the mental health consequences of war and trauma are often exacerbated by a lack of adequate resources and support services. AI’s ability to process large amounts of emotional data can enhance the precision and effectiveness of interventions, ensuring that individuals receive timely and appropriate care. However, [8] stress the importance of ethical considerations when deploying AI in such sensitive contexts. The potential for harm or exploitation is high, as vulnerable populations in war-torn regions may not have the means to protect their personal data or may be subjected to AI systems that lack cultural sensitivity or understanding of their unique experiences. The study calls for responsible deployment of AI technologies that prioritize the dignity and privacy of affected individuals while ensuring they receive the mental health support they need. This approach should include a strong ethical framework, clear data governance policies, and safeguards to prevent misuse, ensuring that AI applications in conflict zones contribute positively to the well-being of individuals without compromising their rights. In both studies, the role of AI in mental health care demonstrates its transformative potential, but it also highlights the need for careful, ethical considerations to ensure that these innovations are deployed in a manner that respects the rights and needs of those they are intended to help. AI can significantly enhance the accessibility and personalization of mental health interventions, but it is crucial to address the challenges related to privacy, trust, and ethical deployment to ensure that these technologies can fulfill their promise in a responsible and beneficial way.

In addition, [12] investigate the transformative potential of artificial intelligence in mental health care, particularly in the realms of early diagnosis and personalized interventions. They underscore the game-changing capabilities of AI, emphasizing its ability to be integrated into virtual reality (VR) and augmented reality (AR) platforms, which are becoming increasingly prominent in the field of mental health therapy. AI-powered VR, for instance, offers the potential to create immersive therapeutic environments that can be tailored to individual patients’ needs. Such platforms are especially beneficial for exposure therapy, where patients are gradually and safely exposed to situations or environments that trigger anxiety, trauma, or phobias. This controlled, repeatable exposure in VR environments allows for a safe space to confront fears, facilitating therapeutic progress that might be more challenging to achieve in traditional settings. Moreover, the personalized and adaptive nature of AI within VR and AR platforms ensures that interventions are not only precise but can evolve with the patient’s progress, ensuring that the treatment remains responsive and relevant. The study advocates for collaboration among multiple stakeholders, including mental health professionals, technologists, and policy makers, to optimize the integration of these advanced technologies into mental health care. A multi-stakeholder approach is essential to ensuring that the AI-driven VR and AR platforms are designed with a deep understanding of therapeutic needs and are implemented with proper safeguards, ethical considerations, and patient-centered frameworks. This type of AI-enhanced therapy offers patients more than just passive interaction; it provides immersive, engaging experiences that could fundamentally alter how therapeutic interventions are delivered. Such technologies offer enormous promise in revolutionizing therapeutic approaches, particularly in terms of accessibility, effectiveness, and personalization, making them valuable tools for a wide range of mental health conditions, including anxiety, PTSD, and depression.

In parallel, [5] explore the role of AI chatbots in enhancing mental health care accessibility, particularly in reducing barriers to seeking help and minimizing the stigma often associated with mental health issues. AI chatbots offer 24/7 availability, providing immediate, anonymous support to users who may not feel comfortable reaching out to human professionals, especially in times of crisis. The convenience and anonymity offered by these chatbots can significantly lower the threshold for individuals who might otherwise delay or avoid seeking help due to fear of judgment. This increased access to support is a critical factor in addressing the mental health care gap, particularly in areas where professional mental health resources are scarce or in regions with high levels of social stigma surrounding mental health. However, the study by [5] also highlights the limitations of AI chatbots. While they are effective in providing immediate, initial support and guidance for mild to moderate mental health conditions, chatbots are not equipped to handle severe mental health crises. Their functionality is limited when it comes to more complex or high-risk conditions such as suicidal ideation, severe depression, or psychosis, which require the intervention of trained mental health professionals. Therefore, the study suggests that AI chatbots should be seen as a supplementary tool rather than a replacement for human professionals. They offer an essential first line of support, particularly for those hesitant to engage with traditional mental health services, but they should be integrated into a broader mental health care system, where they complement, rather than substitute, human intervention. The combination of AI chatbots with in-person or telehealth services could create a more comprehensive, accessible mental health support system, catering to a wide range of needs, from basic mental wellness maintenance to more intensive crisis intervention. [5] advocate for continued development in AI chatbot technology, with an emphasis on improving their ability to triage users effectively and refer them to the appropriate professional help when necessary, ensuring that individuals receive the right level of care at the right time. Together, these studies demonstrate the vast potential of AI to enhance mental health care, particularly in areas of accessibility, early intervention, and personalized treatment. While challenges remain, particularly around the ethical implications and limitations of AI technologies, the integration of these tools into mental health care holds considerable promise for the future.

Meanwhile, [1] provide a comprehensive analysis of Explainable Artificial Intelligence (XAI) and its pivotal role in enhancing digital mental health interventions. A central finding from the study is that XAI significantly improves transparency in the decision-making processes of AI systems, which is particularly important in the context of mental health. Traditional AI models are often perceived as “black boxes,” where users struggle to understand how decisions or recommendations are made, leading to skepticism and distrust. However, by using XAI, which is designed to make AI’s decision-making processes more understandable and interpretable, users can better grasp how diagnoses, recommendations, and treatment options are derived. This transparency is crucial in increasing the acceptance and trust of AI-based systems, especially in sensitive areas like mental health, where users’ concerns about privacy, fairness, and accuracy are heightened. The study emphasizes that a clear and understandable rationale behind AI-driven decisions can foster a sense of reliability, enabling users to feel more confident in using these technologies for their mental health. Trust is a cornerstone of effective mental health interventions, as patients need to feel secure in the tools they rely on for diagnosis and treatment. Furthermore, [1] stress the significance of user-centric design in AI-based mental health interventions, underscoring the necessity for AI tools to be tailored to meet the diverse needs and preferences of users. With mental health conditions spanning various demographics, it is vital that AI systems consider factors such as cultural, social, and individual differences, creating a more personalized experience that increases engagement and efficacy. By designing AI systems that adapt to the unique challenges of diverse populations, such as different age groups, genders, and ethnicities, these tools can ensure that their interventions are not only effective but also equitable and respectful of users’ varying contexts. This aspect of user-centric design is a significant factor in fostering the widespread adoption of AI technologies in mental health care, as it assures users that the systems are responsive to their particular needs, and not generic or one-size-fits-all solutions.

In parallel, [2] explore the potential of AI in adolescent mental health assessments, particularly by leveraging digital activity data. This study investigates how AI models can detect early signs of mental health issues like stress and depression by analyzing digital footprints, which include online behavior, social media interactions, and communication patterns. Adolescents, often hesitant to seek help due to stigma or lack of awareness, present a challenging group for traditional mental health interventions. AI’s ability to unobtrusively monitor and analyze data from adolescents’ daily activities can provide an invaluable tool in identifying mental health issues early, facilitating timely interventions. By using digital interactions as a non-invasive means of monitoring mental health, the study suggests that AI can serve as a preventive tool, intervening before mental health conditions progress into more serious issues. The predictive accuracy of AI improves significantly when data from various sources are integrated, enhancing the comprehensiveness of assessments. For instance, combining data from social media activity, texting patterns, online searches, and other digital interactions can paint a more detailed and accurate picture of an adolescent’s mental state. This multifaceted approach enables AI to pick up on subtle behavioral changes that might indicate emerging stress or depression, which could otherwise go unnoticed in traditional clinical settings. [2] propose that AI-based mental health assessments could eventually become a routine part of adolescent healthcare, providing continuous monitoring and early intervention, helping to reduce the onset of long-term mental health issues. With AI’s ability to analyze vast amounts of data efficiently, these systems could offer real-time support, alerting caregivers, educators, or health professionals to signs of distress and enabling them to take proactive steps.

In addition, [7] introduce innovations in AI’s role in stress detection and resilience-building. The study explores how AI can detect stress markers by analyzing multimodal data, including physiological signals (e.g., heart rate, skin conductance), speech patterns, and digital activity. Stress is a significant risk factor for many mental health disorders, and its early detection is crucial in preventing these conditions from escalating. By utilizing a variety of data inputs, AI models can identify patterns that may indicate stress, even before the individual becomes fully aware of it. This ability to detect stress early provides an opportunity for timely intervention, which can be especially valuable in high-stress environments such as workplaces, schools, or healthcare settings. Furthermore, AI can not only detect stress but also offer personalized interventions aimed at building resilience. These interventions could include mindfulness exercises, breathing techniques, cognitive-behavioral strategies, or suggestions for lifestyle changes that reduce stress. [7] highlight how AI’s ability to customize these interventions based on the individual’s unique stress markers and preferences significantly enhances their effectiveness. AI-driven resilience-building approaches can therefore play a key role in preventive mental health care, empowering individuals to manage stress before it develops into more serious mental health conditions like anxiety or depression. Moreover, the study points to the need for ongoing research to optimize these AI-driven interventions, ensuring that they are applicable and beneficial to diverse populations. As the mental health landscape is increasingly recognized as multifaceted, AI interventions must be continuously refined to cater to different cultural, demographic, and personal factors to maximize their impact. Together, these studies underscore the multifaceted role that AI can play in enhancing mental health interventions. [1] emphasize the importance of transparency and user-centered design in increasing trust and acceptance of AI in mental health, while [2] demonstrate AI’s potential to provide early, non-invasive assessments, especially for adolescents who are often reluctant to seek help. [7] add to this narrative by showcasing AI’s ability to detect stress and promote resilience, offering personalized, preventative strategies to support mental wellness. These advancements collectively illustrate AI’s potential to transform mental health care, from early detection and personalized interventions to preventive strategies that empower individuals to manage their mental well-being proactively. However, as these technologies continue to evolve, it will be essential to address challenges such as privacy, ethics, and accessibility to ensure that AI systems are deployed responsibly and inclusively.

Additionally, [11] explore the transformative potential of artificial intelligence in enhancing diagnostic precision within the mental health sector. By leveraging technologies such as natural language processing (NLP) and predictive analytics, AI systems can analyze vast amounts of unstructured data, including clinical notes, social media content, and personal communication, to identify early signs of mental health disorders such as depression, anxiety, and schizophrenia. NLP allows AI to understand and interpret human language, making it possible to extract valuable insights from written or spoken text that may indicate psychological distress. Predictive analytics, on the other hand, uses historical data to forecast the likelihood of mental health issues, enabling clinicians to make more informed decisions and improve diagnostic accuracy. The study also highlights the integration of AI with wearable devices, such as smartwatches and fitness trackers, which continuously monitor physiological data, including heart rate, sleep patterns, and physical activity levels. These wearable devices can provide real-time insights into a person’s mental health, offering early detection of changes that may signal the onset of conditions like anxiety or depression. For example, fluctuations in heart rate variability or disruptions in sleep patterns can be indicative of mental health issues, allowing for timely intervention before conditions worsen. This combination of real-time data and advanced AI analytics could significantly improve early diagnosis and intervention, preventing the escalation of mental health conditions and reducing the burden on healthcare systems. [11] emphasize that further exploration is needed to fully harness AI’s potential in mental health care, particularly its ability to integrate seamlessly with other healthcare technologies, such as electronic health records (EHRs) and telemedicine platforms. This integrated approach could create a more holistic and proactive mental health care system, where AI-driven insights inform treatment plans, facilitate continuous monitoring, and enhance the overall quality of care. The authors advocate for more research and development in this area, suggesting that the future of mental health care lies in the convergence of AI with wearable devices, predictive analytics, and other healthcare technologies to provide a more personalized, accurate, and timely approach to mental health diagnosis and treatment.

Lastly, [9] explore how artificial intelligence can foster positive mental health by promoting self-awareness and emotional regulation, essential components of overall mental well-being. Their study highlights the potential of AI-powered cognitive-behavioral therapy (CBT) tools to assist individuals in regulating their emotions, which can significantly enhance emotional resilience. These AI tools provide tailored interventions, such as personalized exercises or feedback, that empower users to manage their emotional responses and develop healthier coping strategies. By focusing on emotional regulation, AI-driven CBT can prevent the onset of more severe mental health conditions, such as depression or anxiety, by intervening early in the process. The study emphasizes the need for ethical AI frameworks to ensure that these tools are not only effective but also equitable and accessible to all individuals, regardless of their socioeconomic status, geographic location, or background. Ethical considerations in AI development are critical to ensuring that interventions are free from bias and that individuals’ privacy and data security are protected. As AI continues to evolve, these frameworks will play a vital role in addressing concerns about transparency, accountability, and fairness in mental health care. The ability of AI tools to provide scalable, accessible support for mental health is transformative, particularly in underserved or resource-limited areas where traditional mental health services may be scarce or unavailable. AI’s potential to promote proactive mental health management can improve overall well-being and reduce the long-term impact of untreated mental health disorders. The use of AI in mental health care extends beyond individual interventions and includes system-wide improvements in diagnosis, treatment, and monitoring. Studies by [3,10] and others underline the diverse ways AI is being integrated into mental health care, from early detection of mental health conditions in children and adolescents to real-time monitoring and personalized therapy. These innovations are leading to more accurate diagnoses and tailored treatments that better address the unique needs of individuals. However, as the research indicates, there are significant challenges to overcome in the deployment of AI in mental health care. Ethical concerns surrounding AI-driven interventions must be addressed, including the potential for algorithmic bias, the protection of patient data, and ensuring that AI systems are transparent and explainable. Furthermore, regulatory frameworks need to be developed to guide the use of AI in mental health care, ensuring that these technologies are used responsibly and effectively. Data security remains a pressing issue, particularly as AI systems rely on vast amounts of personal information to make decisions. Ensuring the privacy and security of this sensitive data is crucial to maintaining public trust in AI-based mental health interventions. The future of AI in mental health care is promising, with AI offering significant advancements in diagnosing, treating, and preventing mental health conditions. However, the successful integration of AI into mental health care systems will require careful consideration of its ethical implications, regulatory oversight, and the development of robust data security measures. By addressing these concerns and promoting responsible implementation, AI can be a powerful tool in enhancing mental well-being and providing accessible mental health care for individuals worldwide.

Discussion and Conclusions

In recent years, the growing interest in the application of Artificial Intelligence in mental health care has been fueled by its potential to address some of the most pressing challenges faced by traditional mental health systems. These challenges include limited access to mental health professionals, high treatment costs, stigma surrounding mental health, and the inefficiency of current diagnostic and therapeutic methods. AI technologies, ranging from machine learning (ML) and deep learning to natural language processing (NLP), have demonstrated significant promise in revolutionizing mental health diagnostics, interventions, and therapeutic support, offering new solutions for these longstanding issues. AI’s integration into mental health care has introduced innovative approaches for early detection, personalized treatment, and remote care, improving outcomes for both individuals and healthcare systems at large. One of the most notable innovations has been the application of machine learning and deep learning algorithms to improve diagnosis and treatment. For example, algorithms capable of analyzing large volumes of data, such as patient records, social media interactions, and behavioral patterns, are being used to identify mental health conditions, sometimes before they become apparent to human clinicians. These advances enable earlier intervention, which is critical in reducing the severity of mental health issues and preventing them from escalating into more chronic conditions. [6] exemplifies this trend by discussing the growing role of AI in psychotherapy, noting how algorithms are now capable of delivering psychological support through digital formats such as chatbots and virtual assistants. These AI-driven tools can provide cognitive-behavioral therapy (CBT) and other forms of therapy remotely, making mental health resources more accessible to individuals who may otherwise struggle to access care due to geographic, financial, or social barriers. This is particularly important in underserved regions, where the availability of mental health professionals is often limited, and in populations that may be reluctant to seek care due to stigma or privacy concerns. Moreover, AI’s role in mental health extends beyond treatment delivery to include the real-time monitoring of mental health status. For instance, [7] explored how AI can detect signs of stress and emotional distress through various biometric and behavioral indicators, enabling timely interventions. AI systems can analyze patterns in speech, facial expressions, and even physiological responses, offering valuable insights that human practitioners might miss. This ability to monitor and intervene in real-time is especially valuable in managing chronic mental health conditions, where early detection of warning signs can prevent more severe episodes. The integration of AI also extends to digital platforms that assess mental health based on daily activities and online behavior. [2] demonstrated how AI can track and analyze adolescents’ digital footprints, such as social media interactions and smartphone usage, to detect signs of anxiety, depression, or other mental health issues. By using data from everyday experiences, AI can offer more personalized and contextually relevant care that considers an individual’s lifestyle and environmental factors, leading to better mental health outcomes. One of the most transformative applications of AI in mental health care has been the development of AI-powered chatbots. These systems engage users in conversations that simulate human-like interactions, providing emotional support, coping strategies, and even psychological interventions like CBT. As highlighted by [5], AI chatbots have shown significant promise in promoting emotional well-being and helping users manage mental health concerns in real-time. These tools not only offer immediate assistance but also reduce the stigma often associated with mental health care by providing users with an anonymous, private platform to discuss their struggles. This is particularly beneficial for individuals who may otherwise avoid seeking professional help due to fear of judgment or a lack of understanding. Furthermore, AI chatbots can be programmed to provide personalized support, adapting their responses based on the user’s emotional state, past interactions, and self-reported symptoms, thus offering a highly tailored approach to mental health management. In addition to supporting individuals, AI is also poised to transform mental health care at a systemic level. [12] emphasized AI’s potential to revolutionize mental health through innovative approaches for diagnosis, intervention, and recovery monitoring. These technologies are reshaping the way mental health services are delivered by enabling more efficient, scalable, and data-driven models of care. AI’s ability to monitor patients’ progress and provide real-time feedback means that mental health professionals can intervene more effectively, tracking patients’ responses to treatment and adjusting care plans as needed. This can lead to more precise and individualized treatment protocols, improving patient outcomes and reducing the overall burden on mental health systems. Additionally, AI’s ability to automate certain aspects of care, such as diagnostic assessments and routine check-ins, can free up clinicians to focus on more complex cases, optimizing resource allocation and improving efficiency within mental health services. The impact of AI on mental health extends beyond clinical settings and into policymaking. AI technologies have the potential to influence policy decisions related to mental health care access and affordability, especially in regions where mental health resources are scarce. [11] discussed how AI can play a critical role in the early identification of mental health issues, which can prevent more severe conditions from developing. For example, predictive models could help identify at-risk individuals who may not yet show obvious symptoms, allowing for proactive interventions that could mitigate the long-term impact of mental health conditions. Early intervention is crucial in reducing the societal and economic costs associated with mental illness, including lost productivity, increased healthcare spending, and social exclusion. By providing tools that can identify and treat mental health issues earlier, AI has the potential to significantly reduce the burden of mental health on both individuals and society. Furthermore, AI’s ability to integrate and analyze vast amounts of data can improve public health policies by providing insights into trends and patterns in mental health. This data-driven approach can help policymakers identify key areas where resources need to be allocated, design more effective mental health programs, and evaluate the success of existing initiatives. The integration of AI in mental health is not without its challenges, however. Issues related to data privacy, ethical considerations, and the reliability of AI-driven interventions must be addressed to fully unlock its potential. AI systems rely on large volumes of personal data, raising concerns about data security and user consent. Additionally, as AI technologies are increasingly used to support therapeutic interventions, questions arise about the extent to which AI can replicate the nuances of human empathy and judgment. While AI can provide valuable support, it cannot replace the human touch that is often crucial in the therapeutic process. As such, AI should be seen as a tool to augment, rather than replace, traditional mental health care. Despite these challenges, the integration of AI in mental health care continues to evolve rapidly, offering promising solutions to long-standing problems in the field. Through technological innovations, AI is opening new possibilities for mental health care, offering more accessible, personalized, and effective interventions. As technology continues to mature, it is likely that AI will play an increasingly central role in shaping the future of mental health care, addressing unmet needs, improving outcomes, and reducing the burden on healthcare systems globally.

While AI offers immense potential in revolutionizing mental health care, several challenges must be addressed to fully realize its benefits. One of the primary concerns is data privacy and security. AI systems require vast amounts of personal data to function effectively, raising significant ethical questions regarding user consent and data protection. [10] noted that AI models, particularly those focused on children’s mental health, rely on sensitive data from digital activities, which further complicates concerns around privacy and the safe handling of personal information. Another significant limitation lies in the reliability and validity of AI-driven interventions. While AI applications are advancing rapidly, their ability to replicate the nuanced understanding and empathetic approach of human therapists remains uncertain. [9] emphasized that AI-powered mental health applications must undergo rigorous testing to ensure their effectiveness before widespread clinical implementation. There is also the challenge of providing personalized care through AI models, which often struggle to incorporate the complex social, psychological, and cultural factors that play a crucial role in mental health. The lack of personalized approaches in AI interventions could limit their effectiveness for individuals from diverse backgrounds and with varying mental health needs. Moreover, the issue of bias and fairness in AI models is a growing concern. AI systems are only as reliable as the data they are trained on, and if the datasets used are biased, the resulting interventions can be skewed or unfair. [8] highlighted that AI applications in mental health care could inadvertently exacerbate disparities, particularly if certain demographic groups are underrepresented in training data, leading to less effective treatments for these populations. The risk of AI perpetuating these biases calls for careful consideration in designing and testing mental health AI models to ensure equity in healthcare delivery. Furthermore, as AI systems are increasingly used for decision-making in mental health care, accountability becomes a critical issue. In the event of an AI system making an incorrect diagnosis or providing inadequate treatment, determining liability and responsibility can be complex. This challenge underscores the need for stringent regulation and oversight to ensure that AI applications in mental health care are safe, ethical, and effective. Addressing these challenges is essential for AI to reach its full potential in improving mental health care delivery while safeguarding users’ rights and ensuring equitable outcomes.

AI holds immense promise in transforming mental health care, offering the potential to enhance diagnostic accuracy, improve access to care, and introduce innovative therapeutic interventions. The studies reviewed in this article highlight the diverse ways AI is being applied to address mental health challenges, such as stress detection, digital interventions, and the use of chatbot technologies. These applications allow for more personalized, scalable, and cost-effective solutions, especially in the context of the global rise in mental health issues. AI can bridge gaps in access to care by providing remote, accessible support for individuals who may face barriers due to geography, financial limitations, or stigma. However, for AI to realize its full potential in mental health care, several challenges must be addressed. Issues such as ensuring data privacy and security, evaluating the effectiveness of AI interventions, and mitigating the risk of bias in AI models require continued research, the establishment of ethical guidelines, and regulatory frameworks. Safeguarding personal data while promoting the development of effective AI technologies is crucial in creating a balance between innovation and user protection. Furthermore, as AI technologies evolve, it is important to ensure that these systems are designed to complement, rather than replace, traditional therapeutic approaches. AI should enhance the human experience by providing additional support to mental health professionals, not by substituting human judgment and empathy. The implications of the review suggest several pathways for advancing AI in mental health care. First, rigorous clinical trials are necessary to assess the effectiveness of AI-driven mental health interventions. These trials should focus on clinical outcomes as well as user satisfaction and the long-term impact of these interventions on mental well-being. Additionally, policymakers must develop and enforce regulations that ensure the protection of user data while also fostering the growth of innovative AI applications. Creating a regulatory environment that balances data privacy concerns with the potential benefits of AI will be essential for encouraging continued progress. Lastly, there is a significant opportunity for interdisciplinary collaboration between AI developers, mental health professionals, and regulatory bodies. This collaborative approach could help ensure that AI systems are developed with both technical excellence and ethical considerations in mind, thereby mitigating potential risks while maximizing their ability to improve mental health care. By working together, these diverse stakeholders can guide the integration of AI into mental health care in a way that is both effective and responsible.

Despite the valuable insights presented in the review, it is crucial to recognize several limitations that may affect its comprehensiveness. One significant limitation is the temporal scope of the studies included, which primarily focuses on recent research published in 2024. While this provides an up-to-date view of AI’s role in mental health, it may not encompass the full spectrum of relevant literature, especially older studies that laid the groundwork for current advancements. As the field of AI in mental health is rapidly evolving, it is essential to acknowledge that new developments and applications may not be fully captured in the review. AI technologies are advancing at an unprecedented pace, and new research findings, as well as technological breakthroughs, could provide a more nuanced understanding of the landscape. Future reviews of this topic will need to incorporate these emerging trends to offer a more comprehensive picture of AI’s role in mental health care. Another limitation stems from the lack of diverse perspectives on the social, cultural, and ethical implications of AI in mental health care. While the review touched upon some ethical concerns, it did not delve deeply into how AI might be implemented in various cultural contexts. Different cultures may have unique perceptions of mental health, which could affect the acceptance and effectiveness of AI-driven interventions. Moreover, the challenges faced by underserved populations, including those in low-income regions, were not fully addressed. Understanding how AI can be used to address the needs of diverse populations is essential to ensure that it serves everyone equitably. In addition, the review does not provide a detailed exploration of the potential biases that may exist in AI models, particularly those trained on non-representative datasets. These biases could lead to disparities in the effectiveness of AI interventions for different demographic groups. Addressing these issues is crucial to avoid exacerbating existing inequalities in mental health care.

For future research to address these gaps, several key areas need further exploration. One of the most critical areas for future investigation is the need for longitudinal studies to evaluate the long-term effectiveness and sustainability of AI-driven mental health interventions. While short-term results are valuable, understanding the prolonged impact of these technologies on users’ mental health and overall well-being is vital. Longitudinal studies could provide insights into whether the benefits of AI interventions are sustained over time and whether users experience any unintended negative consequences. Such studies could also help assess whether AI can truly complement or enhance traditional forms of therapy in the long run, rather than simply acting as a temporary substitute. Furthermore, future research should focus on ethical and cultural considerations related to AI in mental health care. As AI technologies are deployed globally, there is a growing need for research that explores how AI can be adapted to various cultural contexts and how different cultural norms and values might influence the acceptance and effectiveness of AI-driven interventions. This research could address cultural biases in AI models, the potential for AI to shape mental health norms, and the implications of AI interventions in societies with limited access to healthcare. Additionally, understanding how AI can be used to improve mental health care accessibility in low-income and underserved regions should be a priority, as these areas often lack adequate mental health resources. Another promising avenue for future research is the integration of AI with traditional therapies. While AI has demonstrated significant potential in supporting mental health care, it is essential to explore how it can work alongside human therapists to provide more comprehensive care. AI can be used to augment existing therapeutic frameworks, providing tools for therapists to better monitor patient progress, detect early warning signs of mental health issues, and personalize treatment plans. Further research should investigate how AI can complement traditional forms of therapy, such as cognitive-behavioral therapy (CBT), and whether combining these approaches results in better patient outcomes than either approach used alone. Finally, there is a growing need for research on AI in preventive mental health. As the global healthcare system increasingly emphasizes prevention, AI can play a pivotal role in early detection and intervention for mental health issues. Future studies should focus on how AI can analyze digital behavior patterns to detect early signs of mental health struggles, such as anxiety or depression, before they escalate into more severe conditions. Additionally, AI could be used to monitor at-risk populations, such as adolescents or individuals with a family history of mental illness, to identify early warning signs and provide preventive support. The integration of AI into preventive mental health strategies could not only improve individual outcomes but also reduce the overall burden on healthcare systems by preventing the development of more severe mental health conditions. While AI holds immense promise for transforming mental health care, there remain significant challenges and limitations that must be addressed through ongoing research. Future studies must focus on understanding the long-term effects of AI interventions, exploring cultural and ethical considerations, investigating the integration of AI with traditional therapeutic approaches, and utilizing AI in preventive mental health care. In a nutshell, by addressing the limitations of small sample sizes and lack of long-term data, AI can be more effectively tailored to improve mental health outcomes across diverse populations. Expanding research to include larger, more representative samples would ensure that AI-driven interventions cater to a wide range of demographics, enhancing their generalizability and impact. Additionally, collecting long-term data would help evaluate the sustained effectiveness of AI technologies in mental health care, ensuring their reliability over time. By overcoming these challenges, AI can contribute to global efforts to make mental health care more accessible, personalized, and effective for individuals worldwide.

Ethics Approval and Consent to Participate

Not applicable

Consent for Publication

Not applicable

Availability of Data and Materials

The study is a narrative review and does not involve the collection or analysis of original data from participants. All information and insights presented in the study are derived from existing literature, publicly available sources, and secondary data obtained from previous research. As such, no new datasets were generated or analyzed during the study.

Competing Interest

I, as the sole author of the article, declare that I have no competing financial or personal interests that could have influenced the work reported. The review article was conducted independently, with no external influences, funding, or affiliations that could have impacted the findings or interpretations presented.

Funding

The author declares that no funding was received for the preparation or publication of the manuscript. The work was conducted independently and does not involve any financial support from external organizations or sponsors.

Author’s Contributions

The sole author has made substantial contributions to the conception, study, and writing of the review article. The author reviewed, edited, and approved the final manuscript, ensuring it met academic standards and provided a balanced, evidence-based discussion. The author confirms that the article represents original work and bears full accountability for the content presented in the publication.

Data Availability

Not applicable

References

Karim RA, Iqbal, W, Ilyas Z (2024) Techniques of Explainable Artificial Intelligence and Machine Learning in Digital Mental Health Intervention. Journal of Development and Social Sciences 5(3): 349-359.
Kim DH, Lee, J, Lee, T, Baek, S, Jin, S, et al. (2024) AI-Based Mental Health Assessment for Adolescents Using Their Daily Digital Activities. In 2024 IEEE 11th International Conference on Data Science and Advanced Analytics (DSAA) (pp. 1-10) IEEE.
Alan H (2024) A comprehensive evaluation of digital mental health literature: an integrative review and bibliometric analysis. Behaviour & Information Technology 1-23.
Alhuwaydi AM (2024) Exploring the Role of Artificial Intelligence in Mental Healthcare: Current Trends and Future Directions–A Narrative Review for a Comprehensive Insight. Risk Management and Healthcare Policy 17: 1339-1348. [crossref]
Gallegos, C, Kausler, R, Alderden, J, Davis, M, Wang L (2024) Can Artificial Intelligence Chatbots Improve Mental Health? A Scoping Review.Computers, Informatics, Nursing 42(10): 731-736. [crossref]
Bhatt S (2024) Digital Mental Health: Role of Artificial Intelligence in Psychotherapy. Annals of Neurosciences, 09727531231221612.
Liu, F, Ju, Q, Zheng, Q, Peng Y (2024) Artificial intelligence in mental health: innovations brought by artificial intelligence techniques in stress detection and interventions of building resilience. Current Opinion in Behavioral Sciences 60, 101452.
Cosic, K, Kopilas, V, Jovanovic T (2024) War, emotions, mental health, and artificial intelligence. Frontiers in psychology 15: 1394045. [crossref]
Thakkar, A, Gupta, A, De Sousa A (2024) Artificial intelligence in positive mental health: a narrative review. Frontiers in Digital Health 6: 1280235. [crossref]
Agarwal, J, Sharma S (2024) Artificial Intelligence enabled cognitive computer-centered digital analysis model for examination of the children’s mental health. Evolutionary Intelligence 1-11.
Olawade DB, Wada OZ, Odetayo, A, David-Olawade AC, Asaolu, F, et al. (2024) Enhancing mental health with Artificial Intelligence: Current trends and future prospects. Journal of Medicine, Surgery, and Public Health 100099.
Dakanalis, A, Wiederhold BK, Riva G (2024) Artificial intelligence: a game-changer for mental health care. Cyberpsychology, Behavior, and Social Networking 27(2): 100-104. [crossref]

How Can Integrating Artificial Intelligence Technologies Advance Mental Health and Wellness in Malaysian Healthcare Systems and Enhance Societal Well-Being?

2 Replies

DOI: 10.31038/AWHC.2025821

Abstract

The global mental health crisis, exacerbated by the pandemic, underscores the urgent need for innovative solutions. With approximately one in eight individuals experiencing a mental disorder, this review assesses the role of Artificial Intelligence (AI) in enhancing mental health care, particularly in Malaysia, where stigma, accessibility issues, and resource shortages hinder traditional services. A systematic literature review was conducted using databases such as PubMed and Scopus, focusing on studies published from 2022 to 2024. The review identified key AI applications, including chatbots and predictive analytics, which offer personalized and accessible mental health support. Results indicated that AI-driven solutions, exemplified by tools like “Chatbot Rakan Sihat,” significantly improve engagement and mental health outcomes for underserved populations. Ethical concerns regarding data privacy and algorithmic bias were highlighted as critical challenges in AI integration. The findings emphasize AI’s potential to reduce stigma and enhance service delivery in Malaysia’s mental health landscape. This review’s novelty lies in its focus on local implementation and ethical considerations, contributing to ongoing discourse on AI’s integration into mental health care. Future research should investigate the long-term effectiveness of AI interventions, user experiences, and collaborative efforts to establish regulatory frameworks that prioritize patient welfare while optimizing mental health care accessibility and effectiveness.

Keywords

Artificial intelligence, Mental health care, Chatbots, Predictive analytics, Ethical considerations in AI

Introduction

The global mental health crisis remains a pressing concern, with approximately one in eight people experiencing a mental disorder, as reported by the World Health Organization (WHO). The COVID-19 pandemic has further intensified this crisis, leading to increased psychological distress across various populations. In response, digital mental health solutions have emerged, aiming to improve access to care and support overall mental well-being. Notably, [1] conducted a retrospective analysis of the AI-driven mental health app Wysa, demonstrating its effectiveness in addressing users’ mental health needs during the pandemic. This review aims to assess the landscape of AI applications in mental health, addressing the challenges and opportunities presented by these technologies. The novelty of this review lies in its focus on AI’s potential to enhance service delivery in Malaysia, where traditional mental health care is hindered by stigma, accessibility issues, and resource shortages. Additionally, this review highlights the importance of ethical considerations surrounding AI use, such as data privacy and algorithmic bias. By evaluating existing literature, this review seeks to contribute to the ongoing discourse on integrating AI technologies into mental health care, ultimately fostering improved outcomes for diverse populations [2].

Methods

This review employed a systematic approach to evaluate the landscape of Artificial Intelligence applications in mental health care, particularly focusing on their implementation in Malaysia. A comprehensive literature search was conducted using databases such as PubMed, Scopus, and Google Scholar, targeting studies published from 2022 to 2024. Keywords included “AI in mental health,” “digital mental health solutions,” “chatbots,” “predictive analytics,” and “Malaysia.” Inclusion criteria focused on empirical studies, reviews, and case analyses that explored AI interventions’ effectiveness, accessibility, and ethical considerations. Selected articles were analyzed to extract key findings related to AI’s impact on mental health outcomes, user engagement, and integration challenges. The review also examined the ethical frameworks surrounding AI applications, considering issues of data privacy and algorithmic bias. By synthesizing this information, the review aims to contribute to the discourse on AI in mental health, identifying opportunities and challenges while emphasizing the need for responsible implementation.

Results and Findings

Artificial Intelligence has emerged as a transformative tool in mental health care, offering innovative and personalized solutions that can significantly enhance the delivery of mental wellness support. AI systems have proven effective at analyzing vast amounts of data, recognizing patterns, and providing insights that human practitioners may overlook. For instance, [3] examined AI-driven interventions, such as chatbots and predictive analytics, designed specifically to reduce suicidal tendencies among young individuals. Their study highlighted AI’s crucial role in raising mental health awareness and improving access to essential resources. In Malaysia, mental health disorders affect nearly 29% of the population (World Health Organization). Traditional mental health services face numerous challenges, including pervasive stigma, limited accessibility, and resource shortages. AI represents a promising avenue to address these barriers by enhancing service accessibility and personalizing care. [4] explored the potential of machine learning in creating adaptive mental health interventions tailored to individual needs, thus enhancing user engagement and promoting overall well-being. The applications of AI in mental health, particularly chatbots and virtual assistants, provide significant benefits. [5] discussed how chatbots improve mental health services by enhancing accessibility and providing personalized support. For instance, Malaysia’s “Chatbot Rakan Sihat” has been integrated into public health initiatives to raise awareness about mental health and provide timely assistance, especially to underserved populations. Virtual therapy platforms, as discussed by, leverage AI to enhance user engagement and improve emotional support processes. These platforms facilitate remote consultations and personalized interventions, making mental health services more flexible and accessible. Consequently, AI has the potential to optimize treatment outcomes by dynamically adjusting treatment plans based on real-time data. Predictive analytics is another essential AI application that utilizes vast datasets to identify individuals at risk of mental health disorders. [6] demonstrated how social media data can be analyzed to inform mental health interventions, enabling early detection of mental health issues. In Malaysia, predictive analytics could significantly improve screening processes, ensuring timely interventions for at-risk individuals. As AI continues to evolve, it holds immense potential to revolutionize mental health care, particularly in addressing accessibility, personalization, and treatment efficacy. However, the integration of AI in mental health care must be guided by ethical frameworks to prioritize patient safety, data security, and transparency. In Malaysia, AI helps mitigate mental health service shortages and reduces stigma by offering anonymous support [7]. [8] advocated for AI as a complementary tool, not a replacement for human therapists. Furthermore, the scalability and cost-effectiveness of AI-driven solutions can address long wait times and limited mental health resources. AI technologies are transforming mental health care by improving access, reducing costs, and providing timely support. For example, Malaysia’s “Chatbot Rakan Sihat” exemplifies how AI can reach underserved populations while overcoming barriers like stigma [9,10]. AI-driven platforms, such as iAssist, offer wellness solutions, particularly for elderly users, with integrated tools that enhance mental and physical health [10]. Additionally, AI reduces treatment costs by automating routine tasks, early detection of issues, and crisis prevention, thereby decreasing the need for intensive care [11]. However, ethical challenges, such as data privacy and algorithmic bias, must be addressed [2]. Human oversight remains crucial to ensure that AI enhances rather than replaces professional care. In sum, regulatory frameworks are necessary to ensure responsible AI use, necessitating collaboration among policymakers, mental health experts, and developers [12,13]. The findings highlight the significant impact AI can have on improving mental health care accessibility and delivery in Malaysia, while also emphasizing the need for ethical consideration and human oversight.

Discussion and Conclusion

This review underscores the transformative potential of Artificial Intelligence in enhancing mental health care, particularly in Malaysia, where traditional services face significant barriers. The novelty of this study lies in its comprehensive evaluation of AI applications, such as chatbots and predictive analytics, that can increase accessibility and personalization in mental health interventions. As evidenced by the findings of [1] and [5], AI-driven solutions can significantly improve mental health outcomes by providing timely and tailored support to underserved populations. However, ethical considerations must be prioritized, including data privacy and algorithmic bias [2]. The implications of this study are profound; integrating AI into mental health services can reduce stigma, enhance service delivery, and ultimately improve the overall mental health landscape in Malaysia. Future research should focus on the long-term effectiveness of AI interventions, explore user experiences, and assess the ethical implications of AI technologies. Collaborative efforts among policymakers, mental health practitioners, and technology developers will be essential to create a regulatory framework that ensures responsible AI deployment, safeguarding patient welfare while optimizing mental health care accessibility and effectiveness [13,14].

Declaration of Competing Interest

None

References

Sinha C, Meheli S, Kadaba M (2023) Understanding digital mental health needs and usage with an artificial intelligence–led mental health app (Wysa) during the COVID-19 pandemic: Retrospective analysis. JMIR Formative Research 7(1), e41913. [crossref]
Dutta D, Mishra SK (2024) Bots for mental health: the boundaries of human and technology agencies for enabling mental well-being within organizations. Personnel Review 53(5).
Rawat B, Bist AS, Fakhrezzy M, Octavyra RD (2023) AI based assistance to reduce suicidal tendency among youngsters. APTISI Transactions on Management 7(2): 102-109.
Oyebode O, Fowles J, Steeves D, Orji R (2023) Machine learning techniques in adaptive and personalized systems for health and wellness. International Journal of Human–Computer Interaction 39(9): 1938-1962.
Jain S, Patil S, Dutt S, Joshi K, Bhuvaneswari V, Jayadeva SM (2022) Contribution of Artificial intelligence to the Promotion of Mental Health. In 2022 5th International Conference on Contemporary Computing and Informatics (IC3I) (pp. 1938-1944) IEEE.
Garg M (2024) Mental disturbance impacting wellness dimensions: Resources and open research directions. Asian Journal of Psychiatry 92: 103876. [crossref]
Garg M (2024) WellXplain: Wellness concept extraction and classification in Reddit posts for mental health analysis. Knowledge-Based Systems 284: 111228.
World Health Organization (WHO) (2023) Artificial intelligence in mental health research: new WHO study on applications and challenges. https: //www.who.int/europe/news/item/06-02-2023-artificial-intelligence-in-mental-health-research–new-who-study-on-applications-and-challenges
Khawaja Z, Bélisle-Pipon JC (2023) Your robot therapist is not your therapist: understanding the role of AI-powered mental health chatbots. Frontiers in Digital Health 5: 1278186. [crossref]
Caloudas AB, Frosio KE, Torous J, Goss CW, Novins DK, Lindsay JA, Shore JH (2024) Mobile mental health applications for American Indian and Alaska Native communities: Review and recommendations. Journal of Technology in Behavioral Science.9(3): 474-485.
Desai VS, Tibrewala A, Saravanan K, Preethika K, Mantri T, Ghiria I (2022) iAssist: An online wellness platform to elevate the physical and mental health of the elderly. In 2022 IEEE Conference on Interdisciplinary Approaches in Technology and Management for Social Innovation (IATMSI) (pp. 1-5) IEEE.
Chandak ML. Help Out-Mental health journaling and supporting application based on artificial intelligence (Doctoral dissertation, Sant Gadge Baba Amravati University).
Yoon S, Goh H, Low XC, Weng JH, Heaukulani C (2023) Perceived Usability, User Preferences and Impact of a Workplace Digital Mental Wellness Platform “Mindline at Work”: A Mixed Methods Study.
Gupta D, Singhal A, Sharma S, Hasan A, Raghuwanshi S (2023) Humans’ Emotional and Mental Well-Being under the Influence of Artificial Intelligence. Journal for Reattach Therapy and Developmental Diversities 6(6s): 184-197.

The Emotional Intelligence of the Clinician : Rethinking Communication as Emotional Calibration

2 Replies

DOI: 10.31038/IJNM.2025621

Abstract

Effective modern clinical communication demands cognitive clarity together with emotional precision. Clinicians working in healthcare settings where critical decisions are made and patients remain vulnerable need to deliver information while expertly managing their emotional presence which is vital yet frequently ignored for building therapeutic trust and determining patient outcomes. This article introduces a new theoretical and clinical framework for emotional calibration in nursing practice which develops emotional intelligence into a strategic and adaptive method for affective regulation that can be measured. The study develops the Emotional Calibration Index (ECI) which operates as both an educational tool and a clinical heuristic by synthesizing decades of nursing communication practice with current educational frameworks. Through the ECI measurement tool clinicians demonstrate their capability to identify emotional states, arrange emotional responses in sequence and adjust emotional dynamics during live patient consultations. It is structured around three basic constructs: The Strategic Affect Modulation approach requires clinicians to adjust their tone, posture, and language to align with patient emotions for anxiety reduction. Methodologically, the research follows a two-phase design: The research methods include both qualitative interviews from skilled nurse communicators and simulation testing in scenarios requiring emotional complexity. The research findings present a structured educational rubric together with a reflective self-assessment model that facilitates emotional calibration integration into nursing education and ongoing professional development as well as clinical mentorship. The framework positions emotional intelligence as a clinical competency that remains crucial for maintaining therapeutic fidelity while restoring trust and achieving sustainable health outcomes. Health care systems now use emotional calibration as an ethical obligation and professional requirement to set new evaluation standards for communication and emotional healing delivery.

Keywords

Emotional intelligence in nursing, Emotional calibration index (ECI), Affective communication, Strategic affect modulation, Emotional triage, Empathic lag, Nurse-patient interaction, Communication science

Introduction

The emotional setting where medical care takes place together with technical precision determines patient outcomes. Clinicians need to master both diagnostic accuracy and emotional communication because patients become especially vulnerable during high-stress medical situations with limited time. Emotional intelligence (EI) which used to be valued solely as a professional quality now stands as a critical clinical requirement. This approach improves diagnostic thinking while strengthening patient relationships and minimizes communication misunderstandings which lead to medical errors and litigation according to Hojat et al., 2011 [1] and Levinson et al., 1997. The large body of research that demonstrates a connection between emotional intelligence and better patient outcomes mainly utilizes frameworks with trait-based models which prioritize dispositional elements like empathy and self-awareness. Most existing models fail to give clinicians the necessary real-time tools to handle emotionally complex interactions. In today’s healthcare environment, characterized by emotional overload and communication-related clinical errors, these limitations call for a shift from emotional disposition to emotional calibration: An educational method enables clinicians to learn adaptive skills for identifying emotional signals and regulating their expressive behavior based on those cues. Nursing communication studies are starting to fill this deficiency. Modern educational frameworks use behavioral heuristic techniques to align emotional presence with trust development and narrative-focused listening while adjusting responses at each moment. These strategies go beyond generic empathy by employing deliberate affective techniques: The use of tone modulation alongside postural shifts and rhythmic pauses with linguistic alignment helps professionals connect with patients by attending to their immediate emotional state [2-4]. The growing evidence that medical training reduces empathy levels demands enhanced tools for emotional calibration. A systematic review by Neumann et al. [5] discovered that medical students experience a pronounced reduction in their ability to empathize during clinical training when their emotional work remains unnoticed and unsupported. Current experts support simulation-based teaching methods that integrate emotional realism by teaching students to manage verbal communication along with silence and emotional difficulties [6,7].

Affective neuroscience further supports this urgency. According to LeDoux’s (1996) [8] research patients process vocal tones and facial expressions through subcortical neural pathways before they consciously understand spoken words. The delivery of technically correct verbal content through detached reassurance as a form of misdirected emotional signaling raises anxiety levels and breaks down trust while hindering information retention [9,10].

This paper presents emotional calibration as a method for intentional emotional expression adjustment in clinical settings to address existing challenges. Calibration involves therapists modifying their tone of voice, speed of speech and body posture in real time to keep therapeutic coherence which differs from empathy that reflects actual emotional experience. The paradigm shift redefines emotional intelligence as a structured set of clinical skills rather than simply a personality characteristic.

The Emotional Calibration Index (ECI) functions as both a training heuristic model and an assessment tool to operationalize the framework. The Emotional Calibration Index (ECI) stems from affective signaling theory together with clinical communication heuristics through its basis in three primary constructs.

Strategic Affect Modulation (SAM) — the micro-adjustment of tone, cadence, posture, and phrasing in response to moment- to-moment patient affect.
Emotional Triage — the clinician’s prioritization of affective needs based on the emotional acuity and risk-level of the encounter.
Empathic Lag — a newly theorized phenomenon describing the temporal misalignment between the clinician’s empathic expression and the patient’s readiness or ability to receive it.

The ECI model is developed through a two-phase methodology: The ECI model develops through simulation-based scenario testing combined with qualitative interviews from experienced clinicians. Using affective narrative analysis clinicians code transcripts to identify both verbal and nonverbal recalibration strategies. The findings deliver both a calibration rubric and a reflective feedback protocol which can be implemented in clinical training and peer coaching programs. In rethinking emotional intelligence through the lens of calibration, this paper advances a broader claim: Effective communication with patients requires clinicians to not just articulate their words but also rhythmically and ethically connect with the complex emotional states of their patients.

Conceptual Framework

Emotional intelligence has gone through significant changes in healthcare to become an essential clinical competency. The progress of emotional intelligence integration into clinician education and professional practice faces barriers due to unclear conceptual definitions and insufficient teaching approaches. This research offers emotional calibration as a theoretical redesign and practical approach to improve affective clinical communication. Emotional Calibration transforms emotional intelligence from a fixed personal characteristic into a deliberate process of expressive alignment that helps clinicians fine-tune their emotional behaviors to attain therapeutic understanding and rebuild trust while maintaining ethical standards. The Emotional Calibration Index (ECI) serves as this paradigm’s core heuristic model to evaluate how clinicians align and modulate their emotional responses based on the patient’s interpretative and emotional condition. Traditional emotional intelligence frameworks focus on internal self-regulation while the ECI emphasizes precise external expression of emotions during clinical interactions. It is organized around three interdependent constructs: The model comprises three interrelated theoretical constructs: Strategic Affect Modulation along with Emotional Triage and Empathic Lag. All three constructs examine unique aspects of affective decision-making when faced with narrative disruption or emotional dissonance and relational strain.

Strategic Affect Modulation (SAM)

The technique known as Strategic Affect Modulation (SAM) involves clinicians deliberately modifying their emotional expressions through tone adjustments, vocal rhythm changes, facial expressions, body posture alterations, silence timing, and lexical framing based on patient emotional responses. SAM transforms emotional management from a passive approach into relational attunement and utilizes emotion as a primary tool for clinical communication instead of treating it as a secondary factor. Through combining affective neuroscience principles with narrative interaction theory this construct shows that achieving therapeutic synchrony requires fine-tuned micro-adjustments. The shift from harsh tones to gentle warmth and turning rapid explanations into deliberate conversations represents recalibrated affective signaling according to research by LeDoux and Rakel. Clinician guides and communication manuals recognize these strategies as clinically effective tools for developing rapport with difficult patients and reducing skeptical responses or resistance [3,4].

Emotional Triage

Emotional triage conceptualizes the clinician’s ability to prioritize emotional responses when multiple affective cues occur simultaneously. Similar to physical triage in emergency medicine, emotional triage asks Which emotional wound requires immediate attention to maintain trust, coherence, and safety?. In real clinical encounters, patients rarely express one emotion at a time. A single encounter may vacillate between withdrawal, sarcasm, grief, and guarded defiance. Emotional triage enables clinicians to recognize emotional layering, such as addressing fear before frustration, or validating silence before confronting resistance. This requires both acute affective discernment and ethical sequencing. Training in emotional triage moves practitioners beyond generalized empathy to targeted affective interventions structured around affective urgency and psychological safety. Communication frameworks that emphasize pacing, narrative listening, and trust repair sequencing support this model [3,4,11,12].

Empathic Lag

Empathic Lag introduces a new dimension to the clinician-patient interaction: There exists a time-based and perceptual delay between when clinicians show empathy and when patients recognize that emotional support. Patients tend to stay emotionally closed or show no response even when clinicians are present and offering verbal encouragement. The trauma-informed care theory describes empathic lag as the condition where past betrayals and medical mistrust alongside unresolved trauma prevent patients from quickly accepting emotional support according to Green et al. (2015) [13]. The delay may lead clinicians to wrongly view it as patient resistance or their own failure which can cause emotional burnout or early termination of the therapeutic relationship. Clinicians who view empathic delay as a timing misalignment instead of an empathic failure will find their ability to stay present and reconnect with patients strengthened through adjusted affective approaches.

The construct supports reflective practice through clinician experience validation and offers chances to recalibrate. When healthcare providers understand empathic lag they can both prevent compassion fatigue and reinforce their position as stable emotional support during challenging patient interactions. The Emotional Calibration Index (ECI) derives its analytic architecture from the combination of three fundamental constructs. These behaviors are observable in practice and can be taught and tested through specific communication acts which lead to measurable training results. As a composite heuristic, the ECI advances clinician development across three critical dimensions: expressive precision, affective sequencing, and emotional timing.

Methodology

The study implemented a structured qualitative methodology to establish and confirm the Emotional Calibration Index (ECI) as a strict framework for measuring clinicians’ immediate emotional responses during emotionally intricate nursing interactions. The research methodology rejected traditional static assessments of emotional intelligence because it embraced the view that nursing emotional expression functions as a real-time performance influenced by communication context and feedback cues. To this end, the research was conducted in two phases: The research methodology incorporated narrative inquiry through semi-structured interviews and simulation-based testing with standardized emotional scenarios. Through complementary phases researchers achieved conceptual modeling alongside empirical verification of the core constructs of ECI-Strategic Affect Modulation (SAM), Emotional Triage, and Empathic Lag.

Phase One: Narrative Inquiry

A total of 25 experienced nurses from various specialties and patient populations took part in detailed semi-structured interviews during the first phase. The interview structure aimed to collect detailed narratives about clinical situations where emotional interactions turned unstable, ambiguous or charged with emotions. The research objective focused on determining the internal thought processes and decision-making patterns that determine expert emotional responses when facing high-stakes situations instead of achieving generalizable results. The research team conducted data analysis through interpretative phenomenological analysis (IPA) adhering to Smith and Osborn’s 2015 [14] protocols. The selected method provided sensitivity to subjective emotional experiences to identify behavioral markers like tone shifts and silence deployment as tools for emotional calibration. The narratives provided the essential framework to develop ECI constructs through differentiating them from similar concepts like empathy or bedside manner.

Phase Two: Simulation-Based Testing

During phase two researchers used purposive sampling to have nurses take part in three simulation exercises which were created to trigger each of the three different ECI constructs. Case archetypes from real-world scenarios in clinical communication literature and patient typology frameworks [3,4] informed the design of the simulations. Scenarios included: Patients experiencing emotional anxiety need affective modulation via vocal tone and pacing techniques. Participants assessed their performance through a prototype ECI rubric after each simulation was recorded and followed by a structured debriefing and reflection session. The evaluation rubric analyzed specific areas including tone-attunement along with verbal-nonverbal coherence and responsiveness to emotional escalation and pacing sensitivity. Through analysis of interview themes and simulation observations as well as pretest consultations with nursing education and clinical psychology experts the rubric underwent iterative refinement.

Data Integration and Construct Validation

Triangulated data-including video transcripts, participant reflections, and third-party observer ratings-were analyzed to identify performance patterns, instances of recalibration, and evidence of construct validity. Emphasis was placed on moments of emotional rupture and repair-such as reframed inquiries, modulated tone adjustments, and reengagement after empathic lag. Cross-analysis with standardized patient feedback and rater scores allowed examination of the alignment between clinician intention and perceived patient effect. This step tested the utility of the ECI not only as a descriptive model, but also as a predictive and evaluative framework for clinician affective responsiveness under pressure. To ensure methodological rigor, all simulation ratings were blindly reviewed by communication specialists trained in the analysis of clinician-patient interactions. Thematic saturation was achieved by the 21st interview and maintained through cross-case synthesis. Ethical approval for the study was granted by the university’s Institutional Review Board, and all participants signed informed consent documents. Data were anonymized and managed according to the Consolidated Criteria for Reporting Qualitative Research (COREQ) [14]. This two-step methodology affirms the ECI as both a pedagogical scaffold and an evaluative tool grounded not in abstraction but in the communicative realities of caregiving. It allows for a multidimensional assessment of emotional calibration, capturing not only what clinicians report but also how they perform emotional alignment amid relational intensity, cognitive fatigue, and the unspoken grammars of therapeutic presence.

Literature Review

Emotional intelligence (EI) has shifted from being considered a basic soft skill to becoming a fundamental component for successful therapeutic outcomes. Research indicates that clinicians who score highly on emotional intelligence assessments achieve better diagnostic results while building stronger therapeutic relationships and reducing malpractice occurrences [1]; Levinson et al., 1997). Although experts agree on the importance of emotional intelligence (EI) its integration into emotionally complex clinical practice remains inadequate because current assessments focus too much on traits and ignore real- time interactional requirements [5,6]. Communication in healthcare is rarely emotionally neutral. Clinical encounters contain emotional stress which forces patients to interpret information through both their cognitive functions and emotional perceptions that stem from their fears and previous experiences. Research in affective neuroscience shows that emotional signals activate the limbic system before cognitive understanding occurs which indicates patients first perceive clinicians’ tone and body language before registering the spoken content [8]. Effective communication in this scenario requires clarity alongside both expressive precision and emotional pacing with affective attunement. The field of applied nursing communication research has experienced a transformation due to this understanding. Current approaches define behavioral heuristics that create trust through emotional presence and narrative adjustment while allowing for specific situational adaptation. The methods of tone modulation, pause calibration, posture shifts, and linguistic synchrony have been developed to address resistant patients and those who are emotionally withdrawn [2-4,12] This approach transcends basic empathy by establishing strategic emotional interventions to build therapeutic effectiveness. The growing importance of emotional memory in healthcare reinforces the pressing need for this transformation. Patients tend to remember their emotional experiences during medical consultations better than the factual information they received. Cognitive memory creates information storage systems while emotional memory preserves feelings of safety and trust plus being heard [9,17]. Studies show that patients experience relational disruptions when clinicians’ reassuring statements are paired with incongruent tone or closed body language despite competent care delivery [10,18].

Communication training programs that use simulations still prioritize strict adherence to protocol instead of realistic emotional expression. The emotional aspects of clinical dialogue which occur during fear, resistance or silence remain inadequately represented in assessments of verbal fluency (Lane & Rollnick, 2007). The recent development of clinician guides and simulation toolkits has started to standardize affective techniques including sequesnced trust repair with vocal recalibration and pacing adaptation as key methods for managing emotionally intense situations [3,4]. Emotional labor represents an important but insufficiently examined area of clinical communication beyond brief interactions. Hochschild (1983) [19] defined emotional labor as affect management which meets job requirements. The lack of emotional labor management among nurses results in compassion ‘ Healthcare communication needs to address issues of historical and cultural trauma. Research in culturally competent care demonstrates that patients from historically marginalized groups enter healthcare settings with multigenerational mistrust strengthened by previous medical mistreatment and communication imbalances [22,23]. Clinical credibility restoration becomes achievable through affective pacing and cultural resonance which together support emotional calibration for patients with embodied memories and relational exhaustion. The concept of empathic lag stands out as a markedly under-researched construct in this discussion. The phenomenon of empathic lag arises from the time misalignment between how clinicians show empathy and when patients can recognize this empathy, particularly during trauma care and palliative consultations as well as in cross-cultural patient interactions. The paper identifies timing and emotional receptivity as essential elements for building trust between individuals. The latest research literature addresses this gap by developing iterative empathy models, reflective pacing techniques, and narrative re-entry strategies [11,24] but fails to present a unified formal structure for these insights. The core importance of emotional intelligence has been established through various studies but no behavior-specific clinical calibration combined with simulation validation exists as a heuristic in the field. This study develops the Emotional Calibration Index (ECI) which serves as an applied framework to identify and correct emotional incongruence through proper sequencing in patient care delivery. The ECI functions beyond description as it serves educational and diagnostic purposes while driving transformative outcomes. The ECI framework empowers clinicians to manage expressive rhythm and emotional pauses while adjusting relational alignment during actual patient interactions which fosters trust through silent moments and creates meaning through emotional synchrony.

Results

Through 25 narrative interviews and 75 simulation sessions in the two-phase data collection process researchers gained multi-layered insights about real-time emotional complexity navigation by clinicians. Research analysis identified three unique domains demonstrating both the theoretical consistency and practical relevance of the Emotional Calibration Index (ECI). Research findings demonstrated both the observable actions which characterize emotional calibration as well as the reflective mental frameworks professionals utilize when dealing with emotional stress.

Strategic Affect Modulation in Practice

During interviews and simulations clinicians reported making purposeful changes to their tone, pace, silence use and body language as means to control the emotional atmosphere during patient interactions. The clinicians’ modulations adhered to patterned responses which frequently relied on implicit connections to patients’ emotional states. Standardized patients experienced greater emotional clarity and trust when clinicians adjusted their tone to be softer and slowed their delivery during perceived withdrawal moments. Over time clinicians integrated these adjustments into their procedures so they performed them reflexively instead of through deliberate effort. As one senior nurse reflected: “Through my practice I automatically adjust my approach based on visual cues of tension because this confirms LeDoux’s research that emotions are detected before cognitive processing”. The framework establishes tone and silence as crucial practices of therapeutic presence for effective communication models [3,4].

Emotional Triage as Affective Prioritization

Simulation studies reveal that healthcare providers face emotional exhaustion when patients display complex emotional signals that combine grief with agitation or fear masked by sarcasm and silence with sadness. High-performing clinicians prioritized addressing fundamental emotions like fear and withdrawal before they treated more obvious emotions such as anger or confusion through emotional triage strategies. Analysis of interview data revealed that clinicians hone emotional calibration abilities during their clinical practice experiences. Beginner clinicians who tackled all emotional signals simultaneously weakened their therapeutic focus while creating more confusion. Expert practitioners, by contrast, demonstrated affective sequencing: The successful therapeutic method requires practitioners to recognize primary emotional triggers before targeting them and then applying supplementary treatment strategies. According to trauma-informed schemas the observed behavior reveals that when practitioners overlook “affective primacy” their therapeutic alliances weaken and the patient narrative becomes disrupted [11]. The research validates affective patient classification systems which interpret sarcasm, defiance and resistance as manifestations of fear rather than obstacles to care [3,12]. Clinicians noticed better patient involvement and trust with improved treatment protocol adherence when they first concentrated on embedded affective signatures before educational or persuasive efforts. As Neumann et al. (2011) [5] and Mistiaen et al. According to research by Mistiaen et al [20] found that lasting therapeutic success requires establishing emotional climate regulation prior to cognitive reorientation.

Empathic Lag

The study developed and validated the concept of Empathic Lag as the perceptual and temporal gap between how clinicians express their affective engagement and how patients understand and incorporate that empathy. The dynamic emerged frequently during simulations and interviews when clinicians talked about times when their use of empathic techniques like verbal mirroring and voice modulation failed to prompt instant emotional responses from patients. Clinicians who continued their therapeutic approach through the pause and identified it as genuine emotional negotiation achieved significantly stronger therapeutic alignment. The observed pattern corresponds with trauma-informed models which state that patients who carry histories of vulnerability or medical mistrust need multiple consistent affective signals to reduce their emotional barriers Green et al., 2015, [11]. The clinician’s emotional presence involves performative aspects alongside timing responsiveness while staying conscious to avoid both overstepping boundaries and excessive withdrawal. Standardized patients gave the highest ratings to clinicians who applied strategic silence that was well-calibrated along with sensitive timing for conversational re-entry and reflective physical posture which were based on sophisticated communication techniques. Recent studies demonstrate that clinician tone and timing have greater effects on trust and emotional recall than content does as shown by Zolnierek & DiMatteo (2009) [18] and Street et al. (2009) [16]. Recent clinical communication guides propose that affective rhythm and empathic pacing together with narrative re-engagement are essential components for addressing patient hesitancy and emotional ambiguity. The emergence of affective delays tends to stem from fear experiences or unresolved trauma and misunderstanding clinician tone which disproportionately affects populations who have faced historical underservice or stigmatization in healthcare [22,23].

The model integrates findings from affective neuroscience which demonstrates that emotional signals precede cognitive understanding thereby supporting the requirement for empathy to be both consistent and retrievable rather than merely well-intentioned [8]. Effective emotional calibration requires practitioners to demonstrate patience for emotional processing delays while systematically attempting to regain dialogue synchrony in therapy.

Integrative Findings and Clinical Validation

The Emotional Calibration Index (ECI) stands as a validated clinical tool which has been created through combining clinical heuristics with simulation findings and affective typology frameworks. The three elements of Strategic Affect Modulation and Emotional Triage alongside Empathic Lag form a tripartite model to understand affective literacy in clinician communication. Each domain maintains conceptual uniqueness while showing clinical visibility and educational practicality. The model connects narrative reflection with simulation realism which supports nursing education instruction and professional development program assessments. The ECI model prioritizes external responsiveness along with precise timing and coherence between verbal and nonverbal cues while traditional EI frameworks focus on internal emotional regulation [11,25]. Evidence from numerous studies shows that when emotional responses fail to align with patient emotions, it can break trust and diminish adherence to treatment despite correct clinical information delivery [3,4]. Patients show stronger retention of emotional memories compared to cognitive information which demonstrates that matching emotional tone to patient emotions improves both the retention of information and clinical relationships. The ECI transforms emotional intelligence into a dynamic care grammar which addresses essential clinical communication training deficiencies while establishing emotional fluency as a fundamental diagnostic skill alongside auscultation and physical examination techniques.

Discussion

The study proposes a crucial update to the understanding of EI in clinical communication by transforming its view from a fixed psychological trait into a situational communicative skill. The foundational EI models established by Goleman (1995) [25] and Hojat et al. (2011) [1] define emotional intelligence through fixed traits including empathy and self-regulation. Traditional emotional intelligence models from researchers like Goleman and Hojat et al. (2011) [1,25] focus on empathy and self-regulation but fail to address how clinical complexity and relational pacing influence real-time emotions and emotional resistance. The Emotional Calibration Index (ECI) provides a solution to the current conceptual and operational gaps by presenting a model that measures behavioral alignment and supports educational application for emotional dynamics. The ECI distinguishes itself from generalized emotional intelligence assessments by providing a triadic structure that includes Strategic Affect Modulation, Emotional Triage, and Empathic Lag which transforms clinician emotional intelligence into an executable and teachable behavioral skill rather than just an internal condition. The approach combines narrative medicine (Charon, 2001) with affective neuroscience [8], trauma-informed care frameworks [13], and practical communication strategies to fulfill the emotional requirements of patient care and educational assessment standards.

Strategic Affect Modulation and the Language of Healing

The concept of Strategic Affect Modulation (SAM) developed because clinicians began using tone, body posture, silence, and vocal rhythm as essential tools for communication during patient care. Traditional communication models label these elements as stylistic while SAM identifies them as clinical instruments that create coherence and alleviate anxiety during emotionally intense interactions according to Rakel et al. (2009) and Banich et al. (2009). Simulation studies demonstrated that clinicians who made slight adjustments to their tone and way of speaking based on patients’ emotions received higher trust ratings and effectiveness evaluations. Neurological research by LeDoux (1996) [8] establishes that emotional responses occur prior to cognitive processing which makes emotional regulation an essential diagnostic starter for verbal reasoning in clinical care. Affectively based clinical guides recommend the integration of SAM by insisting that tonal changes and lexical framing should receive equivalent attention as traditional physical examination methods and patient history collection.

Emotional Triage and Affective Decision-Making

During complex emotional encounters clinicians utilize emotional triage which involves prioritizing certain emotions in their treatment process. Clinicians follow a triage approach similar to emergency medical teams where they first determine which emotional trauma or disrupted story element demands immediate attention to effectively control therapy pace. Research from trauma-informed care demonstrates that initial emotional regulation improves later cognitive involvement especially when emotional barriers precede medical explanations [11,13]. The study revealed that clinicians who recognized and managed primary emotional responses such as fear, silence, or sarcasm produced improved patient adherence results. The triage process supports narrative stability alongside verbal sequencing which enables patients to connect their emotional memory with trust instead of threat. Recent research in affective communication demonstrates that emotional memory persists longer than factual memory while exerting substantial influence over patient compliance and satisfaction levels (Hall et al., 2001) [3].

Empathic Lag and the Ethics of Timing

The ECI’s primary innovation called Empathic Lag explores the time and perceptual disparities between clinicians showing empathy and patients accepting it. The reception of emotional signals can be delayed by factors such as past trauma experiences, mistrust between patients and clinicians or discrepancies in emotional timing. Therapists who recognize these interactions as delayed emotional negotiations can maintain their therapeutic presence more effectively than those who see them as rejection. The discovery changes clinical empathy to move from instant assumptions to iterative empathy with delayed reinforcement through trauma-informed principles according to Neumann et al. (2011) [5] and Greenhalgh & Heath (2010) [24]. Caregivers in emotionally intense environments need to use timed interventions for silence and patient re-engagement rather than simply applying these techniques. The concept corresponds with modern communication studies which demonstrate that empathic pacing together with narrative re-entry is essential for developing rapport and maintaining long-term therapeutic memory [9]. The instruction presents novel teaching methods for empathy which defines it as a rhythm-dependent behavior that requires reinforcement through simulation exercises alongside reflective practices and clinical demonstrations.

Educational and Systemic Implications

The ECI pioneers behaviorally coded metrics which transform emotional intelligence into both a teaching tool and an evaluation method in clinical education. This platform provides curriculum development tools, OSCE simulation methods, and rubric-based feedback systems that adhere to communication standards suitable for trauma-informed and patient-centered care practices. The integrated heuristics developed by Aghanya establish systematic methods for embedding emotional calibration into nursing communication frameworks as well as electronic health record templates while enhancing peer-coaching evaluations through trust-building and patient typology applications. The demand for affective literacy in medical education has positioned emotion at the forefront as a marker of clinical excellence according to Mistiaen et al. (2019) [21]. Simulation laboratories evaluating verbal coherence now require tonal fidelity along with pacing diagnostics and narrative sequencing to guarantee emotional congruence in clinical outcomes. The integration of ECI indicators into electronic health records and patient satisfaction measures establishes a system that allows emotional fidelity to be measured and connected to clinical results. Emotional calibration transforms clinicians’ communication methods and healing performance into a temporally rhythmic and ethically situated practice based on clarity, presence, and affective alignment.

Evaluation

The Emotional Calibration Index (ECI) offers a powerful new interpretation of emotional intelligence that connects clinical foundations with measurable behaviors and educational applications. The value of the Emotional Calibration Index (ECI) stems from its provision of a system for clinicians to assess and manage patient care through language and heuristics focused on emotional dynamics. As a composite framework, the ECI must be evaluated on three axes: conceptual robustness, empirical validity, and educational scalability.

Conceptual Robustness

The ECI effectively separates emotional calibration from related constructs including empathy and emotional intelligence along with affective presence. This work defines emotional calibration as a deliberate clinical intervention that adjusts to specific situations similar to the way auscultation or procedural triage operates. During therapeutic interactions emotional calibration functions not as a trait but as a time-bound communicative technique. The theoretical foundation of this distinction emerges from emotion regulation research (Gross, 2002) [26], trauma-informed care literature (Green et al., 2015) – [13], and relational ethics principles in patient-centered communication [17]. Research in affective neuroscience shows that emotional tone and nonverbal cues have a greater impact on patient memory and trust than verbal information alone [8,10]. The tripartite model consisting of Strategic Affect Modulation (SAM), Emotional Triage, and Empathic Lag provides a clinically verifiable structure for the traditionally abstract concept of “bedside manner.” The ECI incorporates therapeutic approaches from nursing research that utilize tone modulation, silence, and posture adjustments as emotional strategies. Clinical studies have shown these tools effectively transition patients from fragmented storytelling to emotional involvement while reducing their fear to promote treatment compliance.

Empirical Validity

Two-phase research design substantiates the model’s empirical integrity. Narrative inquiry documented how clinicians practiced emotional recalibration which revealed core competencies that correspond to SAM, triage, and lag. The research team converted these narratives into simulation scenarios designed to mirror genuine clinical challenges. Researchers employed performance patterns alongside verbal and nonverbal congruence measures with reflective alignment techniques to confirm the validity of each construct. Clinicians who received high SAM scores demonstrated mastery of expressive flexibility including the ability to adjust tone, pace and posture based on situational emotions supported by findings from affective neuroscience which indicate that tone recognition occurs faster than content understanding (Banich et al., 2009). Emotional triage was demonstrated as a clinical sequencing skill: The sequential response to fear followed by sadness or resistance demonstrated a strong link with enhanced patient engagement and ongoing therapy support according to trauma care studies [11,20]. Empathic Lag stands out as both a groundbreaking and verified psychological construct. Interviews and post-simulation reflections from clinicians revealed their frustration with delays in emotional reciprocity from patients. Advanced clinicians viewed affective misalignment as temporal dissonance instead of failure which they addressed by employing silence and reentry cues to rebuild trust according to intercultural care and trauma research [22,23].

Educational and Clinical Scalability

The ECI provides students with a formative scaffolding system that bridges the historic separation between emotional theory and communication skills development in nursing education. OSCE designers and communication faculty described the ECI rubric as an essential tool because they found it both functional and sophisticated and recognized its necessity as highlighted by research advocating for affective literacy in medical training [5,16]. Clinically, the model is versatile. The timing of emotional responses holds critical importance in palliative care settings while emergency care demands immediate affective triage; however, dynamic adjustments must take into account extended delays and historical distrust in multicultural care environments. The ECI can easily integrate into technology systems for use in patient experience audits as well as faculty coaching scripts and wellness surveys. Studies show that expressive congruence directly correlates with higher clinician job satisfaction and lower burnout levels according to West et al. (2016) [27] and Shanafelt et al. (2017) [28]. The ECI offers support for multi-level implementation that can be used in preceptor orientation programs and residency training as well as continuing education. The method provides structured flexibility for embedding emotional calibration within electronic health record fields to document relational milestones together with medical information.

Limitations and Future Directions

The ECI stands strong but contains inherent limitations. Real-time trauma situations along with ethical challenges and terminal illness cases remain beyond the full replication capabilities of simulation fidelity. The necessity for trained evaluators in its scoring system limits scalability when resources are limited in the system.

The next steps involve combining AI-driven emotional recognition systems that utilize vocal analysis and facial recognition technology for immediate calibration feedback. Recent research within this field shows great potential (Kocaballi et al., 2020; Roter et al., 2021). Cross-cultural validation of the ECI remains an urgent requirement. Existing frameworks rely on emotional openness and straightforward communication although these standards fail to apply in high-context cultures [29,30]. The effects of emotional calibration training on clinician identity and empathy resilience and its impact on burnout vulnerability require further study because their long- term implications remain unexplored. The implementation of emotional calibration as a new standard for communication requires longitudinal studies to evaluate its effects on moral fatigue together with professional sustainability and therapeutic reciprocity.

Recommendations

The research establishes emotional intelligence as a trainable and measurable skill transforming clinical communication practices. To translate the Emotional Calibration Index (ECI) from framework to implementation, the following recommendations are proposed across five key domains: The implementation of the Emotional Calibration Index (ECI) requires recommendations across five main domains which include education policy and simulation together with innovation and global health equity.

Curriculum Recalibration

Medical and nursing schools need to progress past implicit emotional modeling by formally implementing emotional calibration instruction within their curricula. The three-part ECI framework of Strategic Affect Modulation, Emotional Triage, and Empathic Lag becomes part of pre-clinical training and clinical rotations through simulation modules, reflective journaling activities, and formative assessment rubrics. Research findings about decreasing empathy during training highlight the essential role of explicit affective skill development [5,16]. Developing competency frameworks requires incorporating proven behavioral heuristics like pause choreography along with voice modulation and relational silence which research demonstrates enhance trust building and emotional regulation during patient interactions [3,4]. OSCE stations, clinical checklists, and licensure evaluation models can easily incorporate these tools.

Policy Reform and Accreditation Standards

Core communication and professionalism standards need to incorporate emotional calibration competencies according to governing bodies like the American Association of Colleges of Nursing (AACN), Joint Commission International (JCI), and their global counterparts. The present communication policy focuses mainly on information transfer and needs to broaden its approach to incorporate emotional scaffolding during therapeutic interactions [9]. Policy realignment supports the Future of Nursing 2020–2030 framework because it establishes relational equity, psychological safety and person-centered care as foundational elements of modern health systems (National Academy of Medicine, 2021) [31]. Emotional calibration functions as a practical embodiment of these values and requires integration into both national educational frameworks and professional renewal systems for clinicians.

Simulation Investment

The creation of emotionally immersive scenarios should become the main focus for clinical simulation centers while they move past technical checklists to mirror real-world emotional challenges. Simulated patients need training to demonstrate emotional discordance and resistance as well as ambiguity and silence according to scoring standards from the ECI. Research demonstrates that the practice of emotional realism improves both the preservation of empathy and diagnostic precision [6,7]. Simulation debriefing and feedback structures based on ECI principles enhance affective fidelity as well as learner self-awareness. Standardization of emotion-based simulation scoring methods should take place within high-acuity medical specialties such as palliative care, trauma services, and emergency departments.

Fear-Informed Care Integration

Current theoretical developments demonstrate that fear acts both as an obstacle and as a diagnostic tool within emotionally complex healthcare settings. The adoption of a fear-informed communication method enables clinicians to distinguish between resistant behavior and silence induced by fear which brings more depth to trauma- informed care frameworks [32,33]. Emotional calibration heuristics in clinical settings should include fear typologies and narrative cues to help clinicians adjust their tone, pacing and relational presence when dealing with patients experiencing high anxiety. The method fills a deficiency in trauma-informed training through the integration of emotion-specific de-escalation pathways into standard communication education programs.

National Adoption of the Emotional Calibration Index

Healthcare systems should integrate the ECI into their national competency framework and tailor it to meet specific requirements.

Continuing Professional Development (CPD) modules
Residency and preceptor onboarding
Peer-review performance audits
Self-assessment and reflective practice guides

The integration of the ECI framework parallels Canadian medical education’s CanMEDS system which established communication and collaboration as critical clinical skills. The ECI delivers a comparable framework for emotional fluency which affects relational safety and patient care results.

Technological Integration and Affective AI

Automated communication assessment in clinical education platforms and digital health systems requires the embedding of affective signal tracking tools including voice inflection mapping and both eye- tracking and facial recognition technologies. Telemedicine platforms and wearable technology as well as simulation playback software could benefit from real-time integration of ECI-based metrics. The development of these systems follows advances in affective computing which uses emotional responsiveness in AI to improve interpersonal connections and trust calibration [34]. Through structured simulation refinement emotional calibration heuristics become optimal tools for developing machine-learning models that recognize emotions in health technology applications.

Cross-Cultural and Global Application

The cultural encoding of emotion combined with diverse empathy idioms makes cross-cultural calibration of the ECI mandatory. Within high-context settings where behaviors like silence and indirect communication indicate trust or resistance affective calibration requires adaptation via narrative scripts and specific regional and cultural communication models [22,29,30]. Emotional calibration training requires collaboration with regional medical schools along with health ministries and global health organizations to address not just clinical complexity but also historical and sociocultural trauma in patient- provider relationships. These recommendations show the transition from innovative practices towards formal institutional adoption. The formalization of emotional calibration through the ECI extends beyond care improvement to establish therapeutic presence as a discipline while developing emotional precision as a skill and restoring the human element in healing practices. To advance technical precision and ethical care health systems must embrace emotional calibration as a mandatory operational standard and essential cultural element for future clinical practice.

Conclusion

The developing framework of precision medicine now requires communication to be recognized as an essential skill beyond mere empathetic virtue. This study establishes through both theoretical understanding and empirical evidence that clinical emotional expression requires intentionality and measurable alignment with therapeutic practices. Emotional intelligence, though foundational, remains insufficient without its operational counterpart: Calibration requires clinicians to adjust their tone, timing and presence to match the patient’s changing emotional states. The Emotional Calibration Index (ECI) represents an innovative shift away from conventional affective training after its validation through simulation and narrative analysis. The three core constructs—Strategic Affect Modulation, Emotional Triage, and Empathic Lag—transform the concept of emotional intelligence from an innate trait into a teachable and measurable clinical sequence. The findings affirm insights long held in narrative medicine, trauma-informed care, and affective neuroscience: The healing process goes beyond simple physiological repair to include emotional sharing, ethical timing management, and physical embodiment. The model applies previous frameworks which recognized the communicative importance of gesture, pause, vocal modulation, and empathic sequencing [2-4,12] and turns them into structured metrics usable in education and clinical settings. Through constructs like empathic lag and triage sequencing medical literature receives advancement while creating a healing vocabulary which gives clinicians precise rules for handling emotional disturbances with attentiveness and compassion. The implications of emotional calibration affect clinical sustainability as well as patient trust recovery and institutional integrity beyond pedagogy. The ECI connects clinician intentions with patient experiences across epistemic and ethical dimensions. The field of medicine needs to transform its moral vision by moving medicine from procedure-based approaches to presence-based care while shifting from technical methods to the appropriate timing of interventions and evolving empathy from emotional sentiment to precise emotional engagement. Future clinicians will receive evaluations based on their ability to adjust their presence to support patients who arrive with uncertainty and silence alongside their needs. The real measure of care comes from emotional fidelity that goes beyond mere feeling to embody precision, integrity, and therapeutic rhythm. The Emotional Calibration Index represents an early phase rather than the endpoint of emotional research in medical practice. This marks the start of a new standard in relational healing which establishes expression as an intervention method while positioning calibration as its healing solution.

References

Hojat M, Louis DZ, Markham FW, Wender RC, Rabinowitz C, et al. (2011) Physicians’ empathy and clinical outcomes for diabetic patients. Academic Medicine. 86: 359-364. [crossref]
Aghanya N T (2016) Simple tips to developing a productive clinician-patient relationship. iUniverse.
Aghanya NT (2021a) Tips for effective communication: A vital tool for trust development in healthcar TAFFD’s Publishing.
Aghanya N T (2021b) Effective communication: A guidebook for clinicians and TAFFD’s Publishing.
Neumann, M, Edelhäuser, F, Tauschel, D, Fischer, R, Wirtz, M, Woopen, C, Scheffer, C (2011) Empathy decline and its reasons: A systematic review of studies with medical students and residents. Academic Medicine. 86: 996-1009.
Kelm, Z, Womer, J, Walter, K, & Feudtner, C (2014) Interventions to improve pediatric and parent communication: A systematic review. Pediatrics. 133: e596-e615. [crossref]
Lane C, Rollnick S (2007) The use of simulated patients and role-play in communication skills training: A review of the literature to August 2005. Patient Education and Counseling. 67: 13-20. [crossref]
LeDoux, JE (1996) The emotional brain: The mysterious underpinnings of emotional Simon & Schuster.
Street RL, Makoul G, Arora NK, Epstein RM (2009) How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Education and Counseling. 74: 295-301. [crossref]
Hall MA, Dugan E, Zheng B, Mishra AK (2001) Trust in physicians and medical institutions: What is it, can it be measured, and does it matter?. The Milbank Quarterly. 79: 613-639. [crossref]
Back AL, Arnold RM, Tulsky JA, Baile WF, Fryer-Edwards KA (2009) Teaching communication skills to medical oncology fellows. Journal of Clinical Oncology. 27(8), 1130-1134. [crossref]
Aghanya, T (2019) Principles for overcoming communication anxiety and improving trust. Folio Avenue Publishing.
Green BL, Saunders P A, Power E, Dass-Brailsford P, Gra@, K (2015) Trauma- informed medical care: A CME communication training program for primary care Families, Systems, & Health. 33: 18-32. [crossref]
[14]-Smith, A, & Osborn, M (2015) Interpretative phenomenological analysis as a useful methodology for research on the lived experience of pain. British Journal of Pain. 9: 41-42. [crossref]
Tong A, Sainsbury P, Craig J (2007) Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus International Journal for Quality in Health Care. 19: 349-357.
Batt-Rawden S A, Chisolm MS, Anton B, Flickinger TE (2013) Teaching empathy to medical students: An updated, systematic review. Academic Medicine. 88: 1171-1177. [crossref]
Epstein RM, Street RL (2007) Patient-centered communication in cancer care: Promoting healing and reducing National Cancer Institute.
Zolnierek KBH, DiMatteo MR (2009) Physician communication and patient adherence to treatment: A meta-analysis. Medical Care. 47: 826-834. [crossref]
Hochschild AR (1983) The managed heart: Commercialization of human feeling. University of California Press.
Zapf D, Vogt C, Seifert C, Mertini H, Isic A (2001) Emotion work as a source of stress: The concept and development of an instrument. European Journal of Work and Organizational Psychology. 10: 371-400.
Mistiaen, P, Poot, E, & Francke, L (2019) Interventions aimed at improving the nurse-patient relationship in acute care: A systematic review. Patient Education and Counseling. 102: 1380-1387.
Saha S, Beach MC, Cooper LA (2008) Patient centeredness, cultural competence and healthcare quality. Journal of the National Medical Association. 100: 1275-1285. [crossref]
Chapman EN, Kaatz A, Carnes M (2013) Physicians and implicit bias: How doctors may unwittingly perpetuate health care Journal of General Internal Medicine. 28: 1504-1510. [crossref]
Greenhalgh T, Heath I (2010) Measuring quality in the therapeutic relationship— Part 1: Objective Quality in Primary Care. 18: 405-412. [crossref]
Goleman D (1995) Emotional intelligence: Why it can matter more than IQ. Bantam Books.
Gross JJ (2002) Emotion regulation: Affective, cognitive, and social Psychophysiology. 39: 281-291.
West CP, Dyrbye LN, Satele DV, Sloan JA, Shanafelt TD (2016) Concurrent validity of single-item measures of emotional exhaustion and depersonalization in burnout Journal of General Internal Medicine, 27: 1445-1452. [crossref]
Shanafelt TD, Gorringe G, Menaker R, Storz KA, Reeves D, et (2017) Impact of organizational leadership on physician burnout and satisfaction. Mayo Clinic Proceedings. 90: 432-440. [crossref]
Hall ET (1976) Beyond culture. Anchor Books.
Kleinman A (1988) The illness narratives: Suffering, healing, and the human Basic Books.
National Academy of Medicine (2021) The future of nursing 2020-2030: Charting a path to achieve health The National Academies Press.
Corr PJ (2002) J A Gray’s reinforcement sensitivity theory and frustrative nonreward: A theoretical note on expectancies in reactions to Personality and Individual Differences. 32: 1247-1253.
Subba D, Fisher RM (2014) Philosophy of Fearism: A first East-West dialogue. Xlibris.
Picard, R. W (2000) Affective computing. MIT Press.

Detection of Autoimmune Markers in Korean Adults with Diabetes: Role of Anti-GAD and HLA Typing

2 Replies

DOI: 10.31038/EDMJ.2025931

Abstract

Although adult-onset diabetes in Asians often begins as non-insulin-dependent diabetes mellitus (NIDDM), some patients may gradually lose their ability to produce insulin(anti-GAD), transitioning to insulin-dependent diabetes mellitus (IDDM). Since IDDM is known to be autoimmune in nature and associated with genetic predispositions, particularly involving HLA-DQ gene variations and the presence of specific autoantibodies, researchers aimed to explore whether these markers could help estimate how often this autoimmune process occurs in newly diagnosed adult NIDDM patients.

Methods: The prevalences of anti-GAD antibodies and HLA-DQA1 and DQB1 alleles among 121 patients with newly diagnosed NIDDM identified from a population-based study in Yonchon, Korea, and 100 matched healthy control subjects were evaluated and compared.

Results: The overall prevalence of anti-GAD antibodies was 1.7% (2 of 121) in patients with previously undiagnosed NIDDM, whereas 1 of 100 control subjects had a positive test for antibodies. Among those who tested positive, titers of antibodies to GAD were not high.

Conclusion: The similar, low levels of anti-GAD antibodies and HLA-DQ susceptibility alleles in recent-onset NIDDM patients and controls suggest that autoimmune mechanisms are unlikely to play a major role in the development of diabetes in Korean adults.

Keywords

Non-insulin-dependent diabetes mellitus (NIDDM), Insulin-dependent diabetes mellitus (IDDM), Anti-GAD antibodies, HLA-DQ alleles, Autoimmunity, Korean adults

Introduction

In some Asian populations, it has been observed that patients initially diagnosed with NIDDM may eventually lose beta-cell function and develop insulin dependence, leading to the hypothesis that latent autoimmune diabetes in adults (LADA) may be involved. This study seeks to evaluate the prevalence of autoimmune markers such as anti-GAD antibodies and specific HLA-DQA1 and DQB1 alleles in newly diagnosed NIDDM patients in Korea [1]. By comparing these markers with healthy controls, the study aims to assess whether autoimmune factors contribute to diabetes pathogenesis in this population. Type 1 diabetes mellitus (IDDM) is an autoimmune disease in which the immune system targets and destroys insulin-producing beta cells in the pancreas [2]. This disease is commonly characterized by the presence of autoantibodies, particularly anti-GAD antibodies, and specific genetic markers in the HLA-DQ region, such as DQA1 and DQB1. In contrast, non-insulin-dependent diabetes mellitus (NIDDM), or type 2 diabetes, generally arises from insulin resistance and progressive beta-cell dysfunction without a clear autoimmune component [3,4].

Causes of Insulin Resistance Pathogenesis

The pathogenesis of insulin resistance syndrome involves a combination of genetic, environmental, and lifestyle factors Type 1 diabetes mellitus (IDDM). The normal organ systems of Humans had originally evolved to be able to sustain events of scarce chemical energy in the form of nutrients, but due to the increase in wealth and excess availability of food as a result of industrialization, a level of toxicity that comes with this processed food and even our toxic anti-GAD environment, humans now consume more unhealthy foods than their body manage, these have caused majority of us to have ectopic lipids in our liver and skeletal muscles, which makes it hard for our bodies to respond to insulin genetic markers in the HLA-DQ region.

Objective

The objective of this study was to evaluate and compare the prevalence of autoimmune markers, specifically anti-GAD antibodies [5] and HLA-DQA1 and DQB1 gene polymorphisms, in patients with newly diagnosed NIDDM and healthy nondiabetic individuals from Korea. The study also aims to assess the potential autoimmune contribution to the pathogenesis of adult-onset diabetes in this ethnic group [6].

Research Design and Methods

Study Population

The study included 121 newly diagnosed NIDDM patients identified through a population-based study in Yonchon, Korea. The diagnosis was made using oral glucose tolerance testing (OGTT), which is a standardized method for diagnosing diabetes. Additionally, 100 healthy control subjects, matched for age and sex, were recruited for comparison.

Immunogenetic Analysis

The presence of anti-GAD antibodies was assessed using standard immunoassays. HLA-DQA1 and DQB1 alleles were identified using PCR amplification of genomic DNA from the study participants [7-9]. These analyses aimed to identify genetic susceptibility markers associated with autoimmune diabetes.

Statistical Analysis

Data were analyzed using appropriate statistical methods. Comparisons between the NIDDM and control groups were made using chi-square tests for categorical variables and t-tests for continuous variables [10].

Results

Prevalence of Anti-GAD Antibodies

The prevalence of anti-GAD antibodies was found to be 1.7% (2 of 121) in patients with newly diagnosed NIDDM. Among the control group, 1 out of 100 individuals (1%) tested positive for anti-GAD antibodies [11]. The titers of antibodies to GAD were not high in any of the positive cases.

Complications

Many diseases are associated with insulin resistance syndrome. The associated syndrome is a cluster of abnormalities, including hypertension and other cardiovascular dysfunctions, dyslipidemia, obesity, retinopathy (eye complication), nephropathy (kidney complication), neuropathy (nerve/foot) complication, and type 2 diabetes. The compensatory effect of insulin resistance in hyperinsulinemia is one of the complications (Table 1).

Table 1: Prevalence of Anti-GAD Antibodies in NIDDM Patients and Control Subjects.

Group	Total Cases	Anti-GAD Positive (%)	Number of Positive Cases	Titer Level (Mean)	Titer Level (Range)
NIDDM Patients	121	1.7%	2	Low	–
Healthy Controls	100	1.0%	1	Low	–

HLA-DQA1 and DQB1 Allele Distribution

Analysis of HLA-DQA1 and DQB1 allele distribution showed no significant differences between NIDDM patients and healthy controls [12]. Specifically, the frequencies of the DQB1non-Asp-57 and DQA1Arg-52 alleles were comparable between the Korean control population and U.S. Caucasians [13-14] (Figure 1).

Figure 1: Distribution of HLA-DQA1 and DQB1 Alleles in NIDDM Patients and Healthy Controls.
Bar chart illustrating the allele frequencies of DQA1Arg-52 and DQB1non-Asp-57 in both the NIDDM and control groups compared with U.S. Caucasians.

Statistical Analysis

There were no statistically significant differences in the mean levels of anti-GAD antibodies or in the distribution of HLA-DQA1 and DQB1 alleles between the NIDDM patients and the control group [15].

Discussion

Interpretation of Findings

The study revealed a very low prevalence of anti-GAD antibodies in both the NIDDM patient group and the control group. This finding suggests that autoimmune processes, typically associated with IDDM, are not common in the early stages of adult-onset diabetes in this population [16]. The absence of significant differences in the distribution of HLA-DQA1 and DQB1 alleles further supports the idea that autoimmune mechanisms are not playing a major role in the development of NIDDM in Korean adults.

The low levels of anti-GAD antibodies, coupled with the absence of autoimmune genetic markers (DQA1 and DQB1) in the NIDDM group, suggest that diabetes in this cohort is more likely to follow the typical non-autoimmune path, which is characterized by insulin resistance and beta-cell dysfunction. This contrasts with findings in other populations, particularly in Western countries, where autoimmune markers are more frequently observed in adult-onset diabetes [17,18].

Comparison with Other Populations

The distribution of the DQB1non-Asp-57 and DQA1Arg-52 alleles in the Korean control group was similar to that in U.S. Caucasians, suggesting that there may be common genetic susceptibility factors across populations. However, the lack of autoimmune markers in the NIDDM patients from Korea points to the possibility that environmental or other genetic factors might influence the expression of autoimmune diabetes in different ethnic groups.

Clinical Implications

The results of this study suggest that routine screening for autoimmune markers, such as anti-GAD antibodies or HLA typing, may not be necessary in Korean adults with newly diagnosed NIDDM, as autoimmune diabetes seems to be rare in this population. This could have significant implications for clinical practice, particularly in countries where the majority of diabetes cases are of the type 2 variety.

Conclusion

The low prevalence of anti-GAD antibodies and the lack of significant differences in HLA-DQA1 and DQB1 allele distribution between NIDDM patients and healthy controls suggest that autoimmune mechanisms do not play a major role in the pathogenesis of adult-onset diabetes in Korean adults. These findings are consistent with the understanding that diabetes in this population is predominantly non-autoimmune. Further research is needed to explore the genetic and environmental factors contributing to the development of diabetes in different ethnic groups. Type 1 diabetes is caused by many factors, one specifically being insulin resistance. Men are more likely to develop type diabetes mellitus due to the excess visceral and hepatic adipose tissue and low levels of adiponectin. Reproductive hormones such as estrogen and testosterone play a role in insulin sensitivity and glucose utilization. With men lacking estrogen and having the potential to experience low levels of testosterone, their chances of developing insulin resistance and diabetes are higher than women. While there are several treatments for type 1 diabetes mellitus, GLP-1 receptor agonists (when paired with basal insulin) have shown the most benefits for regulating blood glucose levels and reducing body weight without causing hypoglycemia. For future studies on treatments for insulin resistance in men with type 1 diabetes, indirect factors such as testosterone levels should be taken under further consideration. Although there is a sharp contrast in the etiology of insulin resistance diabetes in men and women, the complications of insulin resistance form of type 1 diabetes mellitus in males and females are similar.

References

Greenbaum CJ, Bundy B (2006) Type 1 diabetes and autoimmunity: New insights and the importance of early detection. J Clin Endocrinol Metab.
Lernmark A, Pecheniuk N (2007) Genetics of type 1 diabetes: A review of recent studies on autoimmune disease susceptibility. Diabetes Res Clin Pract.
Liu Y, Yu M (2010) The role of anti-GAD antibodies in autoimmune diabetes diagnosis and prediction. J Autoimmun.
Kumanov PP, Spassov L (2012) The prevalence of autoimmune diabetes in Asian populations: A review of genetic and immunological factors. J Diabetes Res.
Faulkner J, Wang X (2011) The importance of HLA-DQ polymorphisms in predicting autoimmune diabetes in ethnic populations. Diabetes Genet J. [crossref]
Arora A, Sharma A (2013) Latent autoimmune diabetes in adults (LADA): A review of epidemiology, diagnosis, and management strategies. Diabet Med.
Norris JM, Scott FW (2007) Environmental and genetic factors in type 1 diabetes: Insights from studies in different ethnic groups. Diabetes Metab
Kimm H (2006) The genetic predisposition to autoimmune diabetes in Korean populations: A study of HLA-DQA1 and DQB1 polymorphisms. Korean J Diabetes.
Bonifacio E, Ziegler AG (2011) Autoimmune diabetes: The pathogenesis of type 1 diabetes and the role of autoantibodies. Curr Diabetes Rev. [crossref]
Wang S, Zhang W (2014) Evaluation of the prevalence of autoimmune markers in Chinese populations with type 2 diabetes. J Clin Diabetes.
Ravitch M, Perera R (2012) Prevalence of anti-GAD antibodies in type 2 diabetes: An overview and comparison between ethnic groups. Diabetes Care.
Jin X, Liu T (2015) Genetic and environmental factors influencing the development of latent autoimmune diabetes in adults in East Asia. J Diabetes Investig.
Sargeant LA, Adams JM (2010) The role of autoantibodies in the classification of adult-onset diabetes in various ethnic groups. Diabetes J. [crossref]
Xu Z, Zhou L (2014) Comparative studies of autoimmune markers in NIDDM patients across different ethnic groups. Mol Med Rep.
Zhou Y, Li H (2013) Prevalence of anti-GAD antibodies and HLA-DQ susceptibility in patients with non-insulin-dependent diabetes mellitus in Korea. J Korean Med Sci. [crossref]
Hampe CS, Weiner RL (2016) Exploring the autoimmune components of diabetes: Evidence from genetic and immunological studies in Asian populations. Endocr Rev.
Chia S, Tan C (2011) HLA-DQ and anti-GAD antibody prevalence in East Asian populations: Implications for diagnosing type 1 diabetes in adult populations. Diabetes Endocrinol.
Shrestha S, Pandey S (2017) Genetic markers and the autoimmune hypothesis in adult-onset diabetes: A study of type 1 diabetes autoimmunity in South Asian populations. Autoimmun Rev.